Covered_Recipient_Type,Noncovered_Recipient_Entity_Name,Teaching_Hospital_CCN,Teaching_Hospital_ID,Teaching_Hospital_Name,Physician_Profile_ID,Physician_First_Name,Physician_Middle_Name,Physician_Last_Name,Physician_Name_Suffix,Recipient_Primary_Business_Street_Address_Line1,Recipient_Primary_Business_Street_Address_Line2,Recipient_City,Recipient_State,Recipient_Zip_Code,Recipient_Country,Recipient_Province,Recipient_Postal_Code,Physician_Primary_Type,Physician_Specialty,Physician_License_State_code1,Physician_License_State_code2,Physician_License_State_code3,Physician_License_State_code4,Physician_License_State_code5,Principal_Investigator_1_Profile_ID,Principal_Investigator_1_First_Name,Principal_Investigator_1_Middle_Name,Principal_Investigator_1_Last_Name,Principal_Investigator_1_Name_Suffix,Principal_Investigator_1_Business_Street_Address_Line1,Principal_Investigator_1_Business_Street_Address_Line2,Principal_Investigator_1_City,Principal_Investigator_1_State,Principal_Investigator_1_Zip_Code,Principal_Investigator_1_Country,Principal_Investigator_1_Province,Principal_Investigator_1_Postal_Code,Principal_Investigator_1_Primary_Type,Principal_Investigator_1_Specialty,Principal_Investigator_1_License_State_code1,Principal_Investigator_1_License_State_code2,Principal_Investigator_1_License_State_code3,Principal_Investigator_1_License_State_code4,Submitting_Applicable_Manufacturer_or_Applicable_GPO_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Country,Related_Product_Indicator,Covered_or_Noncovered_Indicator_1,Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_1,Product_Category_or_Therapeutic_Area_1,Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_1,Associated_Drug_or_Biological_NDC_1,Covered_or_Noncovered_Indicator_2,Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_2,Product_Category_or_Therapeutic_Area_2,Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_2,Associated_Drug_or_Biological_NDC_2,Covered_or_Noncovered_Indicator_3,Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_3,Product_Category_or_Therapeutic_Area_3,Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_3,Associated_Drug_or_Biological_NDC_3,Covered_or_Noncovered_Indicator_4,Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_4,Product_Category_or_Therapeutic_Area_4,Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_4,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Expenditure_Category1,Expenditure_Category2,Preclinical_Research_Indicator,Delay_in_Publication_Indicator,Name_of_Study,Dispute_Status_for_Publication,Record_ID,Program_Year,Payment_Publication_Date,ClinicalTrials_Gov_Identifier,Research_Information_Link,Context_of_Research
Covered Recipient Teaching Hospital,,330055,6109,NEWYORK-PRESBYTERIAN/QUEENS,,,,,,5645 MAIN STREET,,FLUSHING,NY,11355,United States,,,,,,,,,,101526,SETH,H.,GOLDBARG,,5645 MAIN ST,,FLUSHING,NY,11355,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,MA,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,269.76,8/14/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609100571,2018,6/28/2019,,,527533QPEXCELS
Covered Recipient Teaching Hospital,,63301,7107,CHILDRENS HOSPITAL COLORADO,,,,,,13123 EAST 16TH AVENUE,,AURORA,CO,80045,United States,,,,,,,,,,468656,MARISA,A,WIKTOR,,CHILDRENS HOSPITAL COLORADO,,AURORA,CO,80045,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Anesthesiology|Pediatric Anesthesiology,CO,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Covered,Drug,NEUROSCIENCE;PAIN,EMBEDA,60793-430-01,,,,,,,,,,,,,,,6500,4/11/2018,Cash or cash equivalent,,,No,No,AN OPENLABEL STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PF06412528 IN CHILDREN 717 YEARS FOR THE TREATMENT OF MODERATETOSEVERE PAIN,No,599726875,2018,6/28/2019,,,
Covered Recipient Physician,,,,,24562,FRANKLIN,JOSEPH,ZIEVE,,1201 BROAD ROCK BLVD,HUNTER HOLMES MCGUIRE VA MEDICAL CENTER,RICHMOND,VA,23249-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,VA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,SAR439954,,,,,,,,,,,,,,,,19.99,1/27/2018,In-kind items and services,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi",No,601891619,2018,6/28/2019,NCT03315143,,
Covered Recipient Teaching Hospital,,363300,6385,CHILDRENS HOSPITAL MEDICAL CENTER,,,,,,3333 BURNET AVENUE  MLC #4900,,CINCINNATI,OH,45229,United States,,,,,,,,,,368012,SHEHARYAR,RIZWAN,DURRANI,,3333 BURNET AVE,ML 2000,CINCINNATI,OH,45229-3026,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Allergy & Immunology,CO,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Covered,Drug,IMMUNOLOGY,DUPIXENT,0024-5914-01,,,,,,,,,,,,,,,101.34,9/1/2018,In-kind items and services,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Children 6 to <12 Years of Age With Uncontrolled Persistent Asthma",No,601983415,2018,6/28/2019,NCT02948959,,
Covered Recipient Teaching Hospital,,520098,6608,UNIVERSITY OF WI HOSPITALS & CLINICS,,,,,,600 HIGHLAND AVE,,MADISON,WI,53792,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Siemens Medical Solutions USA, Inc.",1.00E+11,"Siemens Medical Solutions USA, Inc.",PA,United States,Yes,Covered,Device,AT - Fixed interventional x-ray/angiography fluoroscopy,Artis zee,,,,,,,,,,,,,,,,42452,10/9/2018,Cash or cash equivalent,,,Yes,No,,No,536780131,2018,6/28/2019,,,
Covered Recipient Physician,,,,,193300,JOSE,D,BURGOS,,4800 ALBERTA AVE,,EL PASO,TX,79905,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,TX,,,,,,,,,,,,,,,,,,,,,,,,ViiV Healthcare Company,1.00E+11,ViiV Healthcare Company,NC,United States,No,,,,,,,,,,,,,,,,,,,,333.85,1/14/2018,In-kind items and services,,,No,No,"A PHASE III, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY",No,590137925,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,330106,6090,NORTH SHORE UNIVERSITY HOSPITAL,,,,,,300 COMMUNITY DRIVE,,MANHASSET,NY,10030,United States,,,,,,,,,,735793,JEFFERY,M,KATZ,,300 COMMUNITY DRIVE,NSUH DEPARTMENT OF NEUROLOGY,MANHASSET,NY,11030,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,NY,,,,Boehringer Ingelheim Corporate Center GmbH,1.00E+11,Boehringer Ingelheim RCV GmbH & Co KG,,Austria,Yes,Covered,Drug,CARDIOVASCULAR,PRADAXA,0597-0108-60,,,,,,,,,,,,,,,34.3,1/31/2018,In-kind items and services,,,No,No,Secondary Prevention of Stroke,No,605005971,2018,6/28/2019,,,
Covered Recipient Physician,,,,,24562,FRANKLIN,JOSEPH,ZIEVE,,1201 BROAD ROCK BLVD,HUNTER HOLMES MCGUIRE VA MEDICAL CENTER,RICHMOND,VA,23249-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,VA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,SAR439954,,,,,,,,,,,,,,,,19.99,1/27/2018,In-kind items and services,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi",No,601891961,2018,6/28/2019,NCT03315143,,
Covered Recipient Teaching Hospital,,220110,6045,BRIGHAM AND WOMENS HOSPITAL,,,,,,75 FRANCIS ST,,BOSTON,MA,2115,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Kowa Holdings America, Inc.",1.00E+11,"Kowa Holdings America, Inc.",NY,United States,No,,,,,,,,,,,,,,,,,,,,25346.68,5/31/2018,Cash or cash equivalent,,,Yes,No,Cardiovascular medicine research,No,544582643,2018,6/28/2019,,,
Covered Recipient Physician,,,,,803928,ARCHANA,C,CHATTERJEE,,1305 W 18TH ST,,SIOUX FALLS,SD,57105,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Infectious Diseases,NE,,,,,,,,,,,,,,,,,,,,,,,,"GlaxoSmithKline, LLC.",1.00E+11,"GlaxoSmithKline, LLC.",NC,United States,No,,,,,,,,,,,,,,,,,,,,640.84,6/30/2018,In-kind items and services,,,No,No,MMR-162,No,593117711,2018,6/28/2019,,,
Covered Recipient Physician,,,,,217468,SETSUKO,K,CHAMBERS,,1515 N CAMPBELL AVE,,TUCSON,AZ,85724-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,AZ,,,,,,,,,,,,,,,,,,,,,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,150,9/1/2018,Cash or cash equivalent,,,No,No,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF NIRAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH HRD-POSITIVE ADVANCED OVARIAN CANCER FOLLOWING RESPONSE ON FRONT-LINE PLATINUM-BASED CHEMOTHERAPY",No,585644315,2018,6/28/2019,NCT02655016,,
Covered Recipient Physician,,,,,341720,CHRISTOPH,P,CANNON,,75 FRANCIS STREET PBB-1,BRIGHAM AND WOMEN'S HOSPITAL CARDIOVASCULAR DIVISION,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,MA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,SAR439954,,,,,,,,,,,,,,,,20,1/28/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi",No,601892273,2018,6/28/2019,NCT03315143,,
Covered Recipient Teaching Hospital,,220110,6045,BRIGHAM AND WOMENS HOSPITAL,,,,,,75 FRANCIS ST,,BOSTON,MA,2115,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Kowa Holdings America, Inc.",1.00E+11,"Kowa Holdings America, Inc.",NY,United States,No,,,,,,,,,,,,,,,,,,,,2644.18,12/10/2018,Cash or cash equivalent,,,Yes,No,Cardiovascular medicine research,No,544583053,2018,6/28/2019,,,
Covered Recipient Physician,,,,,884257,PETER,EDWARD,SILAS,,4401 HARRISON BLVD,,OGDEN,UT,84403,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics,UT,,,,,,,,,,,,,,,,,,,,,,,,"GlaxoSmithKline, LLC.",1.00E+11,"GlaxoSmithKline, LLC.",NC,United States,No,,,,,,,,,,,,,,,,,,,,84.47,10/31/2018,In-kind items and services,,,No,No,EPI-RSV-005 BOD,No,593117811,2018,6/28/2019,,,
Covered Recipient Physician,,,,,799457,GUILLERMO,R,SANCHEZ,,5900 BYRON CENTER AVE SW,,WYOMING,MI,49519-9606,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology,MA,,,,,,,,,,,,,,,,,,,,,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,400,4/12/2018,Cash or cash equivalent,,,No,No,"A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS",No,585644943,2018,6/28/2019,NCT02715284,,
Covered Recipient Physician,,,,,749063,KEVIN,KEITH,COX,,1182 MARIANO DR,,OJAI,CA,93023-3450,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,CA,,,,,,,,,,,,,,,,,,,,,,,,"Otsuka America Pharmaceutical, Inc.",1.00E+11,"Otsuka Pharmaceutical Development & Commercialization, Inc.",NJ,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,367.83,7/9/2018,Cash or cash equivalent,,,No,No,"A PHASE 3, 12-WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-ARM, FIXED-DOSE TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BREXPIPRAZOLE OPC34712 IN THE TREATMENT OF SUBJECTS WITH AGITATION ASSOCIATED WITH DEMENTIA OF THE ALZHEIMERS TYPE",No,606444029,2018,6/28/2019,NCT03548584,https://clinicaltrials.gov/ct2/show/NCT03548584,
Covered Recipient Teaching Hospital,,50573,7302,EISENHOWER MEDICAL CENTER,,,,,,39000 BOB HOPE DRIVE,,RANCHO MIRAGE,CA,92270,United States,,,,,,,,,,226798,LEON,A.,FELDMAN,,39000 BOB HOPE DR STE K403,,RANCHO MIRAGE,CA,92270,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,CA,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,306.54,2/13/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609101601,2018,6/28/2019,,,QP EXCELS003-014
Covered Recipient Teaching Hospital,,220110,6045,BRIGHAM AND WOMENS HOSPITAL,,,,,,75 Francis St,,Boston,MA,2115,United States,,,,,,,,,,176949,CHERYL,A,SADOW,,75 FRANCIS ST,,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Body Imaging,MA,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1880,12/20/2018,Cash or cash equivalent,,,No,No,"A PHASE 1 DOSE ESCALATION AND COHORT EXPANSION STUDY OF TSR-042, AN ANTI-PD-1 MONOCLONAL ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS",No,585645675,2018,6/28/2019,NCT02715284,,
Covered Recipient Teaching Hospital,,160058,6639,UNIVERSITY OF IOWA HOSP & CLINICS,,,,,,200 HAWKINS DRIVE,,IOWA CITY,IA,52242,United States,,,,,,,,,,1134505,LUDWIG,,GUTMANN,,200 HAWKINS DR,DEPT OF NEUROLOGY,IOWA CITY,IA,52242-1009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,IA,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,NO PRODUCT DISCUSSED,,,,,,,,,,,,,,,,35708,4/24/2018,Cash or cash equivalent,,,No,No,NEOGAA EFC14028 Local US Costs,No,601890005,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,460009,7144,U OF U HOSPITALS & CLINICS,,,,,,50 NORTH MEDICAL DRIVE,,SALT LAKE CITY,UT,84132,United States,,,,,,,,,,944265,DJORDJE,,ATANACKOVIC,,30 N 1900 E RM 5C402,,SALT LAKE CITY,UT,84132-2706,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,UT,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,NO PRODUCT DISCUSSED,,,,,,,,,,,,,,,,2315,10/8/2018,Cash or cash equivalent,,,No,No,Pomdesar Myeloma,No,601982005,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,380004,7183,PROVIDENCE ST. VINCENT MEDICAL CTR,,,,,,9205 SW Barnes Rd,,Portland,OR,97225,United States,,,,,,,,,,51865,KIREN,,KRESA-REAHL,,9427 SW Barnes Rd Ste 295,,Portland,OR,97225,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,OR,,,,"Biogen, Inc.",1.00E+11,"Biogen, Inc.",MA,United States,Yes,Covered,Biological,NEUROLOGY,PLEGRIDY,64406-011-01,,,,,,,,,,,,,,,465,2/2/2018,Cash or cash equivalent,,,No,No,Plegridy Observational Program,No,573426201,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,260141,6652,UNIV OF MISSOURI HEALTH CARE,,,,,,ONE HOSPITAL DRIVE,,COLUMBIA,MO,65212,United States,,,,,,,,,,279389,JANE,ANNE,EMERSON,,315 BUSINESS LOOP 70 W,,COLUMBIA,MO,65203,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Physical Medicine & Rehabilitation,MO,,,,"MERZ NORTH AMERICA, INC.",1.00E+11,"MERZ NORTH AMERICA, INC.",NC,United States,Yes,Covered,Biological,MUSCULOSKELETAL,XEOMIN,0259-1610-01,,,,,,,,,,,,,,,1318.83,1/17/2018,Cash or cash equivalent,,,No,No,"PROSPECTIVE, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PARALLEL GROUP, DOSE RESPONSE STUDY OF THREE DOSES XEOMIN (INCOBOTULINUMTOXINA, NT 201) FOR THE TREATMENT OF UPPER LIMB SPASTICITY ALONE OR COMBINED UPPER AND LOWER LIMB SPASTICITY IN CHILDREN AND ADOLESCENTS (AGE 2   17 YEARS) WITH CEREBRAL PALSY",No,613716105,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,90004,6745,GEORGETOWN UNIVERSITY HOSPITAL,,,,,,"3800 Reservoir Rd., NW",,Washington,DC,20007,United States,,,,,,,,,,1303097,MICHAEL,JON,PISHVAIAN,,3800 RESERVOIR RD NW,PODIUM B,WASHINGTON,DC,20007-2113,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,DC,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,52.5,8/30/2018,Cash or cash equivalent,,,No,No,"Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Arginase Inhibitor INCB001158 (Formerly Known as CB1158) as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors",No,576948161,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,440039,6471,VANDERBILT UNIVERSITY MEDICAL CENTER,,,,,,1211 Medical Center Drive,,Nashville,TN,37232,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Tactile Systems Technology Inc,1.00E+11,Tactile Systems Technology Inc,MN,United States,Yes,Covered,Device,Advanced Pneumatic Compression,,,,,,,,,,,,,,,,,45690,9/30/2018,Cash or cash equivalent,,,No,No,A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment,No,535540813,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50243,7058,DESERT HOSPITAL,,,,,,1150 N INDIAN CANYON DR,,PALM SPRINGS,CA,92262,United States,,,,,,,,,,117887,ELBER,S,CAMACHO,,1180 N INDIAN CANYON DR,W201,PALM SPRINGS,CA,92262,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,CA,,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,Herceptin,50242-134-68,Covered,Biological,BioOncology,Perjeta,50242-145-01,,,,,,,,,,783.9,6/8/2018,Cash or cash equivalent,,,No,No,SYSTHERS REGISTRY,No,590720737,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,450076,7039,UT MD ANDERSON CANCER CENTER,,,,,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,,,,,,,,189527,VIVEK,,SUBBIAH,,1515 HOLCOMBE BLVD,# 87,HOUSTON,TX,77030-4000,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,TX,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,4301.45,3/15/2018,Cash or cash equivalent,,,No,No,M15-819,No,566838963,2018,6/28/2019,NCT02955251,,
Covered Recipient Teaching Hospital,,50625,7268,CEDARS-SINAI MEDICAL CENTER,,,,,,8700 Beverly Blvd,,Los Angeles,CA,90048,United States,,,,,,,,,,996345,TIMOTHY,J,DASKIVICH,,CHS 66 124,CHS 66 124,LOS ANGELES,CA,90095-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Urology,CA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,19007.66,8/20/2018,In-kind items and services,,,No,No,A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab MK-3475 inSubjects with High Risk Non-muscle Invasive Bladder Cancer NMIBC Unresponsive toBacillus Calmette-Guerin BCG Therapy,No,607104979,2018,6/28/2019,,,Study drug provided to a clinical study site.
Covered Recipient Physician,,,,,1180388,MARIOS,,PRIKIS,,"1 SOUTH PROSPECT STREET, UHC, REHAB 2",,BURLINGTON,VT,5401,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,IL,,,,,,,,,,,,,,,,,,,,,,,,GE HEALTHCARE,1.00E+11,GE HEALTHCARE,WI,United States,Yes,Covered,Drug,CONTRAST MEDIA,VISIPAQUE,0407-2222-01,,,,,,,,,,,,,,,247,5/19/2018,In-kind items and services,,,No,No,"PARALLEL-GROUP, PLACEBO CONTROLLED RANDOMISED STUDY INVESTIGATING THE EFFECT OF INTRAVENOUS ISO-OSMOLAR IODINATED CONTRAST MATERIAL IODIXANOL (VISIPAQUE INJECTION 320MGI/ML) ON RENAL FUNCTION IN ADULTS WITH CHRONIC KIDNEY DISEASE(CKD) STAGE III OR IV WHO HAVE UNDERGONE ENDOVASCULAR ANEURYSM REPAIR (EVAR)",No,615614153,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,90004,6745,GEORGETOWN UNIVERSITY HOSPITAL,,,,,,"3800 Reservoir Rd., NW",,Washington,DC,20007,United States,,,,,,,,,,1303097,MICHAEL,JON,PISHVAIAN,,3800 RESERVOIR RD NW,PODIUM B,WASHINGTON,DC,20007-2113,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,DC,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,1761.48,9/29/2018,Cash or cash equivalent,,,No,No,"Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Arginase Inhibitor INCB001158 (Formerly Known as CB1158) as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors",No,576948417,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,160104,6506,TRINITY BETTENDORF,,,,,,4500 UTICA RIDGE ROAD,,BETTENDORF,IA,52722,United States,,,,,,,,,,45952,SANJEEV,H,PURI,,1100 36TH AVENUE,,MOLINE,IL,61265,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,IA,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Covered,Drug,CARDIOVASCULAR,PRALUENT,0024-5901-00,,,,,,,,,,,,,,,35955,2/22/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently E",No,601890663,2018,6/28/2019,NCT01663402,,
Covered Recipient Teaching Hospital,,464009,7145,U OF UTAH NEUROPSYCHIATRIC INSTITUTE,,,,,,501 CHIPETA WAY,,SALT LAKE CITY,UT,84108,United States,,,,,,,,,,1055103,THERESA,LOUISE,WERNER,,2000 CIRCLE OF HOPE DR,408,SALT LAKE CITY,UT,84112,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,UT,,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,Herceptin,50242-134-68,Covered,Biological,BioOncology,Perjeta,50242-145-01,,,,,,,,,,8955,4/23/2018,Cash or cash equivalent,,,No,No,PERJETA SAFETY STUDY IN NEO ADJUVANT BC,No,590721047,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50348,7281,UCI MEDICAL CENTER,,,,,,101 THE CITY DRIVE SOUTH,,ORANGE,CA,92868,United States,,,,,,,,,,236348,DAWN,M,LOMBARDO,,101 THE CITY DR S,,ORANGE,CA,92868-3201,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,CA,,,,Boehringer Ingelheim Corporate Center GmbH,1.00E+11,Boehringer Ingelheim International GmbH,,Germany,Yes,Covered,Drug,DIABETES,JARDIANCE,0597-0152-30,,,,,,,,,,,,,,,21.46,10/2/2018,In-kind items and services,,,No,No,Empagliflozin and Heart failure (HFrEF),No,606860355,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,90004,6745,GEORGETOWN UNIVERSITY HOSPITAL,,,,,,"3800 Reservoir Rd., NW",,Washington,DC,20007,United States,,,,,,,,,,1303097,MICHAEL,JON,PISHVAIAN,,3800 RESERVOIR RD NW,PODIUM B,WASHINGTON,DC,20007-2113,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,DC,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,94.5,11/14/2018,Cash or cash equivalent,,,No,No,"Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Arginase Inhibitor INCB001158 (Formerly Known as CB1158) as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors",No,576948621,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,359820,PETER,E,BRESSLER,,9301 N CENTRAL EXPY,TOWER II SUITE 570,DALLAS,TX,75231-0806,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",TX,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,SAR439954,,,,,,,,,,,,,,,,112.86,1/25/2018,In-kind items and services,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi",No,601890951,2018,6/28/2019,NCT03315143,,
Covered Recipient Teaching Hospital,,330055,6109,NEWYORK-PRESBYTERIAN/QUEENS,,,,,,5645 MAIN STREET,,FLUSHING,NY,11355,United States,,,,,,,,,,101526,SETH,H.,GOLDBARG,,5645 MAIN ST,,FLUSHING,NY,11355,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,MA,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Siello,,,,,,,,,,,,,,,,227.5,4/3/2018,Cash or cash equivalent,,,No,No,SIELLO,No,609100315,2018,6/28/2019,,,SIELLO019-008K1
Covered Recipient Teaching Hospital,,220110,6045,BRIGHAM AND WOMENS HOSPITAL,,,,,,75 FRANCIS STREET,,BOSTON,MA,2115,United States,,,,,,,,,,1252637,RAMIN,,KHORASANI,,75 FRANCIS ST,,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology,MA,,,,GE HEALTHCARE,1.00E+11,GE HEALTHCARE,WI,United States,No,,,,,,,,,,,,,,,,,,,,72000,2/8/2018,Cash or cash equivalent,,,No,No,LICENSING OF TECHNOLOGY TO BETTER MANAGE CRITICAL RADIOLOGY FINDINGS,No,615615369,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,90004,6745,GEORGETOWN UNIVERSITY HOSPITAL,,,,,,"3800 Reservoir Rd., NW",,Washington,DC,20007,United States,,,,,,,,,,937495,GEOFFREY,,GIBNEY,,3970 RESERVOIR RD NW,,WASHINGTON,DC,20007-2126,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,CT,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,17.9,11/28/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2, Open Label, Dose Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies",No,576948737,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,24562,FRANKLIN,JOSEPH,ZIEVE,,1201 BROAD ROCK BLVD,HUNTER HOLMES MCGUIRE VA MEDICAL CENTER,RICHMOND,VA,23249-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,VA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,SAR439954,,,,,,,,,,,,,,,,17.39,1/26/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardi",No,601891275,2018,6/28/2019,NCT03315143,,
Covered Recipient Teaching Hospital,,30103,7141,MAYO CLINIC HOSPITAL,,,,,,5777 EAST MAYO BLVD,,PHOENIX,AZ,85054,United States,,,,,,,,,,231330,SHYAMAL,H,MEHTA,,13400 E SHEA BLVD,,SCOTTSDALE,AZ,85259,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,AZ,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,GZ402671,,,,,,,,,,,,,,,,61,7/1/2018,In-kind items and services,,,No,No,"Multicenter, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of GZ/SAR402671 in Patients With Early-stage Parkinson's Disease",No,601983163,2018,6/28/2019,NCT02906020,,
Covered Recipient Teaching Hospital,,100271,6858,H. LEE MOFFITT CANCER CENTER,,,,,,12902 Magnolia Dr,,Tampa,FL,33612,United States,,,,,,,,,,870590,SOLMAZ,,SAHEBJAM,,123 SUMMER STREET,SAINT VINCENT HOSPITAL DEPARTMENT OF MEDICINE,WORCESTER,MA,1608,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,FL,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,141,12/20/2018,Cash or cash equivalent,,,No,No,"A Platform Study Exploring the Safety, Tolerability, Effect on the Tumor Microenvironment, and Efficacy of INCB Combinations in Advanced Solid Tumors",No,576949307,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,50573,7302,EISENHOWER MEDICAL CENTER,,,,,,39000 BOB HOPE DRIVE,,RANCHO MIRAGE,CA,92270,United States,,,,,,,,,,226798,LEON,A.,FELDMAN,,39000 BOB HOPE DR STE K403,,RANCHO MIRAGE,CA,92270,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,CA,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,306.54,4/3/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609101857,2018,6/28/2019,,,QP EXCELS003-009
Covered Recipient Teaching Hospital,,360180,6422,CLEVELAND CLINIC HOSPITAL,,,,,,9500 Euclid Ave,,Cleveland,OH,44195,United States,,,,,,,,,,271117,PETER,GRAHAM,ROSE,,9500 EUCLID AVE,,CLEVELAND,OH,44195-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,OH,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,32922,1/3/2018,In-kind items and services,,,No,No,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF NIRAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH HRD-POSITIVE ADVANCED OVARIAN CANCER FOLLOWING RESPONSE ON FRONT-LINE PLATINUM-BASED CHEMOTHERAPY",No,585646397,2018,6/28/2019,NCT02655016,,
Covered Recipient Teaching Hospital,,50573,7302,EISENHOWER MEDICAL CENTER,,,,,,39000 BOB HOPE DRIVE,,RANCHO MIRAGE,CA,92270,United States,,,,,,,,,,226798,LEON,A.,FELDMAN,,39000 BOB HOPE DR STE K403,,RANCHO MIRAGE,CA,92270,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,CA,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Plexa,,,,,,,,,,,,,,,,43.23,8/14/2018,Cash or cash equivalent,,,No,No,Plexa,No,609102113,2018,6/28/2019,,,527160PLEXA
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 Brookline Ave,,Boston,MA,2215,United States,,,,,,,,,,873117,JAMES,M,CLEARY,,44 BINNEY ST,DANA-FARBER CANCER INSTITUTE,BOSTON,MA,02115-6013,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MA,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,51852.15,10/23/2018,In-kind items and services,,,No,No,Niraparib in Patients With Pancreatic Cancer,No,585647121,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,340061,6797,UNIVERSITY OF NORTH CAROLINA HOSP.,,,,,,101 MANNING DRIVE,,Chapel Hill,NC,27514,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pelvalon Inc.,1.00E+11,Pelvalon Inc.,CA,United States,No,,,,,,,,,,,,,,,,,,,,4907,12/14/2018,Cash or cash equivalent,,,No,No,LIBERATE,No,584370343,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,310001,6235,HACKENSACK UNIVERSITY MEDICAL CENTER,,,,,,30 Prospect Ave,,Hackensack,NJ,7601,United States,,,,,,,,,,206058,MARTIN,,GUTIERREZ,,92 SECOND STREET,,HACKENSACK,NJ,7601,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,FL,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,32.02,3/28/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies",No,576949531,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,193711,EMILY,,BECKER,,7979 WURZBACH RD FL 3,,SAN ANTONIO,TX,78229,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,CA,,,,,,,,,,,,,,,,,,,,,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Dermatology,Otezla,59572-630-27,,,,,,,,,,,,,,,1966,3/20/2018,In-kind items and services,,,No,No,CC-10004-PPSO-001,No,595023228,2018,6/28/2019,,,
Covered Recipient Physician,,,,,303222,BRADLEY,S,GIEDD,,1928 HOWELL BRANCH RD,,WINTER PARK,FL,32792-1013,United States,,,Doctor of Optometry,Eye and Vision Services Providers|Optometrist,FL,,,,,,,,,,,,,,,,,,,,,,,,Alcon Research Ltd,1.00E+11,Alcon Research Ltd,TX,United States,Yes,Non-Covered,Device,,DD T2,,,,,,,,,,,,,,,,293.8,1/29/2018,Cash or cash equivalent,,,No,No,Clinical Evaluation of the Safety and Performance of a Novel Daily Disposable Contact Lens (DD SiHy Sphere Tier 2),No,572712777,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,330154,6126,MEMORIAL HOSPITAL FOR CANCER AND ALL,,,,,,1275 YORK AVENUE,,NEW YORK,NY,10065,United States,,,,,,,,,,97612,ROBERT,J,MOTZER,,1275 YORK AVE,,NEW YORK,NY,10021-6007,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,NY,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,2599,12/4/2018,Cash or cash equivalent,,,No,No,"A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma",No,608371209,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,30013,7143,YUMA REGIONAL MEDICAL CENTER,,,,,,2400 S AVE A,,YUMA,AZ,85364,United States,,,,,,,,,,25917,JOSEPH,AR,CARDENAS,,2400 S AVENUE A,ATTN YRMC RESEARCH,PHOENIX,AZ,85021,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,AZ,,,,"Cardinal Health, Inc.",1.00E+11,"Cardinal Health 200, LLC",OH,United States,Yes,Covered,Device,Cardiovascular,FlexStent Femoropopliteal Self Expanding Stent System,,,,,,,,,,,,,,,,1312.5,4/2/2018,Cash or cash equivalent,,,No,No,Cordis OPEN,No,613790035,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,30087,7138,SCOTTSDALE SHEA MEDICAL CENTER,,,,,,9003 E Shea Blvd,,Scottsdale,AZ,85260,United States,,,,,,,,,,34591,JASGIT,C,SACHDEV,,1931 E BRENTRUP DR,,TEMPE,AZ,85283-4926,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,AR,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,50976,9/5/2018,In-kind items and services,,,No,No,Study of Niraparib or Carboplatin-Paclitaxel in Combination With TSR-042 or With TSR-042 and Bevacizumab,No,585652599,2018,6/28/2019,NCT03307785,,
Covered Recipient Teaching Hospital,,230053,6543,HENRY FORD HOSPITAL,,,,,,10300 W 8 Mile Rd,,Ferndale,MI,48220,United States,,,,,,,,,,134239,DING,,WANG,,KARMANOS CANCER CENTER,4100 JOHN R HWCRC 4TH FL,DETROIT,MI,48201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,24.6,6/27/2018,Cash or cash equivalent,,,No,No,"A Platform Study Exploring the Safety, Tolerability, Effects on the Tumor Microenvironment, and Efficacy of Pembrolizumab (MK 3475) plus INCB Combinations in Advanced Solid Tumors",No,576950311,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,220110,6045,BRIGHAM AND WOMENS HOSPITAL,,,,,,75 FRANCIS STREET,3714,BOSTON,MA,2115,United States,,,,,,,,,,83876,FREDERICK,GP,WELT,,30 N 1900 E,,Salt Lake City,UT,84132,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,MA,,,,Edwards Lifesciences Corporation,1.00E+11,Edwards Lifesciences Corporation,CA,United States,Yes,Covered,Device,Transcatheter Heart Valves,Edwards SAPIEN XT Transcatheter Heart Valve,,,,,,,,,,,,,,,,5250,5/16/2018,Cash or cash equivalent,,,No,No,PARTNER II 2010-12,No,616303327,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360180,6422,CLEVELAND CLINIC HOSPITAL,,,,,,9500 EUCLID AVE,,CLEVELAND,OH,44195,United States,,,,,,,,,,179406,SEAN,PATRICK,LYDEN,,6000 W CREEK RD STE 10,,INDEPENDENCE,OH,44131,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery,OH,,,,"Cardinal Health, Inc.",1.00E+11,"Cardinal Health 200, LLC",OH,United States,Yes,Covered,Device,Cardiovascular,INCRAFT  AAA Stent Graft System,,,,,,,,,,,,,,,,1250,10/15/2018,Cash or cash equivalent,,,No,No,INSPIRATION,No,613790185,2018,6/28/2019,,,
Covered Recipient Physician,,,,,122454,DARREN,,BRENNAN,,55 Lake Ave N,,Worcester,MA,1655,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology,MA,,,,,,,,,,,,,,,,,,,,,,,,Bristol-Myers Squibb Company,1.00E+11,"E.R. Squibb & Sons, L.L.C.",NJ,United States,Yes,Covered,Biological,Oncology,OPDIVO,0003-3774-12,,,,,,,,,,,,,,,1940,1/4/2018,Cash or cash equivalent,,,No,No,A Phase 3 Randomized Open Label Study of Nivolumab Combined With Ipilimumab Versus Sunitinib Monotherapy in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma,No,566780013,2018,6/28/2019,NCT02231749,,
Covered Recipient Teaching Hospital,,500027,7156,SWEDISH MEDICAL CENTER,,,,,,747 Broadway,,Seattle,WA,98122,United States,,,,,,,,,,306575,JOSHUA,Z,PRESS,,1101 MADISON ST,SUITE 1500,SEATTLE,WA,98104,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology,WA,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,448,8/7/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients with HRD-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy",No,585653275,2018,6/28/2019,NCT02655016,,
Covered Recipient Teaching Hospital,,230053,6543,HENRY FORD HOSPITAL,,,,,,10300 W 8 Mile Rd,,Ferndale,MI,48220,United States,,,,,,,,,,134239,DING,,WANG,,KARMANOS CANCER CENTER,4100 JOHN R HWCRC 4TH FL,DETROIT,MI,48201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,15.4,7/23/2018,Cash or cash equivalent,,,No,No,"Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Arginase Inhibitor INCB001158 (Formerly Known as CB1158) as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors",No,576950423,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,100271,6858,H. LEE MOFFITT CANCER CENTER,,,,,,12902 Magnolia Dr,,Tampa,FL,33612,United States,,,,,,,,,,270265,ALBERTO,A,CHIAPPORI,,12902 USF MAGNOLIA DR,,TAMPA,FL,33612-9416,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,FL,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,32937,1/22/2018,Cash or cash equivalent,Other,,No,No,"ALTA Ph2 Multicenter, Randomized Study",No,586469313,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220071,6048,MASSACHUSETTS GENERAL HOSPITAL,,,,,,FRUIT STREET,,BOSTON,MA,2114,United States,,,,,,,,,,157723,JONATHAN,JAMES,PASSERI,,32 Fruit St Ste 5B,,Boston,MA,02114-2620,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,MA,,,,Edwards Lifesciences Corporation,1.00E+11,Edwards Lifesciences Corporation,CA,United States,Yes,Covered,Device,Transcatheter Heart Valves,Edwards SAPIEN XT Transcatheter Heart Valve,,,,,,,,,,,,,,,,2000,5/16/2018,Cash or cash equivalent,,,No,No,PARTNER II 2010-12,No,616303583,2018,6/28/2019,,,
Covered Recipient Physician,,,,,973320,KARTIK,,KONDURI,,3410 WORTH ST,,DALLAS,TX,75246,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,TX,,,,,,,,,,,,,,,,,,,,,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Oncology,Abraxane,68817-134-50,,,,,,,,,,,,,,,482,5/23/2018,Cash or cash equivalent,,,No,No,ABI-007-NSCL-005,No,595024682,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,520089,6591,MERITER HOSPITAL  INC.,,,,,,202 SOUTH PARK STREET,,MADISON,WI,53715,United States,,,,,,,,,,351834,DAVID,H,LEWIS,,2601 W. BELTLINE HWY,,MADISON,WI,53713,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,WI,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Nutrition and Weight Loss,Belviq,62856-529-60,,,,,,,,,,,,,,,603.13,5/31/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors",No,608371739,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,500008,7176,UNIVERSITY OF WASHINGTON MED CTR,,,,,,1959 NE Pacific St,,Seattle,WA,98195,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Biological,Lower GI,Entyvio,64764-300-20,,,,,,,,,,,,,,,8650.8,3/12/2018,Cash or cash equivalent,Other,,No,No,A Phase 4 Open-Label Study to Evaluate Vedolizumab IV Dose Optimization on Treatment Outcomes In Nonresponders With Moderately to Severely Active Ulcerative Colitis ENTERPRET,No,586465027,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,500027,7156,SWEDISH MEDICAL CENTER,,,,,,747 BROADWAY,,SEATTLE,WA,98122,United States,,,,,,,,,,60322,PHILIP,J,MEASE,,1101 MADISON ST STE 1000,,SEATTLE,WA,98104-3556,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,WA,,,,"UCB, Inc.",1.00E+11,UCB SA,,Belgium,No,,,,,,,,,,,,,,,,,,,,1500,5/4/2018,Cash or cash equivalent,,,No,No,"A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, DOSE-RANGING STUDY TO EVALUATETHE EFFICACY AND SAFETY OF BIMEKIZUMAB IN ACTIVEPSORIATIC ARTHRITIS",No,593508615,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,380009,7189,OHSU HOSPITAL AND CLINICS,,,,,,3181 SAM JACKSON PARK ROAD,,PORTLAND,OR,97239,United States,,,,,,,,,,1027644,CHAFIC,,KARAM,,3303 SW BOND AVE STE 8,,PORTLAND,OR,97239-4501,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,NC,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,GZ402666,,,,,,,,,,,,,,,,91,9/1/2018,In-kind items and services,,,No,No,"A Phase 3 Randomized, Multicenter, Multinational, Double-blinded Study Comparing the Efficacy and Safety of Repeated Biweekly Infusions of NeoGAA (GZ402666) and Alglucosidase Alfa in Treatment-naive P",No,601985197,2018,6/28/2019,NCT02782741,,
Covered Recipient Teaching Hospital,,450054,7024,SCOTT AND WHITE MEMORIAL HOSPITAL,,,,,,2401 S 31ST ST,,TEMPLE,TX,76508,United States,,,,,,,,,,1148902,VINIT,,KARUR,,2401 S 31ST ST DEPT OF HEMATOLOGY AND ONCOLOGY,,TEMPLE,TX,76508,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,PA,TX,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology/Immunology,Rituxan,50242-053-06,Covered,Biological,BioOncology,GAZYVA,50242-070-01,Covered,Biological,BioOncology,VENCLEXTA,0074-0579-28,Non-Covered,Drug,None,Non-Covered Product,1000,4/2/2018,Cash or cash equivalent,,,No,No,OBINUTUZUMAB GAZYVA POLATUZUMAB VEDOTIN VENETOCLAX GDC 0199 IN RR FL DLBCL,No,590724109,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,500027,7156,SWEDISH MEDICAL CENTER,,,,,,747 Broadway,,Seattle,WA,98122,United States,,,,,,,,,,50364,JAMES,,BOWEN,,12333 NE 130TH LN,SUITE 225,KIRKLAND,WA,98034-7467,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,WA,,,,"Alkermes, Inc.",1.00E+11,"Alkermes, Inc.",MA,United States,Yes,Covered,Drug,CNS,DIMETHYL FUMARATE,,Non-Covered,,,,,,,,,,,,,,50,11/1/2018,In-kind items and services,,,No,No,"A Two-Part, Phase 2/3, Randomized Study in Subjects with Relapsing Remitting Multiple Sclerosis (RRMS) to Evaluate the Tolerability of ALKS 8700 Compared with DIMETHYL FUMARATE and the Long-Term Safety and Tolerability of ALKS 8700",No,561739861,2018,6/28/2019,NCT02634307,,
Covered Recipient Teaching Hospital,,360137,6438,UH CLEVELAND MEDICAL CENTER,,,,,,11100 EUCLID AVENUE,,CLEVELAND,OH,44106,United States,,,,,,,,,,861978,AFSHIN,,DOWLATI,,11100 EUCLID AVE,,CLEVELAND,OH,44106-1716,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,OH,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,5900,3/22/2018,Cash or cash equivalent,,,No,No,M16-296,No,566841527,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,100007,6839,FLORIDA HOSPITAL,,,,,,601 EAST ROLLINS STREET,,ORLANDO,FL,32803,United States,,,,,,,,,,216440,KEVIN,DONN,ACCOLA,,217 Hillcrest St,,Orlando,FL,32801-1211,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery),FL,,,,Edwards Lifesciences Corporation,1.00E+11,Edwards Lifesciences Corporation,CA,United States,Yes,Covered,Device,Pericardial Heart Valves,EDWARDS INTUITY Elite valve system,,,,,,,,,,,,,,,,140,5/3/2018,Cash or cash equivalent,,,No,No,TRANSFORM 2011-02,No,616301775,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,140067,6532,SAINT FRANCIS MEDICAL CENTER,,,,,,530 NE Glen Oak Ave,,Peoria,IL,61637,United States,,,,,,,,,,291059,DENNIS,,GARWACKI,,Medical Office,200 E Pennsylvania Ave Ste 101,Peoria,IL,61603-3084,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,IL,,,,"Biogen, Inc.",1.00E+11,"Biogen, Inc.",MA,United States,Yes,Covered,Drug,NEUROLOGY,TECFIDERA,64406-006-02,,,,,,,,,,,,,,,700,5/7/2018,Cash or cash equivalent,,,No,No,Dimethyl Fumarate (DMF) Observational Study,No,573431449,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360134,6376,GOOD SAMARITAN HOSPITAL,,,,,,375 DIXMYTH AVENUE,,CINCINNATI,OH,45220,United States,,,,,,,,,,129044,PUVI,N.,SESHIAH,,3219 Clifton Ave,Ste 400,Cincinnati,OH,45220,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,OH,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Transcatheter Valve Systems,CoreValve Evolut,,,,,,,,,,,,,,,,5196,7/17/2018,Cash or cash equivalent,,,No,No,CoreValve SURTAVI,No,572114987,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,210004,6734,HOLY CROSS HOSPITAL,,,,,,1500 Forest Glen Road,,Silver Spring,MD,20904,United States,,,,,,,,,,957507,JAMES,F,BARTER,,6301 EXECUTIVE BLVD,,ROCKVILLE,MD,20852-3905,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,DC,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,69136.2,10/31/2018,In-kind items and services,,,No,No,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF NIRAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH HRD-POSITIVE ADVANCED OVARIAN CANCER FOLLOWING RESPONSE ON FRONT-LINE PLATINUM-BASED CHEMOTHERAPY",No,585648669,2018,6/28/2019,NCT02655016,,
Covered Recipient Teaching Hospital,,310001,6235,HACKENSACK UNIVERSITY MEDICAL CENTER,,,,,,30 Prospect Ave,,Hackensack,NJ,7601,United States,,,,,,,,,,206058,MARTIN,,GUTIERREZ,,92 SECOND STREET,,HACKENSACK,NJ,7601,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,FL,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,17.9,5/25/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2, Open Label, Dose Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies",No,576949763,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,57683,RONALD,D,PERRONE,,750 WASHINGTON ST,NEMC BOX 836,BOSTON,MA,02111-1526,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,MA,,,,,,,,,,,,,,,,,,,,,,,,"Otsuka America Pharmaceutical, Inc.",1.00E+11,"Otsuka Pharmaceutical Development & Commercialization, Inc.",NJ,United States,Yes,Covered,Drug,NEPHROLOGY,TOLVAPTAN,59148-020-50,,,,,,,,,,,,,,,417.97,10/23/2018,Cash or cash equivalent,,,No,No,"A PHASE 3B, MULTI-CENTER, OPEN-LABEL TRIAL TO EVALUATE THE LONG TERM SAFETY OF TITRATED IMMEDIATE-RELEASE TOLVAPTAN OPC-41061, 30 MG TO 120 MGDAY, SPLIT DOSE IN SUBJECTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE",No,606444561,2018,6/28/2019,NCT02251275,https://clinicaltrials.gov/ct2/show/NCT02251275,
Covered Recipient Teaching Hospital,,300003,6031,MARY HITCHCOCK MEMORIAL HOSP,,,,,,ONE MEDICAL CENTER DRIVE,,LEBANON,NH,3756,United States,,,,,,,,,,448666,RICHARD,A,MORSE,,215 N MAIN ST,,WHITE RIVER JUNCTION,VT,05009-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology,NH,,,,"UCB, Inc.",1.00E+11,UCB Biosciences Inc.,NC,United States,Yes,Covered,Drug,Neurology,Vimpat,0131-2478-35,,,,,,,,,,,,,,,10862.91,2/9/2018,Cash or cash equivalent,,,No,No,"A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PEDIATRIC SUBJECTS WITH EPILEPSY WITH PARTIAL ONSET SEIZURES",No,592950669,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360180,6422,CLEVELAND CLINIC HOSPITAL,,,,,,9500 EUCLID AVENUE,,CLEVELAND,OH,44195,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Edwards Lifesciences Corporation,1.00E+11,Edwards Lifesciences Corporation,CA,United States,Yes,Covered,Device,Transcatheter Heart Valves,Edwards SAPIEN 3 Transcatheter Heart Valve,,,,,,,,,,,,,,,,10770,8/1/2018,Cash or cash equivalent,,,No,No,Safety and Effectiveness of Edwards Lifesciences SAPIEN XT Transcatheter Heart Valve THV in the Chinese Population,No,616302031,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,10033,6942,UNIVERSITY OF ALABAMA HOSPITAL,,,,,,619 SOUTH 19TH STREET,,BIRMINGHAM,AL,35233,United States,,,,,,,,,,1161414,SAHAR,,FATHALLAH SHAYKH,,1600 7TH AVE SO,ACC 516,BIRMINGHAM,AL,35233-1711,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Nephrology,AL,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Covered,Drug,RARE DISEASE METABOLIC,HECTOROL,58468-0121-1,,,,,,,,,,,,,,,705.18,3/26/2018,In-kind items and services,,,No,No,"An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol (Doxercalciferol Capsules) in Pediatric Patients With Chronic Kidney Disease Stages 3 and 4 With Secondary",No,601894295,2018,6/28/2019,NCT02859896,,
Covered Recipient Physician,,,,,321779,STEFAN,S,SCHNEIDER,,1050 LINDEN AVE,,LONG BEACH,CA,90813,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,CA,,,,,,,,,,,,,,,,,,,,,,,,ViiV Healthcare Company,1.00E+11,ViiV Healthcare Company,NC,United States,No,,,,,,,,,,,,,,,,,,,,91.04,3/28/2018,Cash or cash equivalent,,,No,No,"A PHASE III, RANDOMIZED, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY",No,590140563,2018,6/28/2019,,,
Covered Recipient Physician,,,,,1053333,Nedim,,Durakovic,,4545 FOREST PARK AVE,APT 516,Saint Lous,MO,63108,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Otolaryngology,MO,,,,,160658,Craig,,Buchman,,4921 PARKVIEW PL,STE 11A,Saint Lous,MO,63110,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Otolaryngology,MO,,,,Cochlear Ltd,1.00E+11,Cochlear Americas,CO,United States,Yes,Covered,Device,Implantable hearing solution,Nucleus,,Covered,Device,Implantable hearing solution,Baha,,,,,,,,,,,143.65,2/9/2018,Cash or cash equivalent,,,No,No,Clinical Evaluation of the Cochlear Nucleus CI532 Cochlear Implant in Adults,No,569551383,2018,6/28/2019,,,Food and beverage associated with Investigator Meeting
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,2082,SHELLY,MARIE,SEWARD,,4100 JOHN R ST,KARMANOS CANCER CENTER,DETROIT,MI,48201-2013,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,FL,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,38232,6/13/2018,In-kind items and services,,,No,No,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,No,585649467,2018,6/28/2019,NCT02657889,,
Covered Recipient Teaching Hospital,,50017,7234,MERCY GENERAL HOSPITAL,,,,,,4001 J STREET,,SACRAMENTO,CA,95819,United States,,,,,,,,,,17992,ALLEN,S.,MORRIS,,4001 J Street,,Sacramento,CA,95819,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery),CA,,,,Edwards Lifesciences Corporation,1.00E+11,Edwards Lifesciences Corporation,CA,United States,Yes,Covered,Device,Pericardial Heart Valves,EDWARDS INTUITY Elite valve system,,,,,,,,,,,,,,,,44935,8/29/2018,Cash or cash equivalent,,,No,No,TRANSFORM 2011-02,No,616302291,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,330285,6190,STRONG MEMORIAL HOSPITAL,,,,,,601 Elmwood Ave,,Rochester,NY,14642,United States,,,,,,,,,,636294,MEGAN,,HYLAND,,Bldg C,919 Westfall Rd Ste 220,Rochester,NY,14618-2628,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,NY,,,,"Biogen, Inc.",1.00E+11,"Biogen, Inc.",MA,United States,No,,,,,,,,,,,,,,,,,,,,54178.8,12/6/2018,Cash or cash equivalent,,,No,No,MS PATHS Normative Sub-Study,No,573432301,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,363300,6385,CHILDRENS HOSPITAL MEDICAL CENTER,,,,,,3333 BURNET AVENUE MLC 4900,,CINCINNATI,OH,45229,United States,,,,,,,,,,142114,RICHARD,J.,CZOSEK,,3333 Burnet Ave,5021,Cincinnati,OH,45229,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Cardiology,KY,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Cardiac Diagnostics and Monitoring,Reveal XT,,,,,,,,,,,,,,,,572.93,10/24/2018,Cash or cash equivalent,,,No,No,Investigator Sponsored Research,No,572115567,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,380017,7180,LEGACY GOOD SAMARITAN HOSPITAL,,,,,,1200 NW 23rd Ave,,Portland,OR,97210,United States,,,,,,,,,,855909,WILLIAM,EDWARD,WINTER,III,265 N BROADWAY ST,,PORTLAND,OR,97227-1800,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,OR,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,131688,8/15/2018,In-kind items and services,,,No,No,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF NIRAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH HRD-POSITIVE ADVANCED OVARIAN CANCER FOLLOWING RESPONSE ON FRONT-LINE PLATINUM-BASED CHEMOTHERAPY",No,585650289,2018,6/28/2019,NCT02655016,,
Covered Recipient Teaching Hospital,,140067,6532,SAINT FRANCIS MEDICAL CENTER,,,,,,530 NE GLEN OAK AVENUE,,PEORIA,IL,61637,United States,,,,,,,,,,837468,MICHAEL,Y,XU,,530 NE GLEN OAK AVE,,PEORIA,IL,61637-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,IL,MI,,,"UCB, Inc.",1.00E+11,UCB Biosciences Inc.,NC,United States,Yes,Covered,Drug,Neurology,Briviact,50474-370-66,,,,,,,,,,,,,,,11393.9,7/10/2018,Cash or cash equivalent,,,No,No,"An open-label, multinational, multicenter, follow-up study to evaluate the long-term safety and efficacy of brivaracetam, used at a flexible dose up to a maximum of 200 mg/day, in subjects aged 16 years or older suffering from epilepsy.",No,592951017,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,54144,7262,LANGLEY PORTER PSYCHIATRIC HOSPITAL,,,,,,405 PARNASUS,,SAN FRANCISCO,CA,94143,United States,,,,,,,,,,215449,SIBEL,,DEVIREN,,UNIV OF CALIFORNIA SAN FRANCISCO,500 PARNASSUS AVE MU320W,SAN FRANCISCO,CA,94143,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Orthopaedic Surgery,CA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,16090.52,3/26/2018,Cash or cash equivalent,,,No,No,A PHASE 2B RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF STAPHYLOCOCCUS AUREUS 4 ANTIGEN VACCINE SA4AG IN ADULTS UNDERGOING ELECTIVE OPEN POSTERIOR SPINAL FUSION PROCEDURES WITH MULTILEVEL INSTRUMENTATION,No,599732149,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,464009,7145,U OF UTAH NEUROPSYCHIATRIC INSTITUTE,,,,,,501 CHIPETA WAY,,SALT LAKE CITY,UT,84108,United States,,,,,,,,,,378521,ROBERT,GEORGE,GRAY,,3773 W 12600 S,,RIVERTON,UT,84065,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Cardiology,UT,,,,Edwards Lifesciences Corporation,1.00E+11,Edwards Lifesciences Corporation,CA,United States,Yes,Covered,Device,Transcatheter Heart Valves,Edwards SAPIEN 3 Transcatheter Heart Valve,,,,,,,,,,,,,,,,17555.4,6/20/2018,Cash or cash equivalent,,,No,No,COMPASSION S3 2015-01,No,616302547,2018,6/28/2019,,,
Covered Recipient Physician,,,,,138897,ALEXANDRA,,KIMBALL,,330 BROOKLINE AVE,,BOSTON,MA,2215,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,MA,,,,,,,,,,,,,,,,,,,,,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Dermatology,Otezla,59572-630-27,,,,,,,,,,,,,,,1524,3/20/2018,In-kind items and services,,,No,No,CC-10004-PSOR-008,No,595021799,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,450076,7039,UT MD ANDERSON CANCER CENTER,,,,,,1515 Holcombe Blvd,,Houston,TX,77030,United States,,,,,,,,,,251902,NATHAN,,FOWLER,,1515 Holcombe Blvd,Unit 428,Houston,TX,77030,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,TX,,,,"Pharmacyclics LLC, An AbbVie Company",1.00E+11,"Pharmacyclics LLC, An AbbVie Company",CA,United States,Yes,Covered,Drug,Oncology,Ibrutinib,,,,,,,,,,,,,,,,287.77,11/8/2018,Cash or cash equivalent,,,No,No,PCYC-1145-LT,No,583186063,2018,6/28/2019,,,Extended treatment protocol for subjects continuing to benefit from ibrutinib after completion of ibrutinib clinical trials
Covered Recipient Teaching Hospital,,210044,6748,GREATER BALTIMORE MEDICAL CENTER,,,,,,6701 N Charles St,,Baltimore,MD,21204,United States,,,,,,,,,,10169,Brian,,Kaplan,,6565 N CHARLES ST,SUITE 601,BALTIMORE,MD,21204,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Otolaryngology,MD,,,,Cochlear Ltd,1.00E+11,Cochlear Americas,CO,United States,Yes,Covered,Device,Implantable hearing solution,Nucleus,,Covered,Device,Implantable hearing solution,Baha,,,,,,,,,,,265.1,8/29/2018,Cash or cash equivalent,,,No,No,Nucleus Hybrid L24 Implant System New Enrollment Post Approval Study,No,569552981,2018,6/28/2019,,,Research Support
Covered Recipient Teaching Hospital,,420004,6808,MEDICAL UNIVERSITY OF SOUTH CAROLINA,,,,,,169 Ashley Ave,,Charleston,SC,29403,United States,,,,,,,,,,362665,TOMMY,RICHARD,BUCHANAN,JR.,171 ASHLEY AVE,,CHARLESTON,SC,29425-8908,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology,MO,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,49383,3/28/2018,In-kind items and services,,,No,No,"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF NIRAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH HRD-POSITIVE ADVANCED OVARIAN CANCER FOLLOWING RESPONSE ON FRONT-LINE PLATINUM-BASED CHEMOTHERAPY",No,585651043,2018,6/28/2019,NCT02655016,,
Covered Recipient Teaching Hospital,,440039,6471,VANDERBILT UNIVERSITY MEDICAL CENTER,,,,,,1211 Medical Center Drive,,Nashville,TN,37232,United States,,,,,,,,,,165213,DAWN,M,BORROMEO BEAULIEU,,1211 21ST AVE SOUTH,,NASHVILLE,TN,37232-2702,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,TN,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Biological,Lower GI,Entyvio,64764-300-20,,,,,,,,,,,,,,,17895,3/29/2018,Cash or cash equivalent,Other,,No,No,A Randomized Double-Blind Phase 4 Study to Evaluate the Safety and Efficacy of 2  Dose Regimens of Entyvio Vedolizumab in the Treatment of Fistulizing Crohns Disease,No,586467783,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,2301 COMMONWEALTH BLVD,,ANN ARBOR,MI,48105,United States,,,,,,,,,,341112,PETER,DOYLE,HIGGINS,,1500 E MEDICAL CENTER DR,1500 E MEDICAL CENTER DRIVE,ANN ARBOR,MI,48109,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,MI,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,3225,6/13/2018,Cash or cash equivalent,,,No,No,A MULTICENTER OPENLABEL EXTENSION STUDY TO ASSESS LONGTERM SAFETY OF PF00547659 IN SUBJECTS WITH ULCERATIVE COLITIS TURANDOT II,No,599732785,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,390111,6278,HOSPITAL OF THE UNIV OF PENNA,,,,,,3400 SPRUCE STREET,,PHILADELPHIA,PA,19104,United States,,,,,,,,,,338281,WILSON,Y.,SZETO,,51 N 39th St Ste 2A,,Philadelphia,PA,19104-2640,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery),PA,,,,Edwards Lifesciences Corporation,1.00E+11,Edwards Lifesciences Corporation,CA,United States,Yes,Covered,Device,Transcatheter Heart Valves,Edwards SAPIEN 3 Transcatheter Heart Valve,,,,,,,,,,,,,,,,12256.22,5/1/2018,Cash or cash equivalent,,,No,No,COMPASSION S3 2015-01,No,616302807,2018,6/28/2019,,,
Covered Recipient Physician,,,,,416726,CHRISTY,,SAMARAS,,9500 EUCLID AVE,DESK R35,CLEVELAND,OH,44195,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MI,,,,,,,,,,,,,,,,,,,,,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Hematology / Oncology,Pomalyst,59572-502-00,,,,,,,,,,,,,,,442,8/1/2018,In-kind items and services,,,No,No,CC-4047-MM-007,No,595022482,2018,6/28/2019,,,
Covered Recipient Physician,,,,,116924,BRADLEY,N,HINES,,3445 POPLAR AVE,SUITE 7,MEMPHIS,TN,38111-4667,United States,,,Doctor of Optometry,Eye and Vision Services Providers|Optometrist,TN,,,,,,,,,,,,,,,,,,,,,,,,Alcon Research Ltd,1.00E+11,Alcon Research Ltd,TX,United States,Yes,Non-Covered,Device,,DD T2,,,,,,,,,,,,,,,,293.8,1/29/2018,Cash or cash equivalent,,,No,No,Clinical Evaluation of the Safety and Performance of a Novel Daily Disposable Contact Lens (DD SiHy Sphere Tier 2),No,572712315,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,330154,6126,MEMORIAL HOSPITAL FOR CANCER AND ALL,,,,,,1275 YORK AVENUE,,NEW YORK,NY,10065,United States,,,,,,,,,,97612,ROBERT,J,MOTZER,,1275 YORK AVE,,NEW YORK,NY,10021-6007,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,NY,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,1593,9/4/2018,Cash or cash equivalent,,,No,No,"A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma",No,608370897,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,240038,6510,UNITED HOSPITAL,,,,,,1625 RADIO DR,SUITE 250,WOODBURY,MN,55125,United States,,,,,,,,,,81430,MICHAELA,,TSAI,,910 E 26TH ST,,MINNEAPOLIS,MN,55404,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MN,,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,Herceptin,50242-134-68,Covered,Biological,BioOncology,Perjeta,50242-145-01,,,,,,,,,,200.7,4/20/2018,Cash or cash equivalent,,,No,No,PATRICIA,No,590725893,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,330101,6149,NEW YORK PRESBYTERIAN HOSPITAL,,,,,,525 E 68th St,,New York,NY,10065,United States,,,,,,,,,,212827,ELOISE,,CHAPMAN DAVIS,,525 E 68TH ST STE J-130,,NEW YORK,NY,10065-4870,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,IL,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,1482.75,5/22/2018,Cash or cash equivalent,,,No,No,PHASE 12 CLINICAL STUDY OF NIRAPARIB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ADVANCED OR METASTATIC TRIPLE-NEGATIVE BREAST CANCER AND IN PATIENTS WITH RECURRENT OVARIAN CANCER,No,585651753,2018,6/28/2019,NCT02657889,,
Covered Recipient Teaching Hospital,,230053,6543,HENRY FORD HOSPITAL,,,,,,10300 W 8 Mile Rd,,Ferndale,MI,48220,United States,,,,,,,,,,134239,DING,,WANG,,KARMANOS CANCER CENTER,4100 JOHN R HWCRC 4TH FL,DETROIT,MI,48201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,57,3/28/2018,Cash or cash equivalent,,,No,No,"A Platform Study Exploring the Safety, Tolerability, Effects on the Tumor Microenvironment, and Efficacy of Pembrolizumab (MK 3475) plus INCB Combinations in Advanced Solid Tumors",No,576950199,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,190036,6987,OCHSNER CLINIC FOUNDATION,,,,,,1516 JEFFERSON HIGHWAY,,NEW ORLEANS,LA,70121,United States,,,,,,,,,,411712,JULIA,B,GARCIA-DIAZ,,1514 JEFFERSON HWY,,NEW ORLEANS,LA,70121,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,LA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1787.85,2/21/2018,Cash or cash equivalent,,,No,No,A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER,No,599733393,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360180,6422,CLEVELAND CLINIC HOSPITAL,,,,,,9500 EUCLID AVENUE,,CLEVELAND,OH,44195,United States,,,,,,,,,,1207881,BRENT,ROBERT,BLUETT,,213 QUARRY RD RM 2851,,PALO ALTO,CA,94304-1416,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,CA,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,23634.62,5/18/2018,Cash or cash equivalent,,,No,No,M15-562,No,566845629,2018,6/28/2019,NCT02985879,,
Covered Recipient Teaching Hospital,,520138,6589,AURORA HEALTH CARE METRO INC.,,,,,,2900 WEST OKLAHOMA AVENUE,,MILWAUKEE,WI,53215,United States,,,,,,,,,,223001,ANWER,Ali,DHALA,,2801 W Kinnickinnic River Pkwy,Ste 777,Milwaukee,WI,53215,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,WI,,,,"Medtronic, Inc.",1.00E+11,"Medtronic, Inc.",MN,United States,Yes,Covered,Device,Leads,Attain,,Covered,Device,Leads,Sprint Quattro,,Covered,Device,Leads,Performa,,Covered,Device,Leads,Capsure,150,5/30/2018,Cash or cash equivalent,,,No,No,PSR-CVG,No,572078415,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360242,6389,OHIO STATE UNIVERSITY JAMES CANCER H,,,,,,300 W 10th Ave,,Columbus,OH,43210,United States,,,,,,,,,,919966,JAMES,,CHEN,,460 W 10TH AVE,,COLUMBUS,OH,43210-1240,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,IL,,,,"Foundation Medicine, Inc.",1.00E+11,"Foundation Medicine, Inc.",MA,United States,Yes,Covered,Device,ONCOLOGY,FOUNDATIONACT,,,,,,,,,,,,,,,,2500,9/30/2018,In-kind items and services,,,No,No,SARCOMA,No,585899991,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,978948,ANTHONY,,SHIELDS,,4100 JOHN R HWCRC 4TH FL,KARMANOS CANCER CENTER,DETROIT,MI,48201-2013,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,622,3/30/2018,Cash or cash equivalent,,,No,No,"Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies",No,576951437,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,140119,6486,RUSH UNIVERSITY MEDICAL CENTER,,,,,,1653 W Congress Pkwy,,Chicago,IL,60612,United States,,,,,,,,,,92766,RAJ,C,SHAH,,600 S PAULINA ST,,CHICAGO,IL,60612-3806,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,IL,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Drug,Diabetes,Actos,64764-301-14,,,,,,,,,,,,,,,202,2/28/2018,In-kind items and services,Other,,No,No,Study to Qualify a Biomarker to Identify Subjects at Risk for MCI due to AD and to Evaluate Efficacy and Safety of Pioglitazone in Delaying Onset of MCI due to AD,No,586474243,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 JOHN R,,DETROIT,MI,48201,United States,,,,,,,,,,379693,ABHINAV,,DEOL,,4100 JOHN R ST,,DETROIT,MI,48201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MI,,,,"Seattle Genetics, Inc.",1.00E+11,"Seattle Genetics, Inc.",WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,165,1/17/2018,Cash or cash equivalent,,,No,No,Phase 1 study of SGN-CD352A in patients with relapsed or refractory multiple myeloma,No,611523803,2018,6/28/2019,NCT02954796,https://clinicaltrials.gov/ct2/show/NCT02954796,
Covered Recipient Teaching Hospital,,50348,7281,UCI MEDICAL CENTER,,,,,,101 THE CITY DRIVE SOUTH,,ORANGE,CA,92868,United States,,,,,,,,,,60796,TAHSEEN,,MOZAFFAR,,200 S. MANCHESTER AVENUE STE. 110,UCI MEDICAL CENTER,ORANGE,CA,92868,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,CA,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,GZ402666,,,,,,,,,,,,,,,,11055,8/15/2018,In-kind items and services,,,No,No,"A Phase 3 Randomized, Multicenter, Multinational, Double-blinded Study Comparing the Efficacy and Safety of Repeated Biweekly Infusions of NeoGAA (GZ402666) and Alglucosidase Alfa in Treatment-naive P",No,601989343,2018,6/28/2019,NCT02782741,,
Covered Recipient Teaching Hospital,,450051,7043,METHODIST DALLAS MEDICAL CENTER,,,,,,3500 WEST WHEATLAND RD,225357,Dallas,TX,75203,United States,,,,,,,,,,123736,Islam,,Shahin,,1750 N Hampton Raod,,DeSoto,TX,75115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology,TX,,,,Sirtex Medical Inc,1.00E+11,Sirtex Medical Inc,MA,United States,Yes,Covered,Device,Interventional Oncology,SIR-Spheres Microspheres,,,,,,,,,,,,,,,,150,7/31/2018,Cash or cash equivalent,,,No,No,RESiN Registry,No,614584151,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 JOHN R,,DETROIT,MI,48201,United States,,,,,,,,,,259127,ELISABETH,ILJAS,HEATH,,4100 JOHN R ST,,DETROIT,MI,48201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,"Seattle Genetics, Inc.",1.00E+11,"Seattle Genetics, Inc.",WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1320,12/19/2018,Cash or cash equivalent,,,No,No,"A single-arm, open-label, multicenter study of enfortumab vedotin ASG-22CE for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor CPI therapy",No,611524073,2018,6/28/2019,NCT03219333,https://clinicaltrials.gov/ct2/show/NCT03219333,
Covered Recipient Teaching Hospital,,220071,6048,MASSACHUSETTS GENERAL HOSPITAL,,,,,,55 Fruit St,Bulfinch 360,Boston,MA,2114,United States,,,,,,,,,,669507,GREGORY,D,LEWIS,,55 FRUIT ST,GRB 740 BIGELOW TEACHING SERVICE INPATIENT & CARDIOLOG,BOSTON,MA,02114-2696,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,MA,,,,"Actelion Pharmaceuticals US, Inc.",1.00E+11,"Actelion Clinical Research, Inc.",NJ,United States,Yes,Covered,Drug,CARDIOVASCULAR DISORDERS,OPSUMIT MACITENTAN,66215-501-30,,,,,,,,,,,,,,,40.06,12/31/2018,In-kind items and services,,,No,No,SERENADE - AC055G202,No,551885755,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,301351,ULKA,NITIN,VAISHAMPAYAN,,4100 JOHN R HWCRC 4TH FL,,DETROIT,MI,48201-2013,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Drug,Oncology,Opdivo,0003-3772-11,,,,,,,,,,,,,,,5280,6/4/2018,Cash or cash equivalent,Other,,No,No,A Phase 1b Study to Evaluate TAK-659 in Combination With Nivolumab in Patients With Advanced Solid Tumors,No,586475289,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,500036,7159,YAKIMA VALLEY MEMORIAL HOSPITAL,,,,,,2811 TIETON DRIVE,,YAKIMA,WA,98902,United States,,,,,,,,,,241583,VICKY,E,JONES,,808 N 39TH AVE,,YAKIMA,WA,98902-6388,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,WA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,956,1/15/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Phase 2 Trial to Assess Safety and Efficacy of Lenvatinib at Two Different Starting Doses (18 mg vs. 14 mg QD) in Combination With Everolimus (5 mg QD) in Renal Cell Carcinoma Following One Prior VEGF-Targeted Treatment",No,608376841,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 BROOKLINE AVE,,BOSTON,MA,2215,United States,,,,,,,,,,306854,DAVID,C,FISHER,,44 BINNEY ST,D1830,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Ontak,62856-603-01,,,,,,,,,,,,,,,2587,10/2/2018,Cash or cash equivalent,,,No,No,A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous T-Cell Lymphoma,No,608741955,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,70006,6081,THE STAMFORD HOSPITAL,,,,,,30 SHELBURNE RD,,STAMFORD,CT,6904,United States,,,,,,,,,,89893,KWOK MING,STEVE,LO,,34 SHELBURNE RD,,STAMFORD,CT,6902,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,CT,,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,TECENTRIQ,50242-917-01,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,14178.49,10/23/2018,Cash or cash equivalent,,,No,No,PHASE 3 STUDY OF ANTI PDL1 WITH ABRAXANE IN TN MBC,No,590730853,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,945091,HIRVA,MANSURALI,MAMDANI,,4100 JOHN R ST,,DETROIT,MI,48201-2013,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,IN,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,15950,12/18/2018,Cash or cash equivalent,Other,,No,No,"A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive ALK+, Advanced Non-Small-Cell Lung Cancer NSCLC Progressed on Alectinib or Ceritinib",No,586475757,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,40020,6974,ST BERNARDS MEDICAL CENTER,,,,,,225 E Jackson Ave,,Jonesboro,AR,72401,United States,,,,,,,,,,57073,MARC,,MONTE,,300 CARSON ST,,JONESBORO,AR,72401,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,AR,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Hematology / Oncology,Revlimid,59572-405-28,,,,,,,,,,,,,,,5350,1/29/2018,Cash or cash equivalent,,,No,No,Celgene - Connect MDSAML,No,595032655,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,10087,6936,UNIV OF SOUTH ALABAMA MEDICAL CENTER,,,,,,2451 Fillingim St,,Mobile,AL,36617,United States,,,,,,,,,,1095946,RODNEY,P,ROCCONI,,1660 SPRINGHILL AVENUE,,MOBILE,AL,36640-0430,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,AL,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,26762.4,10/22/2018,In-kind items and services,,,No,No,"Phase 2, A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy",No,585654018,2018,6/28/2019,NCT03326193,,
Covered Recipient Teaching Hospital,,230053,6543,HENRY FORD HOSPITAL,,,,,,10300 W 8 Mile Rd,,Ferndale,MI,48220,United States,,,,,,,,,,134239,DING,,WANG,,KARMANOS CANCER CENTER,4100 JOHN R HWCRC 4TH FL,DETROIT,MI,48201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,25.9,7/26/2018,Cash or cash equivalent,,,No,No,"Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Oral Doses of the Arginase Inhibitor INCB001158 (Formerly Known as CB1158) as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors",No,576950541,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,286824,MICHAEL,,MCCLEOD,,8931 COLONIAL CENTER DRIVE,300,FORT MYERS,FL,33905,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,FL,,,,,,,,,,,,,,,,,,,,,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Oncology,Abraxane,68817-134-50,,,,,,,,,,,,,,,4510.75,1/26/2018,Cash or cash equivalent,,,No,No,ABI-007-NSCL-003,No,595025421,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230222,6540,MIDMICHIGAN MEDICAL CTR,,,,,,4000 WELLNESS DR,,MIDLAND,MI,48670,United States,,,,,,,,,,9863,WILLIAM,R,FELTEN,,301 W WACKERLY ST,,MIDLAND,MI,48640-2761,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,MI,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Nutrition and Weight Loss,Belviq,62856-529-60,,,,,,,,,,,,,,,97,2/28/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors",No,608372001,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,240080,6620,UNIVERSITY OF MINNESOTA MEDICAL CTR,,,,,,2450 Riverside Ave,,Minneapolis,MN,55454,United States,,,,,,,,,,284842,MELISSA,A,GELLER,,UNIVERSITY OF MINNESOTA PHYSICIANS,516 DELAWARE STREET SE PWB FIRST FLOOR CLINIC 1C,MINNEAPOLIS,MN,55455,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,MN,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,8102.7,6/5/2018,Cash or cash equivalent,,,No,No,A STUDY OF NIRAPARIB IN PATIENTS WITH OVARIAN CANCER WHO HAVE RECEIVED AT LEAST THREE PREVIOUS CHEMOTHERAPY REGIMENS,No,585654743,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,100006,6851,ORLANDO HEALTH,,,,,,1414 Kuhl Ave,,Orlando,FL,32806,United States,,,,,,,,,,99196,NAREN,RAJ,RAMAKRISHNA,,1400 S ORANGE AVE,,ORLANDO,FL,32806,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology,FL,,,,Novocure Inc.,1.00E+11,Novocure Inc.,NH,United States,Yes,Covered,Device,Oncology,Optune,,,,,,,,,,,,,,,,6175,4/20/2018,Cash or cash equivalent,Patient Care,,No,No,"EF-25  Pivotal, oopen-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)",No,605968553,2018,6/28/2019,,,
Covered Recipient Physician,,,,,1223061,NILANJAN,,GHOSH,,1021 Morehead Medical Dr,Ste A,Charlotte,NC,28204,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,NC,,,,,,,,,,,,,,,,,,,,,,,,"Pharmacyclics LLC, An AbbVie Company",1.00E+11,"Pharmacyclics LLC, An AbbVie Company",CA,United States,Yes,Covered,Drug,Oncology,Ibrutinib,,,,,,,,,,,,,,,,44.9,10/18/2018,Cash or cash equivalent,,,No,No,PCYC-1143-CA,No,583188399,2018,6/28/2019,,,Phase 3 Study of Ibrutinib in Combination with Venetoclax in Subjects with Mantle Cell Lymphoma
Covered Recipient Teaching Hospital,,230222,6540,MIDMICHIGAN MEDICAL CTR,,,,,,4000 WELLNESS DR,,MIDLAND,MI,48670,United States,,,,,,,,,,9863,WILLIAM,R,FELTEN,,301 W WACKERLY ST,,MIDLAND,MI,48640-2761,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,MI,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Nutrition and Weight Loss,Belviq,62856-529-60,,,,,,,,,,,,,,,640.74,5/31/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors",No,608372271,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 BROOKLINE AVE,,BOSTON,MA,2215,United States,,,,,,,,,,3650813,MARISSA,DIANE,WASSERMAN,,75 FRANCIS ST,,BOSTON,MA,02115-6110,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Anesthesiology,MA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,2004.6,7/3/2018,Cash or cash equivalent,,,No,No,"A Single-arm, Multicenter, Phase 2 Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease",No,608736011,2018,6/28/2019,,,
Covered Recipient Physician,,,,,119220,GREGORIO,A,CORTES-MAISONET,,1826 AVE FERNANDEZ JUNCOS,,SAN JUAN,PR,909,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|General Practice,PR,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,1.00E+11,Eli Lilly Export S.A. Puerto Rico Branch,PR,United States,Yes,Covered,Drug,Diabetes,TRULICITY,0002-1433-80,,,,,,,,,,,,,,,32985,12/10/2018,Cash or cash equivalent,,,No,No,"A RANDOMIZED, DOUBLE-BLIND, PARALLEL ARM STUDY OF THE EFFICACY AND SAFETY OF INVESTIGATIONAL DULAGLUTIDE DOSES WHEN ADDED TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS",No,559141711,2018,6/28/2019,NCT03495102,https://clinicaltrials.gov/ct2/show/NCT03495102,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"
Covered Recipient Teaching Hospital,,450076,7039,UT MD ANDERSON CANCER CENTER,,,,,,1515 Holcombe Blvd,,Houston,TX,77030,United States,,,,,,,,,,2776390,TIMOTHY,A,YAP,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,TX,,,,"TESARO, Inc.",1.00E+11,"TESARO, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,ZEJULA,69656-103-90,,,,,,,,,,,,,,,165672,9/24/2018,In-kind items and services,,,No,No,Study of Niraparib or Carboplatin-Paclitaxel in Combination With TSR-042 or With TSR-042 and Bevacizumab,No,585655493,2018,6/28/2019,NCT03307785,,
Covered Recipient Physician,,,,,42589,RICHARD,STEVEN,BERCIK,,800 HOWARD AVE,YALE PHYSICIANS BUILDING- 3RD FLOOR,NEW HAVEN,CT,06519-1369,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecology,CT,,,,,,,,,,,,,,,,,,,,,,,,Coloplast Corp,1.00E+11,Coloplast Corp,MN,United States,Yes,Covered,Device,PELVIC FLOOR REPAIR,RESTORELLE,,,,,,,,,,,,,,,,1681.33,8/17/2018,Cash or cash equivalent,,,No,No,RESTORELLE,No,585806633,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,390111,6278,HOSPITAL OF THE UNIV OF PENNA,,,,,,3701 Market St,,Phila,PA,19104,United States,,,,,,,,,,1153048,GREGORY,,BEATTY,,3400 CIVIC CENTER BOULEVARD,,PHILADELPHIA,PA,19104-5127,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,PA,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,377.16,1/26/2018,Cash or cash equivalent,,,No,No,"A Phase 1, 2, Open Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors, ECHO 207/KEYNOTE 723",No,576950767,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,30103,7141,MAYO CLINIC HOSPITAL,,,,,,5777 E Mayo Blvd,,Phoenix,AZ,85054,United States,,,,,,,,,,309547,TERENCE,TAI WENG,SIO,,13400 E SHEA BLVD,,SCOTTSDALE,AZ,85259,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology,AZ,,,,Novocure Inc.,1.00E+11,Novocure Inc.,NH,United States,Yes,Covered,Device,Oncology,Optune,,,,,,,,,,,,,,,,13000,4/20/2018,Cash or cash equivalent,Patient Care,,No,No,"EF-25  Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)",No,605968653,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,260020,6643,MERCY HOSPITAL - ST. LOUIS,,,,,,615 S New Ballas Rd,,Saint Louis,MO,63141,United States,,,,,,,,,,84842,GEORGE,M,MATUSCHAK,,621 S NEW BALLAS RD,SUITE 228A,SAINT LOUIS,MO,63141-8232,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,MO,,,,"Actelion Pharmaceuticals US, Inc.",1.00E+11,"Actelion Pharmaceuticals, Ltd",CA,United States,Yes,Covered,Drug,CARDIOVASCULAR DISORDERS,OPSUMIT MACITENTAN,66215-501-30,,,,,,,,,,,,,,,900,1/19/2018,Cash or cash equivalent,,,No,No,OPUS - AC-055-503,No,551889875,2018,6/28/2019,NCT02126943,http://clinicaltrials.gov/ct2/show/NCT02126943?term=opus+actelion&rank=1,
Covered Recipient Teaching Hospital,,230038,6550,SPECTRUM HEALTH HOSPITALS,,,,,,100 MICHIGAN NE,,GRAND RAPIDS,MI,49503,United States,,,,,,,,,,243949,WILLIAM,M.,MERHI,,100 Michigan ST NE,Ste 8860,Grand Rapids,MI,49503,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,MI,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,4170,10/16/2018,Cash or cash equivalent,,,No,No,Evolut 34R Addendum,No,572117975,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,200033,6028,EASTERN MAINE MEDICAL CENTER,,,,,,489 STATE STREET,404,BANGOR,ME,4401,United States,,,,,,,,,,633591,SPYRIDON,T.,AKRIVAKIS,,1 NORTHEAST DR,,BANGOR,ME,4401,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,MA,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,50,5/8/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609107173,2018,6/28/2019,,,519228QPEXCELS
Covered Recipient Physician,,,,,49608,DANIEL,M,KATZ,,1 WEBSTER AVE,STE 300,POUGHKEEPSIE,NY,12601-1361,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Urology,NY,,,,,,,,,,,,,,,,,,,,,,,,Coloplast Corp,1.00E+11,Coloplast Corp,MN,United States,Yes,Covered,Device,PELVIC FLOOR REPAIR,RESTORELLE,,,,,,,,,,,,,,,,865,5/11/2018,Cash or cash equivalent,,,No,No,RESTORELLE,No,585807123,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,390111,6278,HOSPITAL OF THE UNIV OF PENNA,,,,,,3701 Market St,,Phila,PA,19104,United States,,,,,,,,,,928426,ERLENE,,SEYMOUR,,4201 SAINT ANTOINE ST,STE 7B,DETROIT,MI,48201-2153,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,95,5/1/2018,Cash or cash equivalent,,,No,No,"An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203)",No,576950881,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,440039,6471,VANDERBILT UNIVERSITY MEDICAL CENTER,,,,,,1211 MEDICAL CENTER DRIVE,,NASHVILLE,TN,37232,United States,,,,,,,,,,165213,DAWN,M,BORROMEO BEAULIEU,,1211 21ST AVE S STE 220,,NASHVILLE,TN,37212,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,TN,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1500,7/11/2018,Cash or cash equivalent,,,No,No,A PHASE 2B DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED PARALLEL GROUP DOSE RANGING STUDY OF ORAL PF06651600 AND PF06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS,No,599737111,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220086,6042,BETH ISRAEL DEACONESS MEDICAL CENTER,,,,,,330 Brookline Ave,ST 207,Boston,MA,919,United States,,,,,,,,,,470147,JACALYN,,ROSENBLATT,,330 BROOKLINE AVENUE KS-121,BETH ISRAEL DEACONESS HOSPITAL,BOSTON,MA,2215,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,MA,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Hematology / Oncology,Pomalyst,59572-502-00,,,,,,,,,,,,,,,21814,2/23/2018,Cash or cash equivalent,,,No,No,CC-4047-MM-007,No,595027534,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,140119,6486,RUSH UNIVERSITY MEDICAL CENTER,,,,,,1653 W. CONGRESS PARKWAY,,CHICAGO,IL,60612,United States,,,,,,,,,,1269562,LUBOV,F,ROMANTSEVA,,1725 W HARRISON ST STE 718,"DEPARTMENT OF PEDIATRICS, SECTION OF CHILD NEUROLOGY",CHICAGO,IL,60612-3863,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology,IL,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Neurology,Fycompa,62856-272-30,,,,,,,,,,,,,,,774,3/1/2018,Cash or cash equivalent,,,No,No,"An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures",No,608372971,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,70010,6069,BRIDGEPORT HOSPITAL,,,,,,267 GRANT STREET,,BRIDGEPORT,CT,6610,United States,,,,,,,,,,30490,STUART,W,ZARICH,,226 MILL HILL AVE,3RD FLOOR,BRIDGEPORT,CT,06610-2811,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,CT,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Nutrition and Weight Loss,Belviq,62856-529-60,,,,,,,,,,,,,,,81,1/30/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors",No,608738695,2018,6/28/2019,,,
Covered Recipient Physician,,,,,104792,REBECCA,J,MCCRERY,,10707 PACIFIC ST,SUITE 101,OMAHA,NE,68114-4762,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Urology,IA,,,,,,,,,,,,,,,,,,,,,,,,Coloplast Corp,1.00E+11,Coloplast Corp,MN,United States,Yes,Covered,Device,PELVIC FLOOR REPAIR,RESTORELLE,,,,,,,,,,,,,,,,1600,9/13/2018,Cash or cash equivalent,,,No,No,RESTORELLE,No,585807617,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,150056,6466,INDIANA UNIVERSITY HEALTH,,,,,,1701 N Senate,,Indianapolis,IN,46202,United States,,,,,,,,,,34159,RAFAT,,ABONOUR,,535 BARNHILL DR,,INDIANAPOLIS,IN,46202-5116,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,IN,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Drug,Oncology,Ninlaro,63020-079-02,,,,,,,,,,,,,,,13.16,10/3/2018,In-kind items and services,Other,,No,No,Study of Dexamethasone Plus IXAZOMIB MLN9708 or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain AL Amyloidosis,No,586472071,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,330182,6114,ST. FRANCIS HOSPITAL,,,,,,100 PORT WASHINGTON BLVD,,ROSLYN,NY,11576,United States,,,,,,,,,,309082,GEORGE,A.,PETROSSIAN,,2200 Northern Blvd,Ste 112,Greenvale,NY,11548,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|General Practice,NY,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,750,7/26/2018,Cash or cash equivalent,,,No,No,Evolut R US IDE,No,572118605,2018,6/28/2019,,,
Covered Recipient Physician,,,,,41721,SHERRY,,THOMAS,,12626 RIVERSIDE DR,411,NORTH HOLLYWOOD,CA,91607-3420,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology,CA,,,,,,,,,,,,,,,,,,,,,,,,Coloplast Corp,1.00E+11,Coloplast Corp,MN,United States,Yes,Covered,Device,PELVIC FLOOR REPAIR,RESTORELLE,,,,,,,,,,,,,,,,4144.77,5/11/2018,Cash or cash equivalent,,,No,No,RESTORELLE,No,585808109,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360035,6393,MOUNT CARMEL HEALTH,,,,,,793 WEST STATE STREET,,COLUMBUS,OH,43222,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Edwards Lifesciences Corporation,1.00E+11,Edwards Lifesciences Corporation,CA,United States,Yes,Covered,Device,Transcatheter Heart Valves,Edwards SAPIEN 3 Transcatheter Heart Valve,,,,,,,,,,,,,,,,1250,3/14/2018,Cash or cash equivalent,,,No,No,Partner3 2015-08,No,616305147,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,160058,6639,UNIVERSITY OF IOWA HOSP & CLINICS,,,,,,200 HAWKINS DRIVE,,IOWA CITY,IA,52242,United States,,,,,,,,,,35650,JENNIFER,G,ROBINSON,,200 HAWKINS DR,,IOWA CITY,IA,52242-1009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,IA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Nutrition and Weight Loss,Belviq,62856-529-60,,,,,,,,,,,,,,,546.25,3/1/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors",No,608374185,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 BROOKLINE AVE,,BOSTON,MA,2215,United States,,,,,,,,,,315530,SARA,M,TOLANEY,,55 FRUIT STREET YAW 7604,MASSACHUSETTS GENERAL HOSPITAL,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Halaven,62856-389-01,,,,,,,,,,,,,,,252.2,8/7/2018,Cash or cash equivalent,,,No,No,"An Open-Label, Single-Arm Multicenter Phase 1b/2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Subjects With Metastatic Triple-Negative Breast Cancer (mTNBC)",No,608739611,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,520138,6589,AURORA HEALTH CARE METRO INC.,,,,,,2900 WEST OKLAHOMA AVENUE,,MILWAUKEE,WI,53215,United States,,,,,,,,,,214580,TANVIR,KHALID,BAJWA,,2801 W Kinnickinnic River Pkwy,Ste 440,Milwaukee,WI,53215,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,WI,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,10799,10/16/2018,Cash or cash equivalent,,,No,No,Evolut R US IDE,No,572118863,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,150056,6466,INDIANA UNIVERSITY HEALTH,,,,,,1701 N Senate,,Indianapolis,IN,46202,United States,,,,,,,,,,34159,RAFAT,,ABONOUR,,535 BARNHILL DR,,INDIANAPOLIS,IN,46202-5116,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,IN,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Drug,Oncology,Ninlaro,63020-079-02,,,,,,,,,,,,,,,15.26,10/3/2018,In-kind items and services,Other,,No,No,Study of Dexamethasone Plus IXAZOMIB MLN9708 or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain AL Amyloidosis,No,586473223,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,70025,6073,HARTFORD HOSPITAL,,,,,,80 SEYMOUR STREET,,HARTFORD,CT,6102,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cook Medical LLC,1.00E+11,Cook Research Incorporated,IN,United States,No,,,,,,,,,,,,,,,,,,,,6000,3/29/2018,Cash or cash equivalent,Patient Care,,Yes,No,,No,556791159,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,210044,6748,GREATER BALTIMORE MEDICAL CENTER,,,,,,6701 N Charles St,,Baltimore,MD,21204,United States,,,,,,,,,,201542,MADHU,,CHAUDHRY,,6569 N CHARLES ST,STE 201,BALTIMORE,MD,21204,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MD,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Hematology / Oncology,Revlimid,59572-405-28,,,,,,,,,,,,,,,6803,2/9/2018,Cash or cash equivalent,,,No,No,CC-5013-NHL-008,No,595029339,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 CLIFTON RD NE,,ATLANTA,GA,30322,United States,,,,,,,,,,1159897,VIRAJ,,MASTER,,1365 CLIFTON RD NE,,ATLANTA,GA,30322,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Urology,GA,,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,TECENTRIQ,50242-917-01,,,,,,,,,,,,,,,169454.7,12/27/2018,Cash or cash equivalent,,,No,No,PHASE III STUDY IN ADJUVANT THERAPY IN RENAL CELL CARCINOMA PATIENTS,No,590729459,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,363302,6437,RAINBOW BABIES & CHILDRENS HOSPITAL,,,,,,11100 EUCLID AVENUE,,CLEVELAND,OH,44106,United States,,,,,,,,,,861978,AFSHIN,N.,DOWLATI,,11100 EUCLID AVE,,CLEVELAND,OH,44106,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,OH,,,,"Seattle Genetics, Inc.",1.00E+11,"Seattle Genetics, Inc.",WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1500,7/30/2018,Cash or cash equivalent,,,No,No,"A phase 1, open-label, dose-escalation study to evaluate the safety and tolerability of SGN-LIV1A in patients with LIV-1-positive metastatic breast cancer",No,611523537,2018,6/28/2019,NCT01969643,https://clinicaltrials.gov/ct2/show/NCT01969643,
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 BROOKLINE AVE,,BOSTON,MA,2215,United States,,,,,,,,,,261486,LORI,J,WIRTH,,44 BINNEY ST SW 430,DFCI HEAD AND NECK ONCOLOGY,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,1203.8,1/18/2018,Cash or cash equivalent,,,No,No,"An Open-Label, Single-Arm, Multicenter, Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)",No,608740487,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,200009,6029,MAINE MEDICAL CENTER,,,,,,22 BRAMHALL STREET,,PORTLAND,ME,4102,United States,,,,,,,,,,898839,SHABBIR,,REZA,,9 HEALTHCARE DRIVE,SUITE 105,BIDDEFORD,ME,4005,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,ME,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Nutrition and Weight Loss,Belviq,62856-529-60,,,,,,,,,,,,,,,603.13,5/31/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors",No,608742425,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220071,6048,MASSACHUSETTS GENERAL HOSPITAL,,,,,,55 FRUIT ST,BULFINCH 360,BOSTON,MA,2114,United States,,,,,,,,,,181407,ERIC,C,KLAWITER,,15 PARKMAN ST,,BOSTON,MA,2114,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,MA,MO,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,Immunology,OCREVUS,50242-150-01,,,,,,,,,,,,,,,21427.16,7/30/2018,Cash or cash equivalent,,,No,No,MNT CHORDS,No,590731199,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360137,6438,UH CLEVELAND MEDICAL CENTER,,,,,,11100 EUCLID AVENUE,,CLEVELAND,OH,44106,United States,,,,,,,,,,1244118,ANGELINA,K,GANGESTAD,,11100 EUCLID AVE,,CLEVELAND,OH,44106-1716,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology,OH,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,3671.5,5/22/2018,Cash or cash equivalent,,,No,No,M14-702,No,566846653,2018,6/28/2019,NCT03213457,,
Covered Recipient Teaching Hospital,,393303,6270,THE CHILDRENS HOSPITAL OF PHILADELP,,,,,,34th & Civic Center Blvd,PARC Business Services,Philadelphia,PA,19104,United States,,,,,,,,,,276939,JENNIFER,R,HEIMALL,,3550 MARKET ST FL 3,CHILDRENS HOSPITAL OF PHILADELPHIA - ALLERGY AND IMMUN,PHILADELPHIA,PA,19104-3365,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology,NJ,,,,"Regeneron Pharmaceuticals, Inc.",1.00E+11,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,INFLAMMATION AND  IMMUNOLOGY,DUPIXENT DUPILUMAB INJECTION,0024-5914-01,,,,,,,,,,,,,,,1792.51,12/12/2018,Cash or cash equivalent,,,No,No,An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Dupilumab in Patients 6 Months to 18 Years of Age With Atopic Dermatitis,No,577344885,2018,6/28/2019,NCT02612454,,
Covered Recipient Teaching Hospital,,240010,6618,MAYO CLINIC HOSPITAL ROCHESTER,,,,,,1216 2nd St SW,,Rochester,MN,55902,United States,,,,,,,,,,10147,ANGELA,,DISPENZIERI,,200 1ST ST SW,,ROCHESTER,MN,55905-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,MN,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Drug,Oncology,Ninlaro,63020-079-02,,,,,,,,,,,,,,,8.36,7/27/2018,Cash or cash equivalent,Other,,No,No,Study of Dexamethasone Plus IXAZOMIB MLN9708 or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain AL Amyloidosis,No,586476265,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220116,6061,TUFTS MEDICAL CENTER,,,,,,750 Washington St,Box 018,Boston,MA,919,United States,,,,,,,,,,243983,WASIF,,SAIF,,800 WASHINGTON ST BOX 245,TUFTS MEDICAL CENTER,BOSTON,MA,2111,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,CT,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Oncology,Abraxane,68817-134-50,,,,,,,,,,,,,,,687.6,2/12/2018,In-kind items and services,,,No,No,ABI-007-PANC-009,No,595033283,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,270049,7087,ST VINCENT HEALTHCARE,,,,,,1233 N 30TH STREET,,BILLINGS,MT,59101,United States,,,,,,,,,,33076,PATRICK,W.,COBB,,1315 GOLDEN VALLEY CIR,,BILLINGS,MT,59102,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MT,,,,"Seattle Genetics, Inc.",1.00E+11,"Seattle Genetics, Inc.",WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,5500,7/30/2018,Cash or cash equivalent,,,No,No,"An Open Label Phase 2 Study of Denintuzumab Mafodotin SGN-CD19A in Combination With RCHOP Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone or RCHP Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Compared With RCHOP Alone as Frontline Therapy in Patients With Diffuse Large B-cell Lymphoma DLBCL or Follicular Lymphoma FL Grade 3b",No,611524859,2018,6/28/2019,NCT02855359,https://clinicaltrials.gov/ct2/show/NCT02855359,
Covered Recipient Teaching Hospital,,390133,6285,LEHIGH VALLEY,,,,,,1200 S Cedar Crest Blvd,,Allentown,PA,18103,United States,,,,,,,,,,72512,BRIAN,J,PATSON,,1240 S CEDAR CREST BLVD,1240 S CEDAR CREST BLVD,ALLENTOWN,PA,18103-6369,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,PA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,7461.45,6/28/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-Blind, Phase III Study of Pembrolizumab MK-3475 plus Chemotherapy vs Placebo plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer - KEYNOTE-355",No,607078641,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,390111,6278,HOSPITAL OF THE UNIV OF PENNA,,,,,,3701 Market St,,Phila,PA,19104,United States,,,,,,,,,,219149,KERRI,A,SMITH,,3400 CIVIC CENTER BLVD,WEST PAVILION-1ST FLOOR-SUITE 1-600 W,PHILADELPHIA,PA,19104-4306,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,MA,,,,United Therapeutics Corporation,1.00E+11,United Therapeutics Corporation,NC,United States,Yes,Covered,Drug,PAH,TYVASO,66302-206-01,,,,,,,,,,,,,,,6069.95,8/31/2018,Cash or cash equivalent,,,No,No,A MULTICENTER RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF INHALED TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION DUE TO PARENCHYMAL LUNG DISEASE,No,615282475,2018,6/28/2019,NCT02630316,,
Covered Recipient Teaching Hospital,,220071,6048,MASSACHUSETTS GENERAL HOSPITAL,,,,,,55 Fruit Street,,Boston,MA,2114,United States,,,,,,,,,,1220063,ALEKSANDAR,,VIDENOVIC,,15 PARKMAN ST,,BOSTON,MA,2114,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|General Practice,MA,,,,"Retrophin, Inc.",1.00E+11,"Retrophin, Inc.",CA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,181.44,11/6/2018,Cash or cash equivalent,,,No,No,024PKAN15004,No,616150099,2018,6/28/2019,NCT03041116,,
Covered Recipient Teaching Hospital,,330285,6190,STRONG MEMORIAL HOSPITAL,,,,,,601 Elmwood Ave,Box 684,Rochester,NY,14642,United States,,,,,,,,,,73030,JAMES,V,AQUAVELLA,,601 ELMWOOD AVE BOX 659,,ROCHESTER,NY,14642-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Ophthalmology,NY,,,,"Johnson & Johnson Vision Care, Inc.",1.00E+11,"Johnson & Johnson Vision Care, Inc.",FL,United States,No,,,,,,,,,,,,,,,,,,,,74569.66,1/12/2018,Cash or cash equivalent,,,No,No,Pilot evaluation of electromyography,No,551879593,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,420027,6806,ANMED HEALTH,,,,,,800 NORTH FANT STREET,,ANDERSON,SC,29621,United States,,,,,,,,,,917678,RICKY,A.,HENDERSON,,2000 E GREENVILLE ST STE 310,,ANDERSON,SC,29621,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,NC,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,259.38,6/13/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609118249,2018,6/28/2019,,,521858QPEXCELS
Covered Recipient Physician,,,,,20046,Hooman,,Melamed,,13160 Mindanao Way,Suite 300,Marina Del Rey,CA,90292,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Orthopaedic Surgery of the Spine,CA,,,,,,,,,,,,,,,,,,,,,,,,"Renovis Surgical Technologies, Inc.",1.00E+11,"Renovis Surgical Technologies, Inc.",CA,United States,Yes,Covered,Device,XLIF,,,,,,,,,,,,,,,,,1750,3/5/2018,Cash or cash equivalent,,,No,No,ALIF,No,593218317,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,420027,6806,ANMED HEALTH,,,,,,800 NORTH FANT STREET,,ANDERSON,SC,29621,United States,,,,,,,,,,83472,JOHN,R.,WENDT,,100 HEALTHY WAY STE 1250,,ANDERSON,SC,29621,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,SC,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Siello,,,,,,,,,,,,,,,,210,11/6/2018,Cash or cash equivalent,,,No,No,SIELLO,No,609118637,2018,6/28/2019,,,535250SIELLO
Covered Recipient Teaching Hospital,,390006,6308,GEISINGER MEDICAL CENTER,,,,,,100 NORTH ACADEMY AVENUE,,DANVILLE,PA,17822,United States,,,,,,,,,,89069,STEPHEN,,VOYCE,,475 MORGAN HWY,,SCRANTON,PA,18508-2605,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,PA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Nutrition and Weight Loss,Belviq,62856-529-60,,,,,,,,,,,,,,,81,3/27/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors",No,604991831,2018,6/28/2019,,,
Covered Recipient Physician,,,,,189972,DAVID,M.,GORSON,,140 Hospital Dr,Ste 301,Bennington,VT,5201,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",VT,,,,,,,,,,,,,,,,,,,,,,,,"Medtronic MiniMed, Inc.",1.00E+11,"Medtronic MiniMed, Inc.",MN,United States,Yes,Covered,Device,Durable Pump,Minimed 530G,,,,,,,,,,,,,,,,600,8/20/2018,Cash or cash equivalent,,,No,No,CEP266 ASPIRE Post Market,No,572185505,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,450647,6909,MEDICAL CITY DALLAS HOSPITAL,,,,,,7777 Forest Ln,,Dallas,TX,75230,United States,,,,,,,,,,52185,JOHN,,NEMUNAITIS,,1325 CONFERENCE DR,,TOLEDO,OH,43614-8009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,OH,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,58.5,3/28/2018,Cash or cash equivalent,,,No,No,"Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies",No,576953843,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,390006,6308,GEISINGER MEDICAL CENTER,,,,,,100 NORTH ACADEMY AVENUE,,DANVILLE,PA,17822,United States,,,,,,,,,,518610,CHRISTOPHER,M,STILLE,,1000 LANGWORTHY ST,,DUBUQUE,IA,52001-7313,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Family Medicine,IA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Nutrition and Weight Loss,Belviq,62856-529-60,,,,,,,,,,,,,,,907.5,3/1/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors",No,604991977,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,223302,6052,CHILDRENS HOSPITAL CORPORATION,,,,,,300 LONGWOOD AVENUE,,BOSTON,MA,2115,United States,,,,,,,,,,285172,GREGORY,,SAWICKI,,300 LONGWOOD AVENUE,,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology,MA,,,,VERTEX PHARMACEUTICALS INCORPORATED,1.00E+11,Vertex Pharmaceuticals Incorporated,MA,United States,Yes,Covered,Drug,CYSTIC FIBROSIS,KALYDECO,51167-200-01,Non-Covered,,,,,,,,,,,,,,34281.66,1/1/2018,Cash or cash equivalent,,,No,No,A Study to Evaluate the Safety and Efficacy of Long Term Treatment With VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis Who Have an F508del-CFTR Mutation,No,585553049,2018,6/28/2019,,,
Covered Recipient Physician,,,,,165063,Thomas,,Abramo,,3601 The Vanderbilt Clinic,,Nashville,TN,37232,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Emergency Medicine,AR,,,,,,,,,,,,,,,,,,,,,,,,"Nonin Medical, Inc.",1.00E+11,"Nonin Medical, Inc.",MN,United States,Yes,Covered,Device,Regional Oximeters,,,,,,,,,,,,,,,,,1446.64,1/1/2018,In-kind items and services,,,No,No,Regional Oximetery PGA study,No,611482285,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,490009,6776,UNIVERSITY OF VIRGINIA MEDICAL CENTE,,,,,,1215 LEE ST PFS,,CHARLOTTESVILLE,VA,22908,United States,,,,,,,,,,217198,DAVID,S.,LIM,,LEE ST FL 2,,CHARLOTTESVILLE,VA,22908,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,VA,,,,"W. L. Gore & Associates, Inc.",1.00E+11,"W. L. Gore & Associates, Inc.",DE,United States,Yes,Non-Covered,Device,Devices,Product in Development,,,,,,,,,,,,,,,,187.5,2/16/2018,Cash or cash equivalent,,,No,No,GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs),No,585075465,2018,6/28/2019,NCT01711983,,
Covered Recipient Teaching Hospital,,450647,6909,MEDICAL CITY DALLAS HOSPITAL,,,,,,7777 Forest Ln,,Dallas,TX,75230,United States,,,,,,,,,,309954,DOWLING,,STOUGH,,3633 CENTRAL AVE,STE N,HOT SPRINGS,AR,71913-6404,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,AR,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,0.38,10/26/2018,Cash or cash equivalent,,,No,No,"A Double Blind, Randomized, Dose Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo",No,576953943,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,160058,6639,UNIVERSITY OF IOWA HOSP & CLINICS,,,,,,200 Hawkins Dr,,Iowa City,IA,52242,United States,,,,,,,,,,35650,JENNIFER,G,ROBINSON,,200 HAWKINS DR,,IOWA CITY,IA,52242-1009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,IA,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Drug,Diabetes,Actos,64764-301-14,,,,,,,,,,,,,,,178,3/12/2018,Cash or cash equivalent,Other,,No,No,Study to Qualify a Biomarker to Identify Subjects at Risk for MCI due to AD and to Evaluate Efficacy and Safety of Pioglitazone in Delaying Onset of MCI due to AD,No,586476763,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48105,United States,,,,,,,,,,36040,MOSHE,,TALPAZ,,1500 EAST MEDICAL CENTER DR,B1 FLOOR CANCER CTR RECP B,ANN ARBOR,MI,48109,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Celgene Corporation,1.00E+11,Celgene Corporation,NJ,United States,Yes,Covered,Drug,Hematology / Oncology,Pomalyst,59572-502-00,,,,,,,,,,,,,,,1678.75,6/15/2018,Cash or cash equivalent,,,No,No,CC-4047-MF-002,No,595034011,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,100009,6333,UNIVERSITY OF MIAMI HOSPITAL,,,,,,1400 NW 12TH AVENUE,,MIAMI,FL,33136,United States,,,,,,,,,,253934,JAIME,R,MERCHAN,,1475 NW 12TH AVE,SUITE 3300,MIAMI,FL,33136-1002,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,FL,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,1805,9/4/2018,Cash or cash equivalent,,,No,No,"A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Advanced Renal Cell Carcinoma",No,608743385,2018,6/28/2019,,,
Covered Recipient Physician,,,,,772486,DAVID,MICHAEL,ZLOTNICK,,875 ELLICOTT ST,,BUFFALO,NY,14203-1070,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,LA,,,,,,,,,,,,,,,,,,,,,,,,ABIOMED,1.00E+11,ABIOMED,MA,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Impella,,,,,,,,,,,,,,,,350,9/11/2018,Cash or cash equivalent,,,No,No,Impella Clinical Immersion,No,612152917,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,40016,6980,UAMS MEDICAL CENTER,,,,,,4301 WEST MARKHAM,,LITTLE ROCK,AR,72205,United States,,,,,,,,,,1129945,JULIA,,LIU,,4301 W MARKHAM ST # 567 UAMS DIV OF F GASTROENTEROLOGY,,LITTLE ROCK,AR,72205-7101,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,MA,,,,"Mauna Kea Technologies, Inc.",1.00E+11,"Mauna Kea Technologies, Inc.",MA,United States,Yes,Covered,Device,Cellvizio,,,,,,,,,,,,,,,,,18764.1,8/28/2018,Cash or cash equivalent,,,No,No,Endomicroscopic Determinants or Relapse in Inflammatory Bowel Disease,No,611162113,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,340014,6796,FORSYTH MEMORIAL HOSPITAL  INC,,,,,,3333 SILAS CREEK PARKWAY,,WINSTON SALEM,NC,27103,United States,,,,,,,,,,1046547,FRANKLIN,,CHEN,,3333 SILAS CREEK PKWY,,WINSTON SALEM,NC,27103-3013,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,NC,,,,"EMD Serono, Inc.",1.00E+11,"EMD Serono, Inc.",MA,United States,Yes,Non-Covered,Biological,Oncology,Bavencio,,,,,,,,,,,,,,,,2898,8/7/2018,Cash or cash equivalent,,,No,No,EMR 100070-005,No,612257581,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50696,7265,KECK HOSPITAL OF USC,,,,,,1441 Eastlake Ave,,Los Angeles,CA,90089,United States,,,,,,,,,,267597,ANTHONY,,EL-KHOUEIRY,,1441 EASTLAKE AVE,NOR 8302E,LOS ANGELES,CA,90089-0112,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,CA,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,2298.42,3/28/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies",No,576952115,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,10033,6942,UNIVERSITY OF ALABAMA HOSPITAL,,,,,,619 19th St S,,Birmingham,AL,35249,United States,,,,,,,,,,113292,TALHA,AZIZ,MALIK,,13400 E SHEA BLVD,,SCOTTSDALE,AZ,85259-5452,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,AZ,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Biological,Lower GI,Entyvio,64764-300-20,,,,,,,,,,,,,,,1000,10/19/2018,Cash or cash equivalent,Other,,No,No,"A prospective, observational, cohort safety study of vedolizumab for imflammatory disease",No,586477327,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 CLIFTON ROAD,,ATLANTA,GA,30302,United States,,,,,,,,,,575200,NIALL,,GALLOWAY,,1365 CLIFTON RD NE,,ATLANTA,GA,30322,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Urology,GA,,,,Cook Medical LLC,1.00E+11,Cook Research Incorporated,IN,United States,No,,,,,,,,,,,,,,,,,,,,1948,6/8/2018,Cash or cash equivalent,Patient Care,,No,No,IND Study 2 - Female SUI,No,556792323,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,260138,6654,ST. LUKES HOSPITAL OF KANSAS CITY,,,,,,4401 WORNALL ROAD,,KANSAS CITY,MO,64111,United States,,,,,,,,,,1199860,TIMOTHY,J.,PLUARD,,4321 WASHINGTON ST STE 4000,,KANSAS CITY,MO,64111,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,KS,,,,"Seattle Genetics, Inc.",1.00E+11,"Seattle Genetics, Inc.",WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,345,10/24/2018,Cash or cash equivalent,,,No,No,"Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib",No,611525391,2018,6/28/2019,NCT02614794,https://clinicaltrials.gov/ct2/show/NCT02614794,
Covered Recipient Teaching Hospital,,520098,6608,UNIVERSITY OF WI HOSPITALS & CLINICS,,,,,,600 HIGHLAND AVE,,MADISON,WI,53792,United States,,,,,,,,,,10509,RUTH,MARY,O REGAN,,600 HIGHLAND AVE,,MADISON,WI,53792-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,GA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Halaven,62856-389-01,,,,,,,,,,,,,,,736,8/7/2018,Cash or cash equivalent,,,No,No,"An Open-Label, Single-Arm Multicenter Phase 1b/2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Subjects With Metastatic Triple-Negative Breast Cancer (mTNBC)",No,608743835,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50424,7273,SCRIPPS GREEN HOSPITAL,,,,,,10666 N Torrey Pines Rd,,La Jolla,CA,92037,United States,,,,,,,,,,1101959,GAUREE,G,KONIJETI,,10666 N TORREY PINES RD,,LA JOLLA,CA,92037-1027,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,CA,,,,"Takeda Pharmaceuticals U.S.A., Inc.",1.00E+11,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Biological,Lower GI,Entyvio,64764-300-20,,,,,,,,,,,,,,,5830.5,2/7/2018,Cash or cash equivalent,Other,,No,No,"A prospective, observational, cohort safety study of vedolizumab for imflammatory disease",No,586477784,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,100088,6840,Baptist Medical Center,,,,,,800 Prudential Drive,,Jacksonville,FL,32207-8202,United States,,,,,,,,,,242650,RICARDO,ALEXANDRE,HANEL,,800 PRUDENTIAL DR TOWER B 11TH FLOOR,,Jacksonville,FL,32207-8202,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Neurological Surgery,FL,,,,"Sequent Medical, Inc.",1.00E+11,"Sequent Medical, Inc.",CA,United States,Yes,Covered,Device,NEUROLOGICAL PRODUCT,WEB,,,,,,,,,,,,,,,,500,9/24/2018,Cash or cash equivalent,,,No,No,WEB,No,615907969,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50348,7281,UCI MEDICAL CENTER,,,,,,101 THE CITY DRIVE SOUTH,,ORANGE,CA,92868,United States,,,,,,,,,,213273,RITESH,,PARAJULI,,3300 NW EXPRESSWAY,,OKLAHOMA CITY,OK,73112,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,IL,,,,"Seattle Genetics, Inc.",1.00E+11,"Seattle Genetics, Inc.",WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,18340,3/19/2018,In-kind items and services,,,No,No,Phase 1b2 study of SGN-LIV1A in combination with pembrolizumab in patients with locally advanced or metastatic triple-negative breast cancer,No,611525651,2018,6/28/2019,NCT03310957,https://clinicaltrials.gov/ct2/show/NCT03310957,
Covered Recipient Teaching Hospital,,520098,6608,UNIVERSITY OF WI HOSPITALS & CLINICS,,,,,,600 HIGHLAND AVE,,MADISON,WI,53792,United States,,,,,,,,,,10509,RUTH,MARY,O REGAN,,600 HIGHLAND AVE,,MADISON,WI,53792-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,GA,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Halaven,62856-389-01,,,,,,,,,,,,,,,1231.36,8/7/2018,Cash or cash equivalent,,,No,No,"An Open-Label, Single-Arm Multicenter Phase 1b/2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Subjects With Metastatic Triple-Negative Breast Cancer (mTNBC)",No,608744135,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,240038,6510,UNITED HOSPITAL,,,,,,333 SMITH AVENUE NORTH,,SAINT PAUL,MN,55102,United States,,,,,,,,,,1033748,SAMITH,T,KOCHUPARAMBIL,,910 E 26TH ST,SUITE 100,MINNEAPOLIS,MN,55404-4526,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,GA,,,,"EMD Serono, Inc.",1.00E+11,"EMD Serono, Inc.",MA,United States,Yes,Non-Covered,Biological,Oncology,Bavencio,,,,,,,,,,,,,,,,1497.6,12/3/2018,Cash or cash equivalent,,,No,No,EMR 100070-007,No,612258653,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50696,7265,KECK HOSPITAL OF USC,,,,,,1441 Eastlake Ave,,Los Angeles,CA,90089,United States,,,,,,,,,,838537,HEINZ-JOSEF,,LENZ,,1441 EASTLAKE AVE.,NOR 8302E,LOS ANGELES,CA,90033-0000,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,CA,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,10.8,11/28/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Select Advanced Cancers",No,576952459,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,80001,6718,CHRISTIANA CARE HEALTH SYSTEM,,,,,,501 W 14th St,,Wilmington,DE,19801,United States,,,,,,,,,,103975,IRENE,,SWIFT,,4745 OGLETOWN-STANTON ROAD,"MAP 1, SUITE 220",NEWARK,DE,19713-2074,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,DE,,,,"Actelion Pharmaceuticals US, Inc.",1.00E+11,"Actelion Pharmaceuticals US, Inc.",CA,United States,Yes,Covered,Drug,CARDIOVASCULAR DISORDERS,OPSUMIT MACITENTAN,66215-501-30,,,,,,,,,,,,,,,7484,12/18/2018,Cash or cash equivalent,,,No,No,AC-055-5,No,551885677,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,390256,6330,MILTON S. HERSHEY MEDICAL CENTER,,,,,,500 University Dr,,Hershey,PA,17033,United States,,,,,,,,,,890865,PATRICIA,,GORDON,,500 UNIVERSITY DR,MC A410,HERSHEY,PA,17033,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.),PA,,,,BioMarin Pharmaceutical Inc.,1.00E+11,BioMarin Pharmaceutical Inc.,CA,United States,Yes,Covered,Drug,PKU,Kuvan,68135-301-22,,,,,,,,,,,,,,,378,1/31/2018,Cash or cash equivalent,,,No,No,"Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU",No,574267707,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,273363,AMMAR,WALLED,SUKARI,,4100 JOHN R,4100 JOHN R,DETROIT,MI,48201-2013,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,1000,7/26/2018,Cash or cash equivalent,,,No,No,"A Randomized Double-Blind, Phase III Study of PlatinumPemtrexed Chemotherapy with or without Pembrolizumab MK-3475 in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects KEYNOTE-189",No,607022333,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,140127,6480,ADVOCATE BROMENN MEDICAL CENTER,,,,,,1304 Franklin Ave,,Normal,IL,61761,United States,,,,,,,,,,387673,MUHYALDEE,,DIA,,4400 W 95TH ST,SUITE 407,OAK LAWN,IL,60453-2654,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology,IL,,,,United Therapeutics Corporation,1.00E+11,United Therapeutics Corporation,NC,United States,Yes,Covered,Drug,PAH,ORENITRAM,66302-302-01,,,,,,,,,,,,,,,500.85,11/30/2018,Cash or cash equivalent,,,No,No,"A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION PH IN HEART FAILURE WITH PRESERVED EJECTION FRACTION HFPEF",No,615281207,2018,6/28/2019,NCT03043651,,
Covered Recipient Physician,,,,,237006,CRAIG,S,THOMPSON,,1040 DELAWARE AVENUE,,MARION,OH,43301,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,OH,,,,,,,,,,,,,,,,,,,,,,,,Amgen Inc.,1.00E+11,Amgen Inc.,CA,United States,Yes,Covered,Biological,Cardiology,Repatha,55513-750-01,,,,,,,,,,,,,,,12720,8/24/2018,Cash or cash equivalent,,,No,No,FOURIER OLE (Ph 4),No,572211677,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,300003,6031,MARY HITCHCOCK MEMORIAL HOSP,,,,,,1 Medical Center Drive,,Lebanon,NH,3756,United States,,,,,,,,,,318646,Mark,,Goldstein,,130 JFK Dr STE 203,Attn Rosemarie De Manna,Atlantis,FL,33462,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,FL,,,,Sunovion Pharmaceuticals Inc.,1.00E+11,Sunovion Pharmaceuticals Inc.,MA,United States,Yes,Non-Covered,Drug,CNS,SEP-363856,,,,,,,,,,,,,,,,2005,1/31/2018,Cash or cash equivalent,,,No,No,"A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis",No,537634213,2018,6/28/2019,NCT02969369,,SEP361-203
Covered Recipient Teaching Hospital,,500054,6521,PROV SACRED HEART MEDICAL CENTER,,,,,,101 W 8th Ave,,Spokane,WA,99204,United States,,,,,,,,,,31446,JITEN,D,PATEL,,212 E CENTRAL AVE,SUITE 315,SPOKANE,WA,99208-6291,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,KS,,,,"Actelion Pharmaceuticals US, Inc.",1.00E+11,"Actelion Pharmaceuticals US, Inc.",CA,United States,Yes,Covered,Drug,CARDIOVASCULAR DISORDERS,OPSUMIT MACITENTAN,66215-501-30,,,,,,,,,,,,,,,18211.5,4/20/2018,Cash or cash equivalent,,,No,No,AC-055-5,No,551886259,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,523300,6595,CHILDRENS HOSPITAL OF WISCONSIN,,,,,,9000 W Wisconsin Ave,,Milwaukee,WI,53226,United States,,,,,,,,,,266175,WILLIAM,,RHEAD,,9000 W WISCONSIN AVE,DIVISION OF GENETICS,MILWAUKEE,WI,53226,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.),WI,,,,BioMarin Pharmaceutical Inc.,1.00E+11,BioMarin Pharmaceutical Inc.,CA,United States,Yes,Covered,Drug,PKU,Kuvan,68135-301-22,,,,,,,,,,,,,,,718.75,1/1/2018,Cash or cash equivalent,,,No,No,"Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU",No,574267963,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50146,7271,CITY OF HOPE NATIONAL MEDICAL CTR,,,,,,1500 E Duarte Rd,,Duarte,CA,91010,United States,,,,,,,,,,963347,YUAN,,YUAN,,1500 EAST DUARTE RD,1500 EAST DUARTE RD,DUARTE,CA,91010,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,CA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,10800,1/31/2018,In-kind items and services,,,No,No,"A Phase II, Multi Center Study of BGB324 in combination with Pembrolizumab in Patients with Previously Treated, Locally Advanced and Unresectable or Metastatic Triple Negative Breast Cancer TNBC or Triple Negative Inflammatory Breast Cancer TN-IBC",No,607022529,2018,6/28/2019,,,Study drug provided to a clinical study site.
Covered Recipient Teaching Hospital,,490059,6766,ST. MARYS HOSPITAL,,,,,,5801 BREMO ROAD,,RICHMOND,VA,23226,United States,,,,,,,,,,41446,MATTHEW,MINH-TRI,NGO,,7001 FOREST AVE STE 200,,RICHMOND,VA,23230,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,FL,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Siello,,,,,,,,,,,,,,,,175,4/10/2018,Cash or cash equivalent,,,No,No,SIELLO,No,609115037,2018,6/28/2019,,,516560SIELLO
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 CLIFTON ROAD,,ATLANTA,GA,30302,United States,,,,,,,,,,2885,HONG,,LI,,3576 SHALLOWFORD RD NE,SUITE A,CHAMBLEE,GA,30341,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Family Medicine,GA,,,,BioMarin Pharmaceutical Inc.,1.00E+11,BioMarin Pharmaceutical Inc.,CA,United States,Yes,Covered,Drug,PKU,Palynziq,68135-058-90,,,,,,,,,,,,,,,8086.5,5/29/2018,Cash or cash equivalent,,,No,No,Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU Prism302,No,574268219,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,54144,7262,LANGLEY PORTER PSYCHIATRIC HOSPITAL,,,,,,401 Parnassus Ave,,San Francisco,CA,94143,United States,,,,,,,,,,254590,PAMELA,,MUNSTER,,12902 USF MAGNOLIA DR,MDC 44,TAMPA,FL,33612-9416,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,CA,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,12.3,6/27/2018,Cash or cash equivalent,,,No,No,"A Platform Study Exploring the Safety, Tolerability, Effects on the Tumor Microenvironment, and Efficacy of Pembrolizumab (MK 3475) plus INCB Combinations in Advanced Solid Tumors",No,576952827,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,450076,7039,UT MD ANDERSON CANCER CENTER,,,,,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,,,,,,,,251902,NATHAN,H.,FOWLER,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,TX,,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,GAZYVA,50242-070-01,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,63796.92,10/24/2018,Cash or cash equivalent,,,No,No,GNE PHASE III RTX REF INHL B VS BG,No,590734341,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,54144,7262,LANGLEY PORTER PSYCHIATRIC HOSPITAL,,,,,,401 Parnassus Ave,,San Francisco,CA,94143,United States,,,,,,,,,,254590,PAMELA,,MUNSTER,,12902 USF MAGNOLIA DR,MDC 44,TAMPA,FL,33612-9416,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,CA,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,28.5,12/20/2018,Cash or cash equivalent,,,No,No,"A Platform Study Exploring the Safety, Tolerability, Effects on the Tumor Microenvironment, and Efficacy of Pembrolizumab (MK 3475) plus INCB Combinations in Advanced Solid Tumors",No,576952941,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,140276,6517,LOYOLA UNIVERSITY MEDICAL CENTER,,,,,,2160 S 1st Ave,,Maywood,IL,60153,United States,,,,,,,,,,1166649,SCOTT,,SMITH,,2160 S FIRST AVE,"(LUH-NORTH ENT., RM. 7604)",MAYWOOD,IL,60153,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,IL,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,3000,5/22/2018,Cash or cash equivalent,,,No,No,"A Phase 2, Open Label, 2 Cohort Study of INCB050465, a PI3Kd Inhibitor, in Subjects With Relapsed or Refractory Marginal Zone Lymphoma With or Without Prior Exposure to a BTK Inhibitor, CITADEL 204",No,576953055,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,50146,7271,CITY OF HOPE NATIONAL MEDICAL CTR,,,,,,1500 E Duarte Rd,,Duarte,CA,91010,United States,,,,,,,,,,657046,DANENG,,LI,,1500 DUARTE RD,1500 DUARTE RD,DUARTE,CA,91010-3012,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,CA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,LENVIMA,62856-712-30,,,,,,,,,,,,,,,213,12/11/2018,In-kind items and services,,,No,No,"A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib E7080,MK-7902 in Combination with Pembrolizumab MK-3475 Versus Lenvatinib in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma LEAP-002",No,607023315,2018,6/28/2019,,,Equipment or non-drug supplies provided to a clinical study site.
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,2301 COMMONWEALTH BLVD,,ANN ARBOR,MI,48105,United States,,,,,,,,,,226980,ELENA,,SCHIOPU,,1500 EAST MEDICAL CENTER DR,3RD FLOOR TAUBMAN CTR RECP A,ANN ARBOR,MI,48109-5370,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,MI,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,10633.47,6/26/2018,Cash or cash equivalent,,,No,No,M15-572,No,566849727,2018,6/28/2019,NCT03104400,,
Covered Recipient Teaching Hospital,,220071,6048,MASSACHUSETTS GENERAL HOSPITAL,,,,,,55 Fruit St,Bulfinch 360,Boston,MA,2114,United States,,,,,,,,,,290751,LECIA,,SEQUIST,,55 FRUIT STREET YAW 7B,HEMATOLOGY/ONCOLOGY,BOSTON,MA,2114,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MA,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,3.6,6/27/2018,Cash or cash equivalent,,,No,No,An Open Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non Small Cell Lung Cancer,No,576953289,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 Brookline Ave,,Boston,MA,2215,United States,,,,,,,,,,1017997,STEVEN,G,DUBOIS,,450 BROOKLINE AVE,450 BROOKLINE AVE,BOSTON,MA,02215-5418,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,CA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,17.86,3/12/2018,In-kind items and services,,,No,No,"A Phase I,II Study of Pembrolizumab MK-3475 in Children with advanced melanoma or a PD-L1 positive advanced, relapsed or refractory solid tumor or lymphoma KEYNOTE-051",No,607023715,2018,6/28/2019,,,Equipment or non-drug supplies provided to a clinical study site.
Covered Recipient Teaching Hospital,,380009,7189,OHSU HOSPITAL AND CLINICS,,,,,,3181 SAM JACKSON PARK ROAD,,PORTLAND,OR,97239,United States,,,,,,,,,,277973,MATTHEW,H,TAYLOR,,3181 SW SAM JACKSON PARK RD,MAIL CODE L586,PORTLAND,OR,97239-3011,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,OR,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,2085,7/12/2018,Cash or cash equivalent,,,No,No,"A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors",No,604993721,2018,6/28/2019,,,
Covered Recipient Physician,,,,,528391,HOPE,E,PETERS,,75 FRANCIS ST,RADIOLOGY BRIGHAM & WOMENS HOSPITAL,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology,MA,,,,,,,,,,,,,,,,,,,,,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,Yes,Covered,Drug,Endocrinology,Orilissa,0074-0038-28,,,,,,,,,,,,,,,2380,11/29/2018,Cash or cash equivalent,,,No,No,M14-702,No,566854339,2018,6/28/2019,NCT03213457,,
Covered Recipient Teaching Hospital,,230146,6573,Henry Ford Wyandotte Hospital,,,,,,2333 Biddle St,,Wyandotte,MI,48192,United States,,,,,,,,,,672836,Kausik,,Umanath,,2799 W Grand Blvd,K-16,Detroit,MI,48202,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,MI,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca Pharmaceuticals LP,DE,United States,Yes,Covered,Drug,Cardiovascular and Metabolism,FARXIGA,0310-6205-30,,,,,,,,,,,,,,,6672.05,3/27/2018,Cash or cash equivalent,,,No,No,A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease,No,556973229,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,160058,6639,UNIVERSITY OF IOWA HOSP & CLINICS,,,,,,UNIVERSITY OF IOWA HOSP & CLINICS,200 Hawkins Dr,Iowa City,IA,52242,United States,,,,,,,,,,1014744,YOUSEF,N,ZAKHARIA,,200 HAWKINS DR,DEP OF INTERNAL MEDICINE,IOWA CITY,IA,52242-1009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,GA,IA,,,"Clovis Oncology, Inc.",1.00E+11,"Clovis Oncology, Inc.",CO,United States,Yes,Covered,Drug,ONCOLOGY,Rubraca,69660-201-91,,,,,,,,,,,,,,,300,8/17/2018,Cash or cash equivalent,,,No,No,Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma (ATLAS),No,582353475,2018,6/28/2019,NCT03397394,,CO-338-085
Covered Recipient Teaching Hospital,,140119,6486,RUSH UNIVERSITY MEDICAL CENTER,,,,,,75 Remittance Dr STE 6807,,Chicago,IL,60675,United States,,,,,,,,,,55892,Ramon,,Solhkhah,,1945 State Hwy 33,,Neptune,NJ,7753,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,NY,,,,Sunovion Pharmaceuticals Inc.,1.00E+11,Sunovion Pharmaceuticals Inc.,MA,United States,Yes,Covered,Drug,CNS,Latuda,63402-304-30,,,,,,,,,,,,,,,10.52,1/31/2018,In-kind items and services,,,No,No,Pediatric Open-Label Extension Study,No,601558861,2018,6/28/2019,NCT01914393,,D1050302
Covered Recipient Physician,,,,,277596,Shamik,,Bhadra,,3114 W Beverly Blvd,,Montebello,CA,90640,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|General Practice,CA,,,,,,,,,,,,,,,,,,,,,,,,"Retrophin, Inc.",1.00E+11,"Retrophin, Inc.",CA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,98.87,12/1/2018,Cash or cash equivalent,,,No,No,021IGAN17001,No,616151729,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,340113,6798,CAROLINAS MEDICAL CENTER,,,,,,501 Billingsley Rd,,Charlotte,NC,28211,United States,,,,,,,,,,1080942,JILL,MARIE,CONWAY,,1350 S KINGS DR,,CHARLOTTE,NC,28207-2134,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,NC,,,,"Adamas Pharmaceuticals, Inc.",1.00E+11,"Adamas Pharmaceuticals, Inc.",CA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,4000,7/26/2018,Cash or cash equivalent,,,No,No,A 3-ARM MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ADS-5102 AMANTADINE EXTENDED RELEASE CAPSULES IN MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT,No,605387011,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,100271,6858,H. LEE MOFFITT CANCER CENTER,,,,,,12902 MAGNOLIA DRIVE,,TAMPA,FL,33612,United States,,,,,,,,,,270265,ALBERTO,A,CHIAPPORI,,12902 MAGNOLIA DRIVE,SUITE 3170,TAMPA,FL,33612,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,FL,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,645,7/23/2018,Cash or cash equivalent,,,No,No,A PHASE 1 OPENLABEL DOSE ESCALATION STUDY OF PF04518600 AS A SINGLE AGENT AND IN COMBINATION WITH PF05082566 IN PATIENTS WITH SELECTED LOCALLY ADVANCED OR METASTATIC CANCERS,No,599758243,2018,6/28/2019,,,
Covered Recipient Physician,,,,,1003306,PATRICIA,CRISTINE,DUGAN,,223 E 34TH ST,,NEW YORK,NY,10016-4852,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Clinical Neurophysiology,NY,,,,,,,,,,,,,,,,,,,,,,,,"NEUROPACE, INC.",1.00E+11,"NEUROPACE, INC.",CA,United States,Yes,Covered,Device,Epilepsy,RNS System,,,,,,,,,,,,,,,,195,7/16/2018,Cash or cash equivalent,,,No,No,Post Approval Study,No,607716101,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,500008,7176,UNIVERSITY OF WASHINGTON MED CTR,,,,,,1959 NE PACIFIC ST,,SEATTLE,WA,98195,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,TECENTRIQ,50242-917-01,,,,,,,,,,,,,,,7273,5/2/2018,Cash or cash equivalent,,,No,No,PHASE II TRIAL OF ATEZOLIZUMAB IN NSCLC,No,590740335,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,460009,7144,U OF U HOSPITALS & CLINICS,,,,,,50 NORTH MEDICAL DRIVE,,SALT LAKE CITY,UT,84132,United States,,,,,,,,,,290372,TIBOR,J,KOVACSOVICS,,3181 SW SAM JACKSON PARK RD,,PORTLAND,OR,97239-3011,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,OR,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,11700.93,7/3/2018,Cash or cash equivalent,,,No,No,M15-538,No,566854595,2018,6/28/2019,NCT02899052,,
Covered Recipient Teaching Hospital,,360085,6390,The Ohio State University Hospital,,,,,,480 Medical Center Dr,,Columbus,OH,43210,United States,,,,,,,,,,299284,David,M,O'malley,,3651 Ridge Mill Dr,--,Hilliard,OH,43026,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology,OH,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca Pharmaceuticals LP,DE,United States,Yes,Covered,Drug,Oncology,LYNPARZA,0310-0657-58,,,,,,,,,,,,,,,2477.45,12/31/2018,In-kind items and services,,,No,No,"A Phase III Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Germline BRCA Mutation Positive Relapsed Ovarian Cancer Patients who are in Complete or Partial Response Following Platinum based Chemotherapy",No,556973731,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50262,7301,RONALD REAGAN UCLA MEDICAL CENTER,,,,,,757 Westwood Plz,,Los Angeles,CA,90095,United States,,,,,,,,,,5050,Susan,L,Perlman,,"710 Westwood Plaza Rnrc 1150, Box 951769",,Los Angeles,CA,90095,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,CA,,,,"Teva Pharmaceuticals USA, Inc.",1.00E+11,"Teva Pharmaceuticals USA, Inc.",PA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,50,3/26/2018,Cash or cash equivalent,,,No,No,"A Multi-Center, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Pridopidine in Patients With Huntington's Disease (Open PRIDE-HD)",No,590411865,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,520138,6589,AURORA HEALTH CARE METRO INC.,,,,,,2900 WEST OKLAHOMA AVENUE,,MILWAUKEE,WI,53215,United States,,,,,,,,,,214580,TANVIR,KHALID,BAJWA,,2801 W Kinnickinnic River Pkwy,Ste 440,Milwaukee,WI,53215,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,WI,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Transcatheter Valve Systems,CoreValve Evolut,,,,,,,,,,,,,,,,675,3/26/2018,Cash or cash equivalent,,,No,No,TAVR Low Risk,No,572129247,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50075,7205,KFH - OAKLAND,,,,,,280 W MacArthur Blvd,,Oakland,CA,94611,United States,,,,,,,,,,468853,SHAFQAT,M,AKHTAR,,401 BICENTENNIAL WAY,401 BICENTENNIAL WAY,SANTA ROSA,CA,95403-2149,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,CA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,143,1/1/2018,Cash or cash equivalent,,,No,No,A PHASE III RANDOMIZED TRIAL COMPARING HIGH DOSE INTERFERON TO MK-3475PEMBROLIZUMAB IN PATIENTS WITH HIGH RISK RESECTED MELANOMA,No,607027339,2018,6/28/2019,,,
Covered Recipient Physician,,,,,88081,Mohd,A,Malik,,5000 Cedar Plaza Pkway,,Saint Louis,MO,63128,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,MO,,,,,,,,,,,,,,,,,,,,,,,,Validus Pharmaceuticals LLC,1.00E+11,Validus Pharmaceuticals LLC,NJ,United States,Yes,Covered,Drug,CNS,Equetro,30698-419-12,,,,,,,,,,,,,,,175.26,6/25/2018,Cash or cash equivalent,Other,,No,No,"""A Phase IV Unequal Randomization Double-Blind Study To Evaluate the Dose Tolerance and Safety of Extended-Release Equetro (carbamazepine) versus Placebo Followed by an Open-Label and Long Term-Maintenance Treatment in Children and Adolescents Aged 10-17 years Diagnosed with Acute Manic or Mixed Bipolar I Disorder""",No,608521157,2018,6/28/2019,NCT02623504,,To gain FDA approval for pediatric and adolescent indication.
Covered Recipient Teaching Hospital,,300003,6031,MARY HITCHCOCK MEMORIAL HOSP,,,,,,One Medical Center Dr,,Lebanon,NH,3756,United States,,,,,,,,,,527236,BRUCE,WAYNE,ANDRUS,,1 MEDICAL CENTER DR,DHMC DEPARTMENT OF MEDICINE CARDIOLOGY,LEBANON,NH,03756-1000,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,NH,,,,United Therapeutics Corporation,1.00E+11,United Therapeutics Corporation,NC,United States,Yes,Covered,Drug,PAH,ORENITRAM,66302-302-01,,,,,,,,,,,,,,,962,8/31/2018,Cash or cash equivalent,,,No,No,AN OPEN-LABEL EXTENSION STUDY OF ORAL TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION PH ASSOCIATED WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION HFPEF - A LONG-TERM FOLLOW-UP TO STUDY TDE-HF-301,No,615283073,2018,6/28/2019,NCT03043651,,
Covered Recipient Teaching Hospital,,450388,7031,METHODIST HOSPITAL,,,,,,7700 FLOYD CURL DRIVE,,San Antonio,TX,78229,United States,,,,,,,,,,462951,BEHYAR,,ZOGHI,,7700 FLOYD CURL DR,,SAN ANTONIO,TX,78229-3902,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,TX,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,20.26,12/20/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double Blind, Placebo Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First Line Acute Graft Versus Host Disease",No,576954053,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,134405,MICHAEL,LEO,REEVES,,725 GLENWOOD DR,SUITE E688,CHATTANOOGA,TN,37404-1163,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",TN,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,NO PRODUCT DISCUSSED,,,,,,,,,,,,,,,,19300,5/17/2018,Cash or cash equivalent,,,No,No,Diabetes Mellitus,No,601906871,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,250001,6952,UNIVERSITY OF MISSISSIPPI MEDICAL,,,,,,2500 N STATE ST,,JACKSON,MS,39216,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DePuy Synthes Sales Inc.,1.00E+11,DePuy Synthes Products LLC,MA,United States,Yes,Covered,Device,Trauma,TFN ADVANCED,,,,,,,,,,,,,,,,24093,4/2/2018,Cash or cash equivalent,,,No,No,Implant Material Evaluation and Characterization,No,551885371,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,30014,7136,JOHN C LINCOLN MEDICAL CENTER,,,,,,250 E DUNLAP AVE,,PHOENIX,AZ,85020,United States,,,,,,,,,,34591,JASGIT,C,SACHDEV,,10510 N 92ND ST,200,SCOTTSDALE,AZ,85258,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,AR,AZ,MS,TN,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,TECENTRIQ,50242-917-01,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,23509,11/14/2018,Cash or cash equivalent,,,No,No,PHASE IB IMMUNO COMBO WITH PDL 1,No,590738643,2018,6/28/2019,,,
Covered Recipient Physician,,,,,183158,MICHAEL,J,COLUMBUS,,4850 RED BANK RD,1 PLASTIC SURGERY PLAZA,CINCINNATI,OH,45227-1545,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Plastic Surgery,KY,,,,,,,,,,,,,,,,,,,,,,,,"Medical Device Business Services, Inc.",1.00E+11,"Medical Device Business Services, Inc.",IN,United States,Yes,Covered,Device,Plastic Surgery,MemoryGel Breast Implants,,,,,,,,,,,,,,,,457.56,12/6/2018,Cash or cash equivalent,,,No,No,A Study of the Safety and Effectiveness of the Mentor Smooth and Textured Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects who are Undergoing Primary Breast Reconstruction or Revision Reconstruction (MEN-15-001),No,556892719,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,393303,6270,THE CHILDRENS HOSPITAL OF PHILADELP,,,,,,34TH STREET & CIVIC CENTER BLVD,,PHILADELPHIA,PA,19104,United States,,,,,,,,,,292959,SOUMYA,,ADHIKARI,,5323 HARRY HINES BLVD,"ROOM G2.236, MC 9063",DALLAS,TX,75390-7201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology,TX,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,NO PRODUCT DISCUSSED,,,,,,,,,,,,,,,,7848.3,5/15/2018,Cash or cash equivalent,,,No,No,Insulin glargine - LANTUS/TOUJ,No,601908239,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 Clifton Rd NE,,Atlanta,GA,30322,United States,,,,,,,,,,194238,ANSHUL,,PATEL,,5671 PEACHTREE DUNWOODY RD,SUITE 300 B,ATLANTA,GA,30342-1786,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,GA,,,,"Medical Device Business Services, Inc.",1.00E+11,"Medical Device Business Services, Inc.",IN,United States,Yes,Covered,Device,Therapeutic Catheters,Thermocool,,,,,,,,,,,,,,,,5200,5/18/2018,Cash or cash equivalent,,,No,No,Prospective Review of the Safety and Effectiveness of the THERMOCOOLSMARTTOUCHSF Catheter Evaluated for Treating Symptomatic PersistenT AF (PRECEPT),No,556892975,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,30103,7141,MAYO CLINIC HOSPITAL,,,,,,5777 EAST MAYO BLVD,,PHOENIX,AZ,85054,United States,,,,,,,,,,1291170,AARON,R,MANGOLD,,13400 E SHEA BLVD,,SCOTTSDALE,AZ,85259,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,AZ,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,15143.61,10/26/2018,Cash or cash equivalent,,,No,No,A PHASE 2A DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF PF06823859 IN ADULT SUBJECTS WITH DERMATOMYOSITIS,No,599753317,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,140010,6476,NORTHSHORE UNIVERSITY HEALTHSYSTEM,,,,,,2650 Ridge Ave,,Evanston,IL,60201,United States,,,,,,,,,,245518,AFIF,,HENTATI,,2650 RIDGE AVE,NEUROLOGY BURCH 309,EVANSTON,IL,60201-1718,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,IL,,,,"Alkermes, Inc.",1.00E+11,"Alkermes, Inc.",MA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,8056.62,4/9/2018,Cash or cash equivalent,,,No,No,A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1,No,561757215,2018,6/28/2019,NCT03093324,,
Covered Recipient Teaching Hospital,,300003,6031,MARY HITCHCOCK MEMORIAL HOSP,,,,,,ONE MEDICAL CENTER DRIVE,,LEBANON,NH,3756,United States,,,,,,,,,,168064,WILLIAM,F C,RIGBY,,1 MEDICAL CENTER DR,DHMC RHEUMATOLOGY,LEBANON,NH,03756-1000,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,NH,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,250,6/7/2018,Cash or cash equivalent,,,No,No,M15-555,No,566852545,2018,6/28/2019,NCT02706951,,
Covered Recipient Teaching Hospital,,220071,6048,MASSACHUSETTS GENERAL HOSPITAL,,,,,,55 Fruit St,Bulfinch 360,Boston,MA,2114,United States,,,,,,,,,,60698,STUART,H,HERSHMAN,,6000 N FEDERAL HWY,,FT LAUDERDALE,FL,33308-2226,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Orthopaedic Surgery of the Spine,MA,,,,"Medical Device Business Services, Inc.",1.00E+11,"Medical Device Business Services, Inc.",IN,United States,Yes,Covered,Device,Spine,LIFENET VIVIGEN,,,,,,,,,,,,,,,,13500,5/8/2018,Cash or cash equivalent,,,No,No,"A Multi-center, Prospective, Single Arm Study of Patients Undergoing a Two or Three Level ACDF Using ViviGen Cellular Bone Matrix in Conjunction with Cervical Allograft Spacers and DePuy Synthes Spine Arterior Cervical Plate Systems.",No,556893231,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,100034,6831,MT. SINAI MEDICAL CENTER,,,,,,4300 Alton Rd,5 WARNER,Miami Beach,FL,33140,United States,,,,,,,,,,590723,MARINA,,KREMYANSKAYA,,1190 5TH AVENUE,BOX 3000,NEW YORK,NY,10029,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,NY,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,5250,4/4/2018,Cash or cash equivalent,,,No,No,"A Phase 2 Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis",No,576954471,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 CLIFTON ROAD,,ATLANTA,GA,30302,United States,,,,,,,,,,202228,SURESH,S,RAMALINGAM,,1365 Clifton Road,,Decatur,GA,30322,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,GA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Covered,Drug,ONCOLOGY,BAVENCIO,44087-3535-1,,,,,,,,,,,,,,,185.25,8/2/2018,Cash or cash equivalent,,,No,No,A PHASE 1B2 OPENLABEL DOSEFINDING STUDY TO EVALUATE SAFETY EFFICACY PHARMACOKINETICS AND PHARMACODYNAMICS OF AVELUMAB MSB0010718C IN COMBINATION WITH EITHER CRIZOTINIB OR PF06463922 IN PATIENTS WITH ADVANCED OR METASTATIC NONSMALL CELL LUNG CANCER,No,599753819,2018,6/28/2019,,,
Covered Recipient Physician,,,,,476449,LISA,NMI,GUSHIN,,203 OWEN DR,,FAYETTEVILLE,NC,28304-3409,United States,,,Doctor of Dentistry,Dental Providers|Dentist|General Practice,NC,,,,,,,,,,,,,,,,,,,,,,,,Kerr Corporation,1.00E+11,Kerr Corporation,CA,United States,Yes,Covered,Device,RESTORATIVE DENTISTRY,OPTIBOND UNIVERSAL,,,,,,,,,,,,,,,,50,2/1/2018,Cash or cash equivalent,,,No,No,Market Research Protocol OptiBond Universal DC 17-04,No,573689985,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,250001,6952,UNIVERSITY OF MISSISSIPPI MEDICAL,,,,,,2500 N STATE ST,,JACKSON,MS,39216,United States,,,,,,,,,,170262,BENJAMIN,M,STRONACH,,2500 NORTH STATE STREET,DEPARTMENT OF ORTHOPEDICS,JACKSON,MS,35216-4500,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Adult Reconstructive Orthopaedic Surgery,MS,,,,"Medical Device Business Services, Inc.",1.00E+11,"Medical Device Business Services, Inc.",IN,United States,Yes,Covered,Device,Ortho-Knee,ATTUNE,,,,,,,,,,,,,,,,3144,7/19/2018,Cash or cash equivalent,,,No,No,Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty,No,556893487,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,54144,7262,LANGLEY PORTER PSYCHIATRIC HOSPITAL,,,,,,401 Parnassus Ave,,San Francisco,CA,94143,United States,,,,,,,,,,1157805,LEE-MAY,,CHEN,,1600 DIVISADERO ST,,SAN FRANCISCO,CA,94143-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,CA,,,,"Clovis Oncology, Inc.",1.00E+11,"Clovis Oncology, Inc.",CO,United States,Yes,Covered,Drug,ONCOLOGY,RUBRACA,69660-201-91,,,,,,,,,,,,,,,475,2/16/2018,Cash or cash equivalent,,,No,No,"A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer (ARIEL3)",No,582351701,2018,6/28/2019,NCT01968213,,CO-338-014
Covered Recipient Teaching Hospital,,100034,6831,MT. SINAI MEDICAL CENTER,,,,,,4300 Alton Rd,5 WARNER,Miami Beach,FL,33140,United States,,,,,,,,,,146115,JOSE,,LUTZKY,,4306 ALTON RD,3RD FLOOR,MIAMI BEACH,FL,33140-2840,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,FL,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,91.2,6/27/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies",No,576954577,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,330059,6130,MONTEFIORE MEDICAL CENTER,,,,,,111 E 210th St,,Bronx,NY,10467,United States,,,,,,,,,,131047,MARK,D,LEVIE,,600 E 233rd St,,Bronx,NY,10466,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology,NY,,,,Bayer HealthCare Pharmaceuticals Inc.,1.00E+11,Bayer HealthCare Pharmaceuticals Inc.,NJ,United States,Yes,Covered,Device,Women's Health,Essure,,,,,,,,,,,,,,,,750,11/9/2018,Cash or cash equivalent,,,No,No,BAY1454032,No,537582215,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50262,7301,Ronald Reagan Ucla Medical Center,,,,,,757 Westwood Plz,,Los Angeles,CA,90095,United States,,,,,,,,,,160,Anjay,,Rastogi,,10833 Le Conte Ave,22-387,Los Angeles,CA,90095,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,CA,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca Pharmaceuticals LP,DE,United States,No,,,,,,,,,,,,,,,,,,,,14609.31,2/27/2018,Cash or cash equivalent,,,No,No,A Phase 3 Randomized Double Blind Placebo Controlled Study Evaluating the Safety and Efficacy of Roxadustat AZD9941 for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis,No,556965777,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50137,7207,KFH - PANORAMA CITY,,,,,,13652 CANTARA STREET,,PANORAMA CITY,CA,91402,United States,,,,,,,,,,694856,BRYON,,QUICK,,280 W MACARTHUR BLVD,,OAKLAND,CA,94611,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine,CA,,,,VERTEX PHARMACEUTICALS INCORPORATED,1.00E+11,Vertex Pharmaceuticals Incorporated,MA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1829.1,3/24/2018,Cash or cash equivalent,,,No,No,A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects with Cystic Fibrosis who are Homozygous for the F508del-CFTR Mutation,No,585554063,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,170122,6715,Via Christi Hospital Wichita,,,,,,929 N Saint Francis St,,Wichita,KS,67214,United States,,,,,,,,,,296039,Seth,Joel,Page,,3243 E Murdock St,Ste 300,Wichita,KS,67208,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,KS,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca Pharmaceuticals LP,DE,United States,Yes,Covered,Drug,Oncology,FASLODEX,0310-0720-10,,,,,,,,,,,,,,,2676,3/8/2018,Cash or cash equivalent,,,No,No,SWOG S1222 Collaborative Post AI Study,No,556966327,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,110083,6811,PIEDMONT HOSPITAL INC.,,,,,,1968 Peachtree Rd NW,,Atlanta,GA,30309,United States,,,,,,,,,,157545,AMY,H,CASE,,3820 MEDICAL PARK DR,,AUSTELL,GA,30106-1110,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,GA,,,,United Therapeutics Corporation,1.00E+11,United Therapeutics Corporation,NC,United States,Yes,Covered,Drug,PAH,TYVASO,66302-206-01,,,,,,,,,,,,,,,8623.4,11/30/2018,Cash or cash equivalent,,,No,No,AN OPEN-LABEL EXTENSION STUDY OF INHALED TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION DUE TO PARENCHYMAL LUNG DISEASE,No,615283909,2018,6/28/2019,NCT02633293,,
Covered Recipient Teaching Hospital,,100168,6844,Boca Raton Regional Hospital,,,,,,800 Meadows Road,,Boca Raton,FL,33486,United States,,,,,,,,,,115655,Alexander,,Kulik,,801 Meadows Rd,Ste 104,Boca Raton,FL,33486,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery),FL,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca Pharmaceuticals LP,DE,United States,Yes,Covered,Drug,Cardiovascular and Metabolism,BRILINTA,0186-0776-60,,,,,,,,,,,,,,,429859.94,1/8/2018,In-kind items and services,,,No,No,Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis TARGET TrialDoes Ticagrelor Improve Graft Patency after Coronary Bypass,No,556966821,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,310073,6254,JERSEY SHORE UNIVERSITY MED CTR,,,,,,1945 Route 33,,Neptune,NJ,7753,United States,,,,,,,,,,92860,KATHLEEN,K,CASEY,,19 DAVIS AVE FL 6,19 DAVIS AVE FL 6,NEPTUNE,NJ,07753-4488,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,NJ,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,INFECTIOUS DISEASE,DELSTRIGO,0006-5007-01,,,,,,,,,,,,,,,1064.76,6/12/2018,In-kind items and services,,,No,No,"A Phase III Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-1439A Once-Daily Versus ATRIPLA  Once-Daily in Treatment-Na ve HIV-1 Infected Subjects",No,607026495,2018,6/28/2019,,,Study drug provided to a clinical study site.
Covered Recipient Teaching Hospital,,103301,6836,MIAMI CHILDRENS HOSPITAL,,,,,,3100 SW 62nd Ave,Attention: Research Financial Analyst,Miami,FL,33155,United States,,,,,,,,,,531936,Ana,,Paredes,,3200 SW 60TH CT,,Miami,FL,33155,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|General Practice,MA,,,,"Retrophin, Inc.",1.00E+11,"Retrophin, Inc.",CA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,7297.1,2/26/2018,Cash or cash equivalent,,,No,No,DUET,No,616151385,2018,6/28/2019,NCT01613118,,
Covered Recipient Teaching Hospital,,380009,7189,OHSU HOSPITAL AND CLINICS,,,,,,3181 SAM JACKSON PARK ROAD,,PORTLAND,OR,97239,United States,,,,,,,,,,277973,MATTHEW,H,TAYLOR,,3181 SW SAM JACKSON PARK RD,MAIL CODE L586,PORTLAND,OR,97239-3011,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,OR,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,2085,2/6/2018,Cash or cash equivalent,,,No,No,"A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors",No,604993447,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,440039,6471,VANDERBILT UNIVERSITY MEDICAL CENTER,,,,,,1211 MEDICAL CENTER DRIVE,,NASHVILLE,TN,37232,United States,,,,,,,,,,263800,DANIEL,,CLAASSEN,,3601 TVC,,NASHVILLE,TN,37232-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,MN,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,59719,7/19/2018,Cash or cash equivalent,,,No,No,M15-562,No,566853825,2018,6/28/2019,NCT02985879,,
Covered Recipient Teaching Hospital,,500044,7166,Deaconess Medical Center,,,,,,800 W 5th Ave,,Spokane,WA,99204,United States,,,,,,,,,,324480,Ronald,John,Graf,,1901 S Cedar St,Ste 205,Tacoma,WA,98405,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",WA,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca Pharmaceuticals LP,DE,United States,Yes,Covered,Drug,Cardiovascular and Metabolism,FARXIGA,0310-6205-30,,,,,,,,,,,,,,,30707.63,3/22/2018,Cash or cash equivalent,,,No,No,"Dapagliflozin Effect on Cardiovascular Events  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes",No,556969929,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50146,7271,CITY OF HOPE NATIONAL MEDICAL CTR,,,,,,1500 E DUARTE ROAD,,DUARTE,CA,91010,United States,,,,,,,,,,100883,AMRITA,YESHODA,KRISHNAN,,1500 DUARTE RD,,DUARTE,CA,91010,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,CA,,,,"Seattle Genetics, Inc.",1.00E+11,"Seattle Genetics, Inc.",WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,18976.46,4/12/2018,Cash or cash equivalent,,,No,No,Phase 1 study of SGN-CD352A in patients with relapsed or refractory multiple myeloma,No,611529657,2018,6/28/2019,NCT02954796,https://clinicaltrials.gov/ct2/show/NCT02954796,
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,2301 COMMONWEALTH BLVD,,ANN ARBOR,MI,48105,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,NO PRODUCT DISCUSSED,,,,,,,,,,,,,,,,1800,5/22/2018,Cash or cash equivalent,,,No,No,systematic sclerosis,No,601910821,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,380009,7189,OHSU HOSPITAL AND CLINICS,,,,,,3181 SAM JACKSON PARK ROAD,,PORTLAND,OR,97239,United States,,,,,,,,,,277973,MATTHEW,H,TAYLOR,,3181 SW SAM JACKSON PARK RD,MAIL CODE L586,PORTLAND,OR,97239-3011,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,OR,,,,Eisai Inc.,1.00E+11,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,2085,3/22/2018,Cash or cash equivalent,,,No,No,"A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors",No,604993585,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 CLIFTON ROAD,,ATLANTA,GA,30302,United States,,,,,,,,,,95854,SETH,,WALKER,,1365 CLIFTON RD NE,,ATLANTA,GA,30322,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,GA,,,,VERTEX PHARMACEUTICALS INCORPORATED,1.00E+11,Vertex Pharmaceuticals Incorporated,MA,United States,Yes,Covered,Drug,CYSTIC FIBROSIS,ORKAMBI,51167-809-01,,,,,,,,,,,,,,,5716,1/1/2018,Cash or cash equivalent,,,No,No,Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor,No,585554441,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,160104,6506,Trinity Bettendorf,,,,,,4500 Utica Ridge Rd,,Bettendorf,IA,52722,United States,,,,,,,,,,45952,Sanjeev,,Puri,,1100 36th Ave,--,Moline,IL,61265,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,IL,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca Pharmaceuticals LP,DE,United States,Yes,Covered,Drug,Cardiovascular and Metabolism,FARXIGA,0310-6205-30,,,,,,,,,,,,,,,107.68,12/31/2018,In-kind items and services,,,No,No,"Dapagliflozin Effect on Cardiovascular Events  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes",No,556970365,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,180103,6865,BAPTIST HEALTH LEXINGTON,,,,,,1740 NICHOLASVILLE RD,,LEXINGTON,KY,40503,United States,,,,,,,,,,212826,CURTIS,ALDEN,GIVEN,II,1760 Nicholasville RD,Ste 301,Lexington,KY,40503,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Neuroradiology,KY,,,,"Medtronic USA, Inc.",1.00E+11,"Medtronic USA, Inc.",MN,United States,Yes,Covered,Device,Flow Diversion,Pipeline,,,,,,,,,,,,,,,,879.6,4/2/2018,Cash or cash equivalent,,,No,No,PREMIER Study,No,572236005,2018,6/28/2019,,,
Covered Recipient Physician,,,,,60547,Bruce,,Baker,,1600 Waters Ridge Drive,,Lewisville,TX,75057,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|General Practice,TX,,,,,,,,,,,,,,,,,,,,,,,,"Retrophin, Inc.",1.00E+11,"Retrophin, Inc.",CA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,24.78,11/30/2018,Cash or cash equivalent,,,No,No,021IGAN17001,No,616151609,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,224007,6047,MCLEAN HOSPITAL,,,,,,115 Mill Street,,BELMONT,MA,2478,United States,,,,,,,,,,45675,Perminder,,Bhatia,,736 E. Bullard St.,Suite 101,Fresno,CA,93710,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,CA,,,,Sunovion Pharmaceuticals Inc.,1.00E+11,Sunovion Pharmaceuticals Inc.,MA,United States,Yes,Non-Covered,Drug,CNS,SEP-363856,,,,,,,,,,,,,,,,6.18,3/31/2018,In-kind items and services,,,No,No,"A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis",No,601559015,2018,6/28/2019,NCT02969369,,SEP361-203
Covered Recipient Teaching Hospital,,360180,6422,CLEVELAND CLINIC HOSPITAL,,,,,,9500 EUCLID AVE,,CLEVELAND,OH,44195,United States,,,,,,,,,,170769,JORGE,A,GARCIA,,9500 EUCLID AVE,,CLEVELAND,OH,44195,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,OH,,,,"Genentech, Inc.",1.00E+11,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,TECENTRIQ,50242-917-01,,,,,,,,,,,,,,,2304.9,3/28/2018,Cash or cash equivalent,,,No,No,ATEZOLIZUMAB IN MUSCLE INVASIVE BLADDER CANCER MIBC,No,590740645,2018,6/28/2019,,,
Covered Recipient Physician,,,,,714351,HELEN,M.,BRONTE-STEWART,,213 Quarry RD,,Palo Alto,CA,94304,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,CA,,,,,,,,,,,,,,,,,,,,,,,,"Medtronic USA, Inc.",1.00E+11,"Medtronic USA, Inc.",MN,United States,No,,,,,,,,,,,,,,,,,,,,4599,10/16/2018,In-kind items and services,,,No,No,Investigator Sponsored Research,No,572237669,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50660,7266,USC NORRIS CANCER HOSPITAL,,,,,,1975 Zonal Ave KAM 314,,Los Angeles,CA,90089,United States,,,,,,,,,,77794,Raymond,,Manning,,8309 Telegraph Rd,Attn Thomas Tran,Pico Rivera,CA,90660,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,CA,,,,Sunovion Pharmaceuticals Inc.,1.00E+11,Sunovion Pharmaceuticals Inc.,MA,United States,Yes,Non-Covered,Drug,CNS,Sep-363856,,,,,,,,,,,,,,,,311.65,1/31/2018,In-kind items and services,,,No,No,A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia,No,601559163,2018,6/28/2019,NCT02969382,,SEP361-201
Covered Recipient Teaching Hospital,,160058,6639,UNIVERSITY OF IOWA HOSP & CLINICS,,,,,,200 HAWKINS DRIVE,,IOWA CITY,IA,52242,United States,,,,,,,,,,547235,ANTONIO,J,SANCHEZ,,200 HAWKINS DR,,IOWA CITY,IA,52242-1009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hepatology,FL,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,1521.39,7/10/2018,Cash or cash equivalent,,,No,No,M16-135,No,566855187,2018,6/28/2019,NCT03089944,,
Covered Recipient Teaching Hospital,,50660,7266,USC NORRIS CANCER HOSPITAL,,,,,,1441 Eastlake Ave,,Los Angeles,CA,90089,United States,,,,,,,,,,70270,MITCHELL,,GROSS,,9033 WILSHIRE BLVD,SUITE 300,BEVERLY HILLS,CA,90211-1837,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,CA,,,,"Clovis Oncology, Inc.",1.00E+11,"Clovis Oncology, Inc.",CO,United States,Yes,Covered,Drug,ONCOLOGY,Rubraca,69660-201-91,,,,,,,,,,,,,,,4843.07,7/16/2018,Cash or cash equivalent,,,No,No,A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency (TRITON3),No,582354401,2018,6/28/2019,NCT02975934,,CO-338-063
Covered Recipient Teaching Hospital,,53304,7283,CHILDRENS HOSPITAL OF ORANGE COUNT,,,,,,455 S Main St,,Orange,CA,92868,United States,,,,,,,,,,852516,ADAM,J,SCHWARZ,,1201 W LA VETA AVE,,ORANGE,CA,92868-4203,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Critical Care Medicine,AZ,,,,La Jolla Pharmaceutical Company,1.00E+11,La Jolla Pharmaceutical Company,CA,United States,Yes,Covered,Drug,GIAPREZA,GIAPREZA,68547-501-02,,,,,,,,,,,,,,,500,7/30/2018,Cash or cash equivalent,,,No,No,A STUDY OF LJPC-501 IN PEDIATRIC PATIENTS WITH HYPOTENSION,No,615673049,2018,6/28/2019,NCT03431077,https://ClinicalTrials.gov/show/NCT03431077,
Covered Recipient Teaching Hospital,,363302,6437,RAINBOW BABIES & CHILDRENS HOSPITAL,,,,,,11100 Euclid Ave,,Cleveland,OH,44106,United States,,,,,,,,,,197382,Kent,P,Bashford,,1725 E Prospect Rd,,Fort Collins,CO,80525-1307,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Ophthalmology,CO,KS,,,Glaukos Corporation,1.00E+11,Glaukos Corporation,CA,United States,Yes,Covered,Device,Glaucoma,iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM,,,,,,,,,,,,,,,,200,9/14/2018,Cash or cash equivalent,,,No,No,Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty,No,616474857,2018,6/28/2019,NCT02327312,,
Covered Recipient Teaching Hospital,,270049,7087,ST VINCENT HEALTHCARE,,,,,,1233 N 30th St,,Billings,MT,59101,United States,,,,,,,,,,277844,PIERRE,,TRIOZZI,,MEDICAL CENTER BLVD,,WINSTON SALEM,NC,27157-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,NC,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,10.8,11/28/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of INCB24360 Administered in Combination With Nivolumab in Select Advanced Cancers",No,576956635,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,230077,6541,ST. MARYS OF MICHIGAN,,,,,,800 S WASHINGTON AVE,,SAGINAW,MI,48601,United States,,,,,,,,,,361199,PETER,,FATTAL,,1015 S WASHINGTON AVE,,SAGINAW,MI,48601-2556,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,MI,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Drug,CARDIOVASCULAR,ENTRESTO,0078-0659-20,,,,,,,,,,,,,,,80462.31,11/28/2018,Cash or cash equivalent,,,No,No,A MULTICENTER RANDOMIZED DOUBLE BLIND ACTIVE CONTROLLED STUDY TO EVALUATE THE EFFECTS OF LCZ696 COMPARED TO VALSARTAN ON COGNITIVE FUNCTION AS ASSESSED BY COMPREHENSIVE NEUROCOGNITIVE BATTERY AND BRAIN AMYLOID PLAQUE DEPOSITION AS ASSESSED BY PET IMAGING IN PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION,No,584633125,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,140119,6486,RUSH UNIVERSITY MEDICAL CENTER,,,,,,1653 W CONGRESS PARKWAY,,CHICAGO,IL,60612,United States,,,,,,,,,,84581,MELODY,,COBLEIGH,,1725 W HARRISON ST STE 821,,CHICAGO,IL,60612-3841,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,IL,,,,"Seattle Genetics, Inc.",1.00E+11,"Seattle Genetics, Inc.",WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1950,9/5/2018,Cash or cash equivalent,,,No,No,"Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib",No,611531933,2018,6/28/2019,NCT02614794,https://clinicaltrials.gov/ct2/show/NCT02614794,
Covered Recipient Teaching Hospital,,220110,6045,BRIGHAM AND WOMENS HOSPITAL,,,,,,75 FRANCIS STREET,3714,BOSTON,MA,2115,United States,,,,,,,,,,59058,PAUL,,SAX,,75 FRANCIS ST,,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,MA,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HIV,Biktarvy,61958-2501-1,,,,,,,,,,,,,,,2220,6/20/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Switching from a Regimen of FTC/TAF and Dolutegravir to a FDC of bictegravir/FTC/TAF in HIV 1 Infected Subjects who are Virologically Suppressed",No,585498319,2018,6/28/2019,,,;GS-US-380-4030;GSQOAPPCU999W;GILDA;3355303;3355303-1;042312909;10008319;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,440104,6930,ERLANGER MEDICAL CENTER,,,,,,975 EAST THIRD STREET,,CHATTANOOGA,TN,37403,United States,,,,,,,,,,307777,HARISH,,MANYAM,,979 E 3RD ST STE C520,,CHATTANOOGA,TN,37403,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,OH,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,390,10/10/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609125979,2018,6/28/2019,,,533056QPEXCELS
Covered Recipient Teaching Hospital,,50262,7301,RONALD REAGAN UCLA MEDICAL CENTER,,,,,,757 Westwood Plz,,Los Angeles,CA,90095,United States,,,,,,,,,,1379211,GOTTFRIED,E,KONECNY,,200 1ST ST SW,,ROCHESTER,MN,55905-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,CA,,,,"Clovis Oncology, Inc.",1.00E+11,"Clovis Oncology, Inc.",CO,United States,Yes,Covered,Drug,ONCOLOGY,Rubraca,69660-201-91,,,,,,,,,,,,,,,30,1/30/2018,Cash or cash equivalent,,,No,No,"A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)",No,582357465,2018,6/28/2019,NCT01891344,,CO-338-017
Covered Recipient Teaching Hospital,,50348,7281,UCI MEDICAL CENTER,,,,,,101 THE CITY DR S,,ORANGE,CA,92868,United States,,,,,,,,,,213273,RITESH,,PARAJULI,,3300 NW EXPRESSWAY,,OKLAHOMA CITY,OK,73112-4418,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,CA,IL,OK,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Drug,ONCOLOGY,KISQALI,0078-0860-01,,,,,,,,,,,,,,,75217.14,5/16/2018,Cash or cash equivalent,,,No,No,AN OPEN LABEL MULTICENTER PHASE IIIB STUDY OF RIBOCICLIB LEE011 IN COMBINATION WITH LETROZOLE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE HR HER2 NEGATIVE HER2 ADVANCED BREAST CANCER ABC WHO RECEIVED NO PRIOR HORMONAL THERAPY FOR ADVANCED DISEASE,No,584633381,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,500027,7156,SWEDISH MEDICAL CENTER,,,,,,747 BROADWAY,,SEATTLE,WA,98122,United States,,,,,,,,,,60322,PHILIP,J,MEASE,,601 BROADWAY  600,,SEATTLE,WA,98122,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,WA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Covered,Biological,DERMATOLOGY;INFLAMMATION;PAIN,ENBREL,58406-435-04,,,,,,,,,,,,,,,810,11/16/2018,Cash or cash equivalent,,,No,No,A MULTICENTER OPENLABEL STUDY OF ETANERCEPT WITHDRAWAL AND RETREATMENT IN SUBJECTS WITH NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS WHO ACHIEVED ADEQUATE 24 WEEK RESPONSE,No,599766627,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,63301,7107,CHILDRENS HOSPITAL COLORADO,,,,,,13123 EAST 16TH AVENUE,,AURORA,CO,80045,United States,,,,,,,,,,1178051,ELIZABETH,,MCFARLAND,,1056 E 19TH AVE,,DENVER,CO,80218,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Infectious Diseases,CO,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HIV,Tybost,61958-1401-1,,,,,,,,,,,,,,,1562,6/20/2018,Cash or cash equivalent,,,No,No,"A Phase 2/3, Multicenter, Open-label, Multicohort, Two Part Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat boosted Darunavir (DRV/co), Administered with a  Background Regimen (BR) in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects",No,585498575,2018,6/28/2019,,,;GS-US-216-0128;GSQOAPPCU983I;GILDA;3355495;3355495-1;840166760;10016778;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,360137,6438,UH CLEVELAND MEDICAL CENTER,,,,,,11100 Euclid Ave,,Cleveland,OH,44106,United States,,,,,,,,,,901945,James,,Chmiel,,11100 Euclid Avenue,"Department Of Dermatology, Bolwell Building",Cleveland,OH,44106,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology,IN,,,,"Teva Pharmaceuticals USA, Inc.",1.00E+11,"Teva Pharmaceuticals USA, Inc.",PA,United States,Yes,Covered,Biological,Respiratory,Cinqair,59310-610-31,,,,,,,,,,,,,,,2422,11/16/2018,Cash or cash equivalent,,,No,No,"A 52-Week Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Reslizumab 110 mg Fixed, Subcutaneous Dosing in Patients With Uncontrolled Asthma and Elevated Blood Eosinophils",No,590416341,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,440104,6930,ERLANGER MEDICAL CENTER,,,,,,975 EAST THIRD STREET,,CHATTANOOGA,TN,37403,United States,,,,,,,,,,307777,HARISH,,MANYAM,,979 E 3RD ST STE C520,,CHATTANOOGA,TN,37403,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,OH,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,39,2/13/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609126237,2018,6/28/2019,,,QP EXCELS057-037
Covered Recipient Teaching Hospital,,210011,6726,ST. AGNES HOSPITAL,,,,,,900 Caton Ave,,Baltimore,MD,21229,United States,,,,,,,,,,20019,CAROLE,,MILLER,,900 CATON AVE,,BALTIMORE,MD,21229-5201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MD,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,22.94,6/27/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK 3475 in Combination With INCB024360 in Subjects With Selected Cancers",No,576956859,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,450076,7039,UT MD ANDERSON CANCER CENTER,,,,,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,,,,,,,,566462,SAIRAH,,AHMED,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030-4009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,NC,TX,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KYMRIAH,0078-0846-19,,,,,,,,,,,,,,,18060.39,3/2/2018,Cash or cash equivalent,,,No,No,A MULTICENTER STUDY OF APHERESIS COLLECTION OF PERIPHERAL BLOOD MONONUCLEAR CELLS PBMC IN PATIENTS WITH CD19 EXPRESSING MALIGNANCIES WHO COULD BE ELIGIBLE FOR A CTL019 CLINICAL RESEARCH TRIAL,No,584633637,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50262,7301,RONALD REAGAN UCLA MEDICAL CENTER,,,,,,757 WESTWOOD PLZ,,LOS ANGELES,CA,90095,United States,,,,,,,,,,648593,ANTOINETTE,,GOMES,,757 WESTWOOD PLZ,,LOS ANGELES,CA,90095,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology,CA,,,,Merit Medical Systems Inc,1.00E+11,Merit Medical Systems Inc,UT,United States,Yes,Covered,Device,Radiology,Quadrasphere Microspheres,,,,,,,,,,,,,,,,5462,12/22/2018,Cash or cash equivalent,,,No,No,HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer (HiQuality),No,545631261,2018,6/28/2019,,,
Covered Recipient Physician,,,,,338981,BRUCE,,CREE,,350 PARNASSUS AVE,,SAN FRANCISCO,CA,94117-3612,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,CA,,,,,,,,,,,,,,,,,,,,,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Drug,NEUROSCIENCE,GILENYA,0078-0607-51,,,,,,,,,,,,,,,957.57,4/22/2018,In-kind items and services,,,No,No,RESEARCH RELATED PUBLICATION SUPPORT,No,584630817,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,100007,6839,FLORIDA HOSPITAL,,,,,,601 E ROLLINS ST,,ORLANDO,FL,32803,United States,,,,,,,,,,20341,TAREK,M,MEKHAIL,,2501 N ORANGE AVE,,ORLANDO,FL,32804,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,FL,OH,,,"Genentech, Inc.",1.00E+11,F. Hoffmann-La Roche AG,,Switzerland,Yes,Covered,Drug,BioOncology,Tarceva,50242-064-01,Covered,Biological,BioOncology,TECENTRIQ,50242-917-01,Non-Covered,Drug,None,Non-Covered Product,,,,,,1382.63,6/28/2018,Cash or cash equivalent,,,No,No,1L NSCLC NON SQUAMOUS DX ALL COMER ABRAXANE,No,590712199,2018,6/28/2019,,,
Covered Recipient Physician,,,,,301464,JAMES,C,LODEN,,520 RIVERGATE PARKWAY,,GOODLETTSVILLE,TN,37072-2030,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Ophthalmology,TN,,,,,,,,,,,,,,,,,,,,,,,,"Johnson & Johnson Surgical Vision, Inc.",1.00E+11,"Johnson & Johnson Surgical Vision, Inc.",CA,United States,Yes,Covered,Device,Optics,Tecnis 1-piece IOL,,Covered,Device,Optics,Tecnis 3-piece IOL,,,,,,,,,,,2940,12/11/2018,Cash or cash equivalent,,,No,No,SUR-CAT-652-01,No,556915289,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,180103,6865,BAPTIST HEALTH LEXINGTON,,,,,,1740 NICHOLASVILLE RD,,LEXINGTON,KY,40503,United States,,,,,,,,,,186481,GERY,F.,TOMASSONI,,1720 NICHOLASVILLE RD STE 601,,LEXINGTON,KY,40503,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,KY,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,121.25,8/14/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609123667,2018,6/28/2019,,,527412QPEXCELS
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,301351,ULKA,NITIN,VAISHAMPAYAN,,4100 JOHN R HWCRC 4TH FL,4100 JOHN R HWCRC 4TH FL,DETROIT,MI,48201-2013,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,150,5/22/2018,Cash or cash equivalent,,,No,No,Phase II Trial of Pembrolizumab MK-3475 in Subjects with Metastatic Castration-Resistant Prostate Cancer mCRPC KEYNOTE-199,No,607080909,2018,6/28/2019,,,
Covered Recipient Physician,,,,,21583,REETI,,JOSHI,,3560 DELAWARE ST STE 301,,BEAUMONT,TX,77706-3060,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,TX,,,,,,,,,,,,,,,,,,,,,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Biological,DERMATOLOGY,COSENTYX,0078-0639-41,,,,,,,,,,,,,,,382,1/31/2018,In-kind items and services,,,No,No,RESEARCH RELATED PUBLICATION SUPPORT,No,584631073,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,440039,6471,VANDERBILT UNIVERSITY MEDICAL CENTER,,,,,,1211 MEDICAL CENTER DRIVE,,NASHVILLE,TN,37232,United States,,,,,,,,,,113426,PETER,,HEDERA,,3601 TVC,,NASHVILLE,TN,37232-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,TN,,,,Ipsen Pharma SAS,1.00E+11,Ipsen Pharma SAS,,France,Yes,Covered,Drug,Neurology,Dysport,15054-0500-1,,,,,,,,,,,,,,,123.07,11/13/2018,Cash or cash equivalent,,,No,No,"An International, Multicentre, Prospective, Single-Arm Study to Assess the Effect on Voluntary Movements ofAbobotulinumtoxinA1500 U Administered in Both Upper and Lower Limbs in Conjunction With a Guided Self-Rehabilitation Contract in Adult Subjects With Spastic Hemiparesis",No,584630249,2018,6/28/2019,NCT02969356,,
Covered Recipient Physician,,,,,1172748,STUART,C.,MARSHALL,JR.,PO BOX 150,,WEST JORDAN,UT,84084-0150,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Orthopaedic Surgery,UT,,,,,,,,,,,,,,,,,,,,,,,,"Medacta USA, Inc.",1.00E+11,"Medacta USA, Inc.",IL,United States,Yes,Covered,Device,Hip,MasterLoc,,,,,,,,,,,,,,,,2318,7/2/2018,Cash or cash equivalent,,,No,No,MasterLoc,No,611119039,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,500027,7156,SWEDISH MEDICAL CENTER,,,,,,747 BROADWAY,,SEATTLE,WA,98122,United States,,,,,,,,,,42108,WILLIAM,IRA,BENSINGER,,1221 MADISON ST STE 1020,,SEATTLE,WA,98104,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,WA,,,,"Seattle Genetics, Inc.",1.00E+11,"Seattle Genetics, Inc.",WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,495,4/11/2018,Cash or cash equivalent,,,No,No,Phase 1 study of SGN-CD352A in patients with relapsed or refractory multiple myeloma,No,611530705,2018,6/28/2019,NCT02954796,https://clinicaltrials.gov/ct2/show/NCT02954796,
Covered Recipient Teaching Hospital,,100007,6839,FLORIDA HOSPITAL,,,,,,601 EAST ROLLINS STREET,,ORLANDO,FL,32803,United States,,,,,,,,,,180405,INDRANI,E.,ACOSTA,,1768 Business Center Dr,Ste 100,Reston,VA,20190,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,FL,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Cardiac Diagnostics and Monitoring,Reveal LINQ,,,,,,,,,,,,,,,,355,8/17/2018,Cash or cash equivalent,,,No,No,Stroke AF,No,572130743,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,180103,6865,BAPTIST HEALTH LEXINGTON,,,,,,1740 NICHOLASVILLE RD,,LEXINGTON,KY,40503,United States,,,,,,,,,,186481,GERY,F.,TOMASSONI,,1720 NICHOLASVILLE RD STE 601,,LEXINGTON,KY,40503,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,KY,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,121.25,8/14/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609123923,2018,6/28/2019,,,527438QPEXCELS
Covered Recipient Teaching Hospital,,363302,6437,RAINBOW BABIES & CHILDRENS HOSPITAL,,,,,,11100 Euclid Ave,,Cleveland,OH,44106,United States,,,,,,,,,,1381936,MOLLY,MEGAN,GALLOGLY,,11100 EUCLID AVE,,CLEVELAND,OH,44106-1716,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,OH,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,593.01,1/26/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double Blind, Placebo Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First Line Acute Graft Versus Host Disease",No,576955925,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,167911,POLLY,,NIRAVATH,,1 BAYLOR PLZ,BCM 660,HOUSTON,TX,77030-3411,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,TX,,,,,,,,,,,,,,,,,,,,,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Drug,ONCOLOGY,KISQALI,0078-0860-01,,,,,,,,,,,,,,,837.88,3/23/2018,In-kind items and services,,,No,No,RESEARCH RELATED PUBLICATION SUPPORT,No,584631333,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,450076,7039,Ut Md Anderson Cancer Center,,,,,,1515 Holcombe Blvd,,Houston,TX,77030,United States,,,,,,,,,,248876,William,G.,Wierda,,1515 Holcombe Blvd,--,Houston,TX,77030,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,TX,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,Acerta Pharma LLC,CA,United States,Yes,Covered,Drug,Oncology,CALQUENCE,0310-0512-28,,,,,,,,,,,,,,,47818.92,5/9/2018,Cash or cash equivalent,,,No,No,A Phase 1 Multicenter Open label and Dose escalation Study of ACP196 in Subjects with Chronic Lymphocytic Leukemia Richters Syndrome or Prolymphocytic Leukemia,No,556974945,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,53304,7283,CHILDRENS HOSPITAL OF ORANGE COUNT,,,,,,455 S Main St,,Orange,CA,92868,United States,,,,,,,,,,1020760,DELMA,J,NIEVES,,455 S MAIN ST,455 S MAIN ST,ORANGE,CA,92868-3874,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics,CA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,INFECTIOUS DISEASE,ZERBAXA,67919-030-01,,,,,,,,,,,,,,,11.81,6/26/2018,In-kind items and services,,,No,No,"A Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozone,Tazobactam MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Subjects with Complicated Intra-Abdominal Infections",No,607028439,2018,6/28/2019,,,Equipment or non-drug supplies provided to a clinical study site.
Covered Recipient Teaching Hospital,,230053,6543,HENRY FORD HOSPITAL,,,,,,2799 W Grand Blvd,,Detroit,MI,48202,United States,,,,,,,,,,23021,IGOR,I,RYBKIN,,2799 W GRAND BLVD,2799 W GRAND BLVD,DETROIT,MI,48202-2608,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MI,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,4844.16,3/6/2018,In-kind items and services,,,No,No,"A Phase III Randomized, Double-Blind, Placebo-controlled Trial of Pembrolizumab MK-3475,SCH900475 in Combination with Etoposide,Platinum Cisplatin or Carboplatin for the First-line Treatment of Subjects with Extensive Stage Small Cell Lung Cancer",No,607081057,2018,6/28/2019,,,Study drug provided to a clinical study site.
Covered Recipient Physician,,,,,218562,AHMAD,,TARHINI,,200 LOTHROP ST,,PITTSBURGH,PA,15213-2546,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,OH,PA,,,,,,,,,,,,,,,,,,,,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Drug,ONCOLOGY,MEKINIST,0078-0666-15,,,,,,,,,,,,,,,2356.25,5/3/2018,In-kind items and services,,,No,No,RESEARCH RELATED PUBLICATION SUPPORT,No,584631589,2018,6/28/2019,,,
Covered Recipient Physician,,,,,29038,ANDREW,E,HENDIFAR,,8700 BEVERLY BLVD,,WEST HOLLYWOOD,CA,90048-1827,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,CA,,,,,,,,,,,,,,,,,,,,,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,69.96,6/3/2018,In-kind items and services,,,Yes,No,,No,566856837,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,380007,7181,LEGACY EMANUEL HOSPITAL & HEALTH CTR,,,,,,1919 NW LOVEJOY,,PORTLAND,OR,97209,United States,,,,,,,,,,840769,BRIAN,PHILLIP,YOUNG,,1015 NW 22ND AVE,,PORTLAND,OR,97210,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine,MO,,,,Hollister Incorporated,1.00E+11,Hollister Incorporated,IL,United States,Yes,Covered,Device,CRITICAL CARE,ANCHORFAST SUBGLOTTIC,,,,,,,,,,,,,,,,2128,5/18/2018,Cash or cash equivalent,,,No,No,ANCHORFAST GUARD,No,576705913,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230041,6565,BAY REGIONAL MEDICAL CENTER,,,,,,1900 COLUMBUS AVE,,BAY CITY,MI,48708,United States,,,,,,,,,,352260,KALIL,,MASRI,,3175 W PROFESSIONAL BLVD,,BAY CITY,MI,48706-2823,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,MI,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Drug,CARDIOVASCULAR,ENTRESTO,0078-0659-20,,,,,,,,,,,,,,,16335,2/20/2018,Cash or cash equivalent,,,No,No,OBSERVATIONAL REGISTRY OF TREATMENT PATTERNS IN US HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION,No,584631845,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230165,6546,ST JOHN HOSPITAL & MEDICAL CENTER,,,,,,22101 MOROSS,,DETROIT,MI,48236,United States,,,,,,,,,,54050,DOUGLAS,R.,MOORE,,24211 LITTLE MACK AVE STE A,,SAINT CLAIR SHORES,MI,48080,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,MI,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Protego,,,,,,,,,,,,,,,,212.5,5/8/2018,Cash or cash equivalent,,,No,No,Protego DF4,No,609124693,2018,6/28/2019,,,519307PROTEGO
Covered Recipient Teaching Hospital,,73300,6076,CONNECTICUT CHILDRENS MEDICAL CENTER,,,,,,282 WASHINGTON ST,,HARTFORD,CT,6106,United States,,,,,,,,,,1270833,FRANCIS,,DIMARIO,,282 WASHINGTON ST,,HARTFORD,CT,06106-3322,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology,CT,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Drug,ONCOLOGY,AFINITOR,0078-0566-51,,,,,,,,,,,,,,,3432,1/22/2018,Cash or cash equivalent,,,No,No,AN OPEN LABEL IIIB MULTI CENTER EVEROLIMUS ROLL OVER PROTOCOL FOR PATIENTS HAVE COMPLETED EXIST3 A NOVARTIS SPONSORED EVEROLIMUS STUDY IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX TSC WHO HAVE REFRACTORY PARTIAL ONSET SEIZURES AND WHO ARE JUDGED BY THE INVESTIGATOR TO BENEFIT FROM CONTINUED EVEROLIMUS TREATMENT,No,584632101,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,150021,6450,PARKVIEW HOSPITAL,,,,,,11109 Parkview Plaza Dr,,Fort Wayne,IN,46845,United States,,,,,,,,,,917941,SUSHIL,,JAIN,,11050 PARKVIEW CIRCLE DR,11050 PARKVIEW CIRCLE DR,FORT WAYNE,IN,46845,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,IN,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,612,5/24/2018,In-kind items and services,,,No,No,A Randomized Phase 2 Study of the Combination of Pembrolizumab MK-3475 Plus Epacadostat INCB024360 with Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo as First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer,No,607029051,2018,6/28/2019,,,Equipment or non-drug supplies provided to a clinical study site.
Covered Recipient Teaching Hospital,,310073,6254,JERSEY SHORE UNIVERSITY MED CTR,,,,,,1945 ROUTE 33,,NEPTUNE,NJ,7753,United States,,,,,,,,,,312029,EVAN,,NAYLOR,,1301 ROUTE 72 W,SUITE 340,MANAHAWKIN,NJ,08050-2483,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,NJ,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Drug,ONCOLOGY,KISQALI,0078-0860-01,,,,,,,,,,,,,,,67091.78,1/11/2018,Cash or cash equivalent,,,No,No,MONALEESA 3 A RANDOMIZED DOUBLE BLIND PLACEBOCONTROLLED STUDY OF RIBOCICLIB IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER WHO HAVE RECEIVED NO OR ONLY ONE LINE OF PRIOR ENDOCRINE TREATMENT,No,584632357,2018,6/28/2019,,,
Covered Recipient Physician,,,,,43723,JOHN,M,KEGGI,,1579 STRAITS TURNPIKE SUITE E,ORTHOPAEDICS NEW ENGLAND PC,MIDDLEBURY,CT,6762,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Orthopaedic Surgery,CT,,,,,,,,,,,,,,,,,,,,,,,,Corin USA,1.00E+11,Corin USA,FL,United States,No,,,,,,,,,,,,,,,,,,,,1186.5,10/15/2018,Cash or cash equivalent,,,No,No,COC,No,590195459,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360180,6422,CLEVELAND CLINIC HOSPITAL,,,,,,9500 EUCLID AVENUE,,CLEVELAND,OH,44195,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cook Medical LLC,1.00E+11,Cook Incorporated,IN,United States,No,,,,,,,,,,,,,,,,,,,,659838,1/29/2018,Cash or cash equivalent,Patient Care,,Yes,No,,No,556791479,2018,6/28/2019,,,
Covered Recipient Physician,,,,,793898,KIRSTEN,L,JOHANSEN,,701 PARK AVE,,MINNEAPOLIS,MN,55415,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,CA,,,,,,,,,,,,,,,,,,,,,,,,"GlaxoSmithKline, LLC.",1.00E+11,"GlaxoSmithKline, LLC.",NC,United States,No,,,,,,,,,,,,,,,,,,,,128.92,1/22/2018,In-kind items and services,,,No,No,"A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P",No,593096349,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,450021,7050,BAYLOR UNIVERSITY MEDICAL CTR,,,,,,3500 GASTON AVENUE,,DALLAS,TX,75246,United States,,,,,,,,,,57517,MICHAEL,L.,FOREMAN,,2710 SWISS AVE,,DALLAS,TX,75204-5900,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Surgery|Trauma Surgery,TX,,,,Haemonetics Corporation,1.00E+11,Haemonetics Corporation,MA,United States,Yes,Covered,Device,Devices,TEG,,,,,,,,,,,,,,,,106.29,1/9/2018,In-kind items and services,,,No,No,TEG Comparison Study to assess parameters between TEG6s and TEG5000 in patients with traumatic injuries,No,614203133,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,450054,7024,SCOTT AND WHITE MEMORIAL HOSPITAL,,,,,,2401 S 31st St,,Temple,TX,76508,United States,,,,,,,,,,360800,MICAH,,BURCH,,3410 WORTH ST,,DALLAS,TX,75246-2003,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,TX,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,28.65,6/27/2018,Cash or cash equivalent,,,No,No,"A Double Blind, Double Dummy Phase 2 Randomized Study to Evaluate the Efficacy and Safety of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET 272)",No,576956433,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,30103,7141,MAYO CLINIC HOSPITAL,,,,,,5777 E MAYO BLVD,,PHOENIX,AZ,85054,United States,,,,,,,,,,96518,CRAIG,,REEDER,,5777 E MAYO BLVD,,PHOENIX,AZ,85054,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,AZ,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KYMRIAH,0078-0846-19,,,,,,,,,,,,,,,6826.09,4/18/2018,Cash or cash equivalent,,,No,No,PHASE II DIFFUSE LARGE B CELL LYMPHOMA DLBCL,No,584632613,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220071,6048,MASSACHUSETTS GENERAL HOSPITAL,,,,,,FRUIT STREET,,BOSTON,MA,2114,United States,,,,,,,,,,38960,SCOTT,B.,SILVERMAN,,52 2nd Ave,,Waltham,MA,2451,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,MA,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Cardiac Diagnostics and Monitoring,Reveal LINQ,,,,,,,,,,,,,,,,5398,2/15/2018,Cash or cash equivalent,,,No,No,Stroke AF,No,572132435,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220086,6042,BETH ISRAEL DEACONESS MEDICAL CENTER,,,,,,330 Brookline Ave,ST 207,Boston,MA,2215,United States,,,,,,,,,,364826,MARY,K,BUSS,,330 BROOKLINE AVE,"BETH ISRAEL DEACONESS MEDICAL CENTER, YAMINS 109",BOSTON,MA,02215-5400,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MA,,,,"Clovis Oncology, Inc.",1.00E+11,"Clovis Oncology, Inc.",CO,United States,Yes,Covered,Drug,ONCOLOGY,Rubraca,69660-201-91,,,,,,,,,,,,,,,210,9/7/2018,Cash or cash equivalent,,,No,No,"A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer (ARIEL3)",No,582356921,2018,6/28/2019,NCT01968213,,CO-338-014
Covered Recipient Teaching Hospital,,230038,6550,SPECTRUM HEALTH  HOSPITALS,,,,,,100 Michigan St NE,,Grand Rapids,MI,49503,United States,,,,,,,,,,87256,SYED MUNEER,,ABIDI,,145 MICHIGAN ST NE,SUITE 5200,GRAND RAPIDS,MI,49503-2562,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,28.65,12/20/2018,Cash or cash equivalent,,,No,No,"A Randomized, Double Blind, Placebo Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First Line Acute Graft Versus Host Disease",No,576956537,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,264345,PETER,,SHALIT,,901 BOREN AVE STE 850,,SEATTLE,WA,98104,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,WA,,,,,,,,,,,,,,,,,,,,,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HIV,Descovy,61958-2002-1,,,,,,,,,,,,,,,30104,10/22/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection",No,585498063,2018,6/28/2019,,,;GS-US-412-2055;G2285634;GILDA;3544752;3544752-2;10054141;10054141;VPL NAME AND SLN
Covered Recipient Teaching Hospital,,460009,7144,U OF U HOSPITALS & CLINICS,,,,,,50 NORTH MEDICAL DRIVE,,SALT LAKE CITY,UT,84132,United States,,,,,,,,,,765990,JOHN,,VALENTINE,,50 N MEDICAL DR,SOM 4R118,SALT LAKE CITY,UT,84132-2410,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,UT,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,Yes,Covered,Biological,Immunology,Humira,0074-4339-02,,,,,,,,,,,,,,,6432.52,8/9/2018,Cash or cash equivalent,,,No,No,M14-033,No,566858119,2018,6/28/2019,NCT02065622,,
Covered Recipient Teaching Hospital,,390164,6318,UPMC - PRESBYTERIAN SHADYSIDE,,,,,,200 LOTHROP STREET,,PITTSBURGH,PA,15213,United States,,,,,,,,,,1389412,MATTHEW,DAVID,NEAL,,200 LOTHROP ST,,PITTSBURGH,PA,15213,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Surgery,PA,,,,Haemonetics Corporation,1.00E+11,Haemonetics Corporation,MA,United States,Yes,Covered,Device,Devices,TEG,,,,,,,,,,,,,,,,11360,9/27/2018,In-kind items and services,,,No,No,TEG Comparison Study to assess parameters between TEG6s and TEG5000 in patients with traumatic injuries,No,614203389,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,440104,6930,ERLANGER MEDICAL CENTER,,,,,,975 EAST THIRD STREET,,CHATTANOOGA,TN,37403,United States,,,,,,,,,,307777,HARISH,,MANYAM,,979 E 3RD ST STE C520,,CHATTANOOGA,TN,37403,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,OH,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,97.5,1/3/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609125723,2018,6/28/2019,,,QP EXCELS057-005
Covered Recipient Teaching Hospital,,220116,6061,TUFTS MEDICAL CENTER,,,,,,800 WASHINGTON ST,,BOSTON,MA,2111,United States,,,,,,,,,,153298,KATHLEEN,,VIVEIROS,,75 FRANCIS ST,,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,MA,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HBV,Vemlidy,61958-2301-1,,,,,,,,,,,,,,,1245,10/24/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Positive, Chronic Hepatitis B",No,585501135,2018,6/28/2019,,,;GS-US-320-0110;G2296282;IPP;3548590;3548590-1;043400617;10126755;VPL PI NAME AND PI SLN
Covered Recipient Physician,,,,,475935,Emilie,V,Cheung,,300 Pasteur Dr,"Edwards Building, Rm R105B",Palo Alto,CA,94305,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Orthopaedic Surgery,MN,,,,,,,,,,,,,,,,,,,,,,,,"Exactech, Inc.",1.00E+11,"Exactech, Inc.",FL,United States,Yes,Covered,Device,Orthopaedic,Equinoxe,,,,,,,,,,,,,,,,352,3/23/2018,Cash or cash equivalent,,,No,No,"An Open Label, Multi-Center, Retrospective and Prospective Evaluation of Shoulder Arthroplasty Clinical and Radiographic Outcomes",No,606117779,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,80001,6718,Christiana Care Health System,,,,,,501 W 14th St,,Wilmington,DE,19801,United States,,,,,,,,,,146730,M. James,James,Lenhard,JR,501 W 14th St,Fl 4,Wilmington,DE,19801,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",DE,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca UK Limited,,Great Britain (Uk),Yes,Covered,Drug,Cardiovascular and Metabolism,FARXIGA,0310-6205-30,,,,,,,,,,,,,,,2829.31,6/13/2018,Cash or cash equivalent,,,No,No,Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes,No,556974103,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220116,6061,TUFTS MEDICAL CENTER,,,,,,750 Washington St,Box 018,Boston,MA,2111,United States,,,,,,,,,,1010770,DAVID,,ROSMARIN,,800 WASHINGTON ST # 114,DEPARTMENT OF DERMATOLOGY,BOSTON,MA,02111-1552,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,MA,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,76.4,4/26/2018,Cash or cash equivalent,,,No,No,"A Double Blind, Randomized, Dose Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo",No,576957923,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,220110,6045,BRIGHAM AND WOMENS HOSPITAL,,,,,,75 Francis St,,Boston,MA,2115,United States,,,,,,,,,,44673,SAMUEL,Z,GOLDHABER,,75 FRANCIS ST,CARDIOVASCULAR DIVISION BRIGHAM AND WOMEN'S HOSPITAL,BOSTON,MA,02115-6110,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,MA,,,,"BTG International, Inc.",1.00E+11,EKOS Corporation,WA,United States,Yes,Covered,Device,PERIPHERAL VASCULAR,EKOSONIC,,,,,,,,,,,,,,,,4464,4/11/2018,Cash or cash equivalent,,,No,No,PE Study PE  Optylase,No,616844627,2018,6/28/2019,NCT02396758,,
Covered Recipient Teaching Hospital,,10033,6942,UNIVERSITY OF ALABAMA HOSPITAL,,,,,,619 SOUTH 19TH STREET,,BIRMINGHAM,AL,35233,United States,,,,,,,,,,1293060,MICHAEL,JEFFREY,VINIKOOR,,101 MANNING DR,,CHAPEL HILL,NC,27514,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|General Practice,NC,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HBV,Viread,61958-0401-1,,,,,,,,,,,,,,,47365,4/2/2018,Cash or cash equivalent,,,No,No,Chronic hepatitis B virus clinical epidemiology in a representative sample of Zambian adults,No,585501391,2018,6/28/2019,,,;IN-US-174-3939;GSQOAPPCU8WG9;CLINENT;3204273-28424802;3204273-28424802-1;636005396;11100840;NPPES PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,440039,6471,VANDERBILT UNIVERSITY MEDICAL CENTER,,,,,,1211 MEDICAL CENTER DRIVE,,NASHVILLE,TN,37232,United States,,,,,,,,,,2688841,JONATHAN,MERLE,LEHMAN,,209 LIGHT HL,,NASHVILLE,TN,37232-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,TN,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,323,8/9/2018,Cash or cash equivalent,,,No,No,M16-300,No,566861453,2018,6/28/2019,NCT03026166,,
Covered Recipient Teaching Hospital,,110010,6813,Emory University Hospital,,,,,,1364 Clifton Rd Ne,,Atlanta,GA,30322,United States,,,,,,,,,,67491,Sagar,,Lonial,,1365c Clifton Rd Ne,--,Atlanta,GA,30322,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,GA,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca UK Limited,,Great Britain (Uk),Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1763.1,12/31/2018,In-kind items and services,,,No,No,A Phase I Open-Label Study to Assess the Safety Tolerability Pharmacokinetics and Preliminary Efficacy of Ascending Doses of AZD0156 Monotherapy or in Combination With Either Cytotoxic Chemotherapies or Novel Anti-Cancer Agents in Patients With Advanced Malignancies,No,556974849,2018,6/28/2019,,,
Covered Recipient Physician,,,,,145318,KYLE,,COLLE,,1723 Broadway ST Suite 410,,Cape Girardeau,MO,63701,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Neurological Surgery,MO,,,,,,,,,,,,,,,,,,,,,,,,"RTI Surgical, Inc.",1.00E+11,"RTI Surgical, Inc.",FL,United States,Yes,Covered,Device,Spinal Screws,SImmetry Sacroiliac Fusion System,,,,,,,,,,,,,,,,300,2/12/2018,Cash or cash equivalent,Other,,No,No,EVSI,No,580646133,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 Brookline Ave,,Boston,MA,2215,United States,,,,,,,,,,302616,PHILIPPE,,ARMAND,,450 BROOKLINE AVE,450 BROOKLINE AVE,BOSTON,MA,02215-5418,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,29940.96,3/2/2018,In-kind items and services,,,No,No,"A Phase 2 Study of pembrolizumab MK-3475 after Autologous Stem Cell Transplantation in Patients with Relapsed,Refractory Classical Hodgkin Lymphoma and Diffuse Large B Cell Lymphoma",No,607124773,2018,6/28/2019,,,Study drug provided to a clinical study site.
Covered Recipient Teaching Hospital,,460009,7144,U OF U HOSPITALS & CLINICS,,,,,,50 N Medical Dr,,Salt Lake City,UT,84132,United States,,,,,,,,,,461929,IGNACIO,,GARRIDO-LAGUNA,,1950 CIRCLE OF HOPE,CLINIC 1A,SALT LAKE CITY,UT,84112-5500,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,UT,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,4443.54,1/15/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2, Open Label, Dose Escalation/Dose Expansion, Safety and Tolerability Study of INCB057643 in Subjects with Advanced Malignancies",No,576958029,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,500054,6521,PROV SACRED HEART MEDICAL CENTER,,,,,,101 W 8th Ave,,Spokane,WA,99204,United States,,,,,,,,,,197489,JAYSON,S,BROWER,,801 S STEVENS ST,,SPOKANE,WA,99204-2654,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology,AZ,,,,"BTG International, Inc.",1.00E+11,EKOS Corporation,WA,United States,Yes,Covered,Device,PERIPHERAL VASCULAR,EKOSONIC,,,,,,,,,,,,,,,,1300,2/7/2018,Cash or cash equivalent,,,No,No,PE Study PE  Optylase,No,616845387,2018,6/28/2019,NCT02396758,,
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 CLIFTON ROAD,,ATLANTA,GA,30302,United States,,,,,,,,,,62409,MICHAEL,J,GAMBELLO,,2165 N DECATUR RD,,DECATUR,GA,30033-5307,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.),GA,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,GZ402666,,,,,,,,,,,,,,,,233,10/1/2018,In-kind items and services,,,No,No,"A Phase 3 Randomized, Multicenter, Multinational, Double-blinded Study Comparing the Efficacy and Safety of Repeated Biweekly Infusions of NeoGAA (GZ402666) and Alglucosidase Alfa in Treatment-naive P",No,602003979,2018,6/28/2019,NCT02782741,,
Covered Recipient Teaching Hospital,,390049,6276,ST. LUKES HOSPITAL,,,,,,801 Ostrum St,,Bethlehem,PA,18015,United States,,,,,,,,,,1289635,SANJIV,S,AGARWALA,,801 OSTRUM STREET,801 OSTRUM STREET,BETHLEHEM,PA,18015-1000,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|General Practice,PA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,1450,8/14/2018,Cash or cash equivalent,,,No,No,"A Randomized Double-Blind, Phase III Study of PlatinumPemtrexed Chemotherapy with or without Pembrolizumab MK-3475 in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects KEYNOTE-189",No,607082529,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,363300,6385,CHILDRENS HOSPITAL MEDICAL CENTER,,,,,,3333 BURNET AVENUE  MLC #4900,,CINCINNATI,OH,45229,United States,,,,,,,,,,270320,WILLIAM,,BALISTRERI,,3333 BURNET AVE,,CINCINNATI,OH,45229,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology,KY,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HCV,Sovaldi,61958-1501-1,,,,,,,,,,,,,,,1376,7/18/2018,Cash or cash equivalent,,,No,No,A Long Term Follow-up Registry for Pediatric Subjects Who Received Treatment in Gilead-Sponsored Chronic Hepatitis C Infection Trials,No,585498831,2018,6/28/2019,,,;GS-US-334-1113;GSQOAPPCU98O8;GILDA;3400770;3400770-1;310833936;10076939;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,390174,6297,Thomas Jefferson Univ. Hospital,,,,,,111 S 11th St,2210 Gibbon Building,Philadelphia,PA,19107,United States,,,,,,,,,,147048,Serge,A.,Jabbour,,211 S 9th St,Ste 600,Philadelphia,PA,19107,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",PA,,,,AstraZeneca Pharmaceuticals LP,1.00E+11,AstraZeneca UK Limited,,Great Britain (Uk),Yes,Covered,Drug,Cardiovascular and Metabolism,BYDUREON,0310-6530-01,,,,,,,,,,,,,,,2360,4/4/2018,Cash or cash equivalent,,,No,No,A 28 week Multicenter Randomized Double Blind Active Controlled Phase 3 Study with a 24 week Extension Phase to Evaluate the Efficacy and Safety of Simultaneous Administration of Exenatide Once Weekly 2 mg and Dapagliflozin Once Daily 10 mg Compared to Exenatide Once Weekly 2 mg Alone and Dapagliflozin Once Daily 10 mg Alone in Patients with Type 2 Diabetes who have Inadequate Glycemic Control on Metformin,No,556966849,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50625,7268,CEDARS-SINAI MEDICAL CENTER,,,,,,8700 Beverly Blvd,,Los Angeles,CA,90048,United States,,,,,,,,,,2793609,MARWA,,KAISEY,,127 S San Vicente Blvd Ste A6600,,Los Angeles,CA,90048-3311,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,CA,,,,"Biogen, Inc.",1.00E+11,"Biogen, Inc.",MA,United States,Yes,Covered,Drug,NEUROLOGY,TECFIDERA,64406-006-02,,,,,,,,,,,,,,,627,10/1/2018,Cash or cash equivalent,,,No,No,Dimethyl Fumarate (DMF) Observational Study,No,585596269,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,440104,6930,ERLANGER MEDICAL CENTER,,,,,,975 EAST THIRD STREET,,CHATTANOOGA,TN,37403,United States,,,,,,,,,,307777,HARISH,,MANYAM,,979 E 3RD ST STE C520,,CHATTANOOGA,TN,37403,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,OH,,,,BIOTRONIK INC.,1.00E+11,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Sentus,,,,,,,,,,,,,,,,302.26,7/10/2018,Cash or cash equivalent,,,No,No,QP ExCELs,No,609126493,2018,6/28/2019,,,525418QPEXCELS
Covered Recipient Teaching Hospital,,230156,6575,ST. JOSEPH MERCY HOSPITAL - ANN ARBO,,,,,,5301 Huron River Drive,,Ypsilanti,MI,48197,United States,,,,,,,,,,38869,TAREQ,,AL BAGHDADI,,5301 E HURON RIVER DR,STE C-139,YPSILANTI,MI,48197-1051,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,IN,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,1908,4/25/2018,Cash or cash equivalent,,,No,No,"PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED STATES ACADEMIC OR COMMUNITY CLINICAL PRACTICES",No,576956969,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,310014,6223,COOPER UNIVERSITY HOSPITAL,,,,,,ONE COOPER PLAZA,,CAMDEN,NJ,8103,United States,,,,,,,,,,878277,WILLIAM,,CHASANOV,,400 SAVANNAH RD,,LEWES,DE,19958,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,DE,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HIV,Biktarvy,61958-2501-1,,,,,,,,,,,,,,,6250,9/24/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9883/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naive Adults",No,585499087,2018,6/28/2019,,,;GS-US-380-1489;GSQMKW8WVDAJW;GILDA;2619332;2619332-1;210634462;10805136;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,100271,6858,H. LEE MOFFITT CANCER CENTER,,,,,,12902 MAGNOLIA DR,,TAMPA,FL,33612,United States,,,,,,,,,,986500,CHRISTINE,H.,CHUNG,,12902 USF MAGNOLIA DR,,TAMPA,FL,33612,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,FL,MD,TN,,"Genentech, Inc.",1.00E+11,F. Hoffmann-La Roche AG,,Switzerland,Yes,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,,,,,,750,12/19/2018,Cash or cash equivalent,,,No,No,STARTRK 2 RXDX 101 02,No,590736875,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230053,6543,HENRY FORD HOSPITAL,,,,,,2799 W Grand Blvd,,Detroit,MI,48202,United States,,,,,,,,,,520795,Reena,J,Salgia,,2799 W Grand Blvd,,Detroit,MI,48202,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hepatology,MI,,,,Bayer HealthCare Pharmaceuticals Inc.,1.00E+11,Bayer HealthCare Pharmaceuticals Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Stivarga,50419-171-03,,,,,,,,,,,,,,,77.88,6/15/2018,Cash or cash equivalent,,,No,No,Observational Study Agreement,No,537586603,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,310014,6223,COOPER UNIVERSITY HOSPITAL,,,,,,1000 S 10th St,,Camden,NJ,8103,United States,,,,,,,,,,1055598,DAVID,P,WARSHAL,,900 CENTENNIAL BLVD,SUITE F,VOORHEES,NJ,08043-4689,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,NJ,PA,,,"Clovis Oncology, Inc.",1.00E+11,"Clovis Oncology, Inc.",CO,United States,Yes,Covered,Drug,ONCOLOGY,Rubraca,69660-201-91,,,,,,,,,,,,,,,27500,11/5/2018,Cash or cash equivalent,,,No,No,A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy (ATHENA),No,582358383,2018,6/28/2019,NCT03522246,,CO-338-087
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 CLIFTON ROAD,,ATLANTA,GA,30302,United States,,,,,,,,,,298384,KIMBERLY,,WORKOWSKI,,550 PEACHTREE ST NE STE 1230,,ATLANTA,GA,30308,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,GA,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HIV,Descovy,61958-2002-1,,,,,,,,,,,,,,,10198,11/21/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection",No,585499343,2018,6/28/2019,,,;GS-US-412-2055;G2293288;GILDA;3608797;3608797-1;580566256;10027049;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,390100,6279,LANCASTER GENERAL HOSPITAL,,,,,,555 NORTH DUKE STREET,3555,LANCASTER,PA,17604,United States,,,,,,,,,,1304415,MURRAY,S.,FLASTER,,555 N Duke ST,,Lancaster,PA,17602,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Vascular Neurology,AZ,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Cardiac Diagnostics and Monitoring,Reveal LINQ,,,,,,,,,,,,,,,,38,8/17/2018,Cash or cash equivalent,,,No,No,Stroke AF,No,572134041,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,170016,6712,ST.FRANCIS HEALTH CENTER,,,,,,1700 SW 7th St,,Topeka,KS,66606,United States,,,,,,,,,,810467,DANIEL,,ANDERSON,,3931 LOUISIANA AVE S,PO BOX 1309 MAIL STOP 21110Q,ST LOUIS PARK,MN,55426-5000,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MN,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,42.11,9/28/2018,Cash or cash equivalent,,,No,No,"PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED STATES ACADEMIC OR COMMUNITY CLINICAL PRACTICES",No,576957177,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,316498,BARBARA,A,KONKLE,,921 TERRY AVE,PUGET SOUND BLOOD CENTER,SEATTLE,WA,98104,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,PA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,BIOVERATIV THERAPEUTICS INC.,MA,United States,Yes,Covered,Drug,HEMATOLOGY,ELOCTATE,71104-801-01,,,,,,,,,,,,,,,926,9/12/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2a, Open-Label, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Injection of rFVIIIFc-VWF-XTEN (BIVV001) in Previously Treated Adult",No,601974634,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,390111,6278,HOSPITAL OF THE UNIV OF PENNA,,,,,,3400 SPRUCE STREET,,PHILADELPHIA,PA,19104,United States,,,,,,,,,,271387,KUCHIKALA,,REDDY,,3400 SPRUCE ST FL 3,,PHILADELPHIA,PA,19104,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,PA,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HCV,Harvoni,61958-1801-1,,,,,,,,,,,,,,,2050,4/18/2018,Cash or cash equivalent,,,No,No,A Long Term Follow-up Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response to Treatment for HCV Infection in Gilead-Sponsored Trials,No,585499599,2018,6/28/2019,,,;GS-US-337-1431;GSQOAPPCU99MC;IPP;3245906;3245906-1;231352685;10077792;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,240047,6615,ST. LUKES HOSPITAL OF DULUTH,,,,,,915 EAST FIRST STREET,,DULUTH,MN,55805,United States,,,,,,,,,,87183,CYNTHIA,A,WEAVER,,1000 E 1ST ST,STE. 203,DULUTH,MN,55805-2297,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,MN,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,Yes,Covered,Biological,Immunology,Humira,0074-4339-02,,,,,,,,,,,,,,,150,8/24/2018,Cash or cash equivalent,,,No,No,M14-465,No,566859655,2018,6/28/2019,NCT02629159,,
Covered Recipient Teaching Hospital,,50348,7281,UCI MEDICAL CENTER,,,,,,101 The City Dr S,,Orange,CA,92868,United States,,,,,,,,,,722137,JOHN,P,FRUEHAUF,,UCI MEDICAL CENTER,UCI MEDICAL CENTER,ORANGE,CA,92868,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,CA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,7007.4,4/17/2018,Cash or cash equivalent,,,No,No,"A Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab MK-3475 in Combination with Axitinib versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma mRCC KEYNOTE-426",No,607123167,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50262,7301,RONALD REAGAN UCLA MEDICAL CENTER,,,,,,RONALD REAGAN UCLA MEDICAL CENTER,,757 WESTWOOD PLAZA,CA,90095,United States,,,,,,,,,,253101,PERRY,,SHIEH,,300 MEDICAL PLAZA,#B200,LOS ANGELES,CA,90095-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,CA,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,GZ402666,,,,,,,,,,,,,,,,35,11/1/2018,In-kind items and services,,,No,No,"A Phase 3 Randomized, Multicenter, Multinational, Double-blinded Study Comparing the Efficacy and Safety of Repeated Biweekly Infusions of NeoGAA (GZ402666) and Alglucosidase Alfa in Treatment-naive P",No,602001525,2018,6/28/2019,NCT02782741,,
Covered Recipient Physician,,,,,108978,MICHAEL,DOMINIC,TARANTINO,,9128 N LINDBERGH DR,,PEORIA,IL,61615-1422,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,IL,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,BIOVERATIV THERAPEUTICS INC.,MA,United States,Yes,Non-Covered,Drug,,NO PRODUCT DISCUSSED,,,,,,,,,,,,,,,,419,9/27/2018,Cash or cash equivalent,,,No,No,Natural History Study of Factor IX Treatment and Complications (B-Natural),No,601975837,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50075,7205,KFH - OAKLAND,,,,,,275 W MACARTHUR BLVD,,OAKLAND,CA,94611,United States,,,,,,,,,,23927,CHARLES,,HARE,,2425 GEARY BLVD,,SAN FRANCISCO,CA,94115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,CA,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HIV,Odefsey,61958-2101-1,,,,,,,,,,,,,,,4800,1/10/2018,Cash or cash equivalent,,,No,No,"A Phase 3b, Randomized, Double-Blind Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Subjects who are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (FTC/RPV/TDF)",No,585499855,2018,6/28/2019,,,;GS-US-366-1216;GSQOAPPCU9DB9;IPP;3091284;3091284-1;941105628;11090866;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,330285,6190,STRONG MEMORIAL HOSPITAL,,,,,,601 Elmwood Ave,Box 684,Rochester,NY,14642,United States,,,,,,,,,,207002,MARCUS,,NOEL,,601 ELMWOOD AVE,BOX 58,ROCHESTER,NY,14642-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,NY,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,209.8,3/28/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies",No,576957389,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,1272339,AMY,D,SHAPIRO,,8326 NAAB RD,,INDIANAPOLIS,IN,46260-1920,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,IN,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,BIOVERATIV THERAPEUTICS INC.,MA,United States,Yes,Covered,Drug,HEMATOLOGY,ELOCTATE,71104-801-01,,,,,,,,,,,,,,,1026,4/3/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2a, Open-Label, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Injection of rFVIIIFc-VWF-XTEN (BIVV001) in Previously Treated Adult",No,601983857,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,54144,7262,LANGLEY PORTER PSYCHIATRIC HOSPITAL,,,,,,405 PARNASUS,,SAN FRANCISCO,CA,94143,United States,,,,,,,,,,18654,PHILIP,,ROSENTHAL,,500 PARNASSUS MU 4TH FL E,,SAN FRANCISCO,CA,94143,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics,CA,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HCV,Epclusa,61958-2201-1,,,,,,,,,,,,,,,3838,1/22/2018,Cash or cash equivalent,,,No,No,"A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children with Chronic HCV Infection",No,585500111,2018,6/28/2019,,,;GS-US-342-1143;GSQOAPPCU9E4E;IPP;3098520;3098520-1;946036493;10029630;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,330285,6190,STRONG MEMORIAL HOSPITAL,,,,,,601 Elmwood Ave,Box 684,Rochester,NY,14642,United States,,,,,,,,,,207002,MARCUS,,NOEL,,601 ELMWOOD AVE,BOX 58,ROCHESTER,NY,14642-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,NY,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,61.02,6/27/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies",No,576957491,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,42295,MARGARET,V,RAGNI,,5115 CENTRE AVE,UPMC CANCER PAVILLION,PITTSBURGH,PA,15232-1301,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,PA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,BIOVERATIV THERAPEUTICS INC.,MA,United States,Yes,Covered,Drug,HEMATOLOGY,ELOCTATE,71104-801-01,,,,,,,,,,,,,,,898,11/2/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2a, Open-Label, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Injection of rFVIIIFc-VWF-XTEN (BIVV001) in Previously Treated Adult",No,602005613,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360059,6447,METROHEALTH MEDICAL CENTER,,,,,,2500 METROHEALTH DRIVE,,CLEVELAND,OH,44109,United States,,,,,,,,,,134955,ANN,,AVERY,,2500 METROHEALTH DR,,CLEVELAND,OH,44109,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,OH,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HIV,Descovy,61958-2002-1,,,,,,,,,,,,,,,1000,7/5/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex with Men and Are At Risk of HIV-1 Infection",No,585500367,2018,6/28/2019,,,;GS-US-412-2055;GSQOAPPCU9BB7;IPP;3382501;3382501-1;346004382;10030211;VPL PI NAME AND PI SLN
Covered Recipient Physician,,,,,119282,GUY,A,YOUNG,,10833 LE CONTE AVENUE,12-441 MDCC,LOS ANGELES,CA,90095-3075,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,CA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,BIOVERATIV THERAPEUTICS INC.,MA,United States,Yes,Non-Covered,Drug,,NO PRODUCT DISCUSSED,,,,,,,,,,,,,,,,166.51,11/26/2018,In-kind items and services,,,No,No,"A Non-controlled, Open-Label, Multicenter, Study of Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Subjects With Inhibitors Undergoing the First ITI Treatment",No,602021209,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,380009,7189,OHSU HOSPITAL AND CLINICS,,,,,,3181 SAM JACKSON PARK ROAD,,PORTLAND,OR,97239,United States,,,,,,,,,,235563,STEPHEN,,SPURGEON,,3181 SW SAM JACKSON PARK RD,,PORTLAND,OR,97239,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,OR,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,ONC,Zydelig,61958-1702-1,,,,,,,,,,,,,,,8625,5/2/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination with Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia",No,585500623,2018,6/28/2019,,,;GS-US-312-0119;GSQOAPPCU9D2B;IPP;3266560;3266560-1;931176109;10834265;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 Brookline Ave,,Boston,MA,2215,United States,,,,,,,,,,1089372,PRISCILLA,K,BRASTIANOS,,55 FRUIT ST,55 FRUIT ST,BOSTON,MA,02114-2621,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,15276,3/6/2018,In-kind items and services,,,No,No,Phase II Trial of Pembrolizumab in Central Nervous System Metastases from Multiple Histologies,No,607124095,2018,6/28/2019,,,Study drug provided to a clinical study site.
Covered Recipient Teaching Hospital,,360163,6378,THE CHRIST HOSPITAL,,,,,,2139 Auburn Ave,,Cincinnati,OH,45219,United States,,,,,,,,,,303083,PHILIP,,LEMING,,4460 RED BANK RD,SUITE 200,CINCINNATI,OH,45227-2172,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,KY,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,300,8/2/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK 3475 in Combination With INCB024360 in Subjects With Selected Cancers",No,576957707,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,330285,6190,STRONG MEMORIAL HOSPITAL,,,,,,175 CORPORATE WOODS  SUITE 225,,ROCHESTER,NY,14623,United States,,,,,,,,,,478364,CHRISTOPHER,J,DRINKWATER,,601 ELMWOOD AVE,BOX 665,ROCHESTER,NY,14642-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Orthopaedic Surgery|Adult Reconstructive Orthopaedic Surgery,NY,,,,"Smith & Nephew, Inc.",1.00E+11,"Smith & Nephew, Inc.",TN,United States,Yes,Covered,Device,Recon Hips,Birmingham Hip Resurfacing,,,,,,,,,,,,,,,,4275,8/9/2018,Cash or cash equivalent,,,No,No,Birmingham Hip Resurfacing System BHR Post Approval Study US,No,596694105,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,520098,6608,UNIVERSITY OF WI HOSPITALS & CLINICS,,,,,,600 HIGHLAND AVE,,MADISON,WI,53792,United States,,,,,,,,,,229311,OANA,C,DANCIU,,UNIV OF ILLINOIS AT CHICAGO,840 S WOOD STREET 820E CSB,CHICAGO,IL,60612,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,IL,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Covered,Drug,ONCOLOGY,IBRANCE,0069-0187-21,,,,,,,,,,,,,,,175408.8,10/23/2018,In-kind items and services,,,No,No,2015 ASPIRE BREAST CANCER  A SINGLE ARM PHASE II STUDY OF PALBOCICLIB IN COMBINATION WITH TAMOXIFEN AS FIRST LINE THERAPY FOR METASTATIC HORMONE RECEPTOR POSITIVE BREAST CANCER,No,599772409,2018,6/28/2019,,,Study Drug
Covered Recipient Physician,,,,,1272339,AMY,D,SHAPIRO,,8326 NAAB RD,,INDIANAPOLIS,IN,46260-1920,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,IN,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,BIOVERATIV THERAPEUTICS INC.,MA,United States,Yes,Covered,Drug,HEMATOLOGY,ELOCTATE,71104-801-01,,,,,,,,,,,,,,,898,11/2/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2a, Open-Label, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Injection of rFVIIIFc-VWF-XTEN (BIVV001) in Previously Treated Adult",No,602045653,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,310096,6686,ST. MICHAELS MEDICAL CENTER,,,,,,111 CENTRAL AVENUE,,NEWARK,NJ,7102,United States,,,,,,,,,,198127,JIHAD,,SLIM,,268 DR MARTIN LUTHER KING JR BLVD,,NEWARK,NJ,7102,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,NJ,,,,"Gilead Sciences, Inc.",1.00E+11,"Gilead Sciences, Inc.",CA,United States,Yes,Covered,Drug,HIV,Biktarvy,61958-2501-1,,,,,,,,,,,,,,,646,7/23/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Double-Blinded Study of the Safety and Efficacy of a Fixed Dose Combination of GS-9883/ Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV 1 Infected, Antiretroviral Treatment-Naive Adults",No,585500879,2018,6/28/2019,,,;GS-US-380-1490;GSQOAPPCU986U;GILDA;3403093;3403093-1;463487442;10046338;VPL PI NAME AND PI SLN
Covered Recipient Teaching Hospital,,440039,6471,Vanderbilt University Medical Center,,,,,,1211 Medical Center Drive,,Nashville,TN,37232,United States,,,,,,,,,,1063107,Joern-Hendrik,,Weitkamp,,2200 Children's Way,,Nashville,TN,37232-9550,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Neonatal-Perinatal Medicine,TN,,,,ONY Biotech Inc.,1.00E+11,ONY Biotech Inc.,NY,United States,Yes,Covered,Drug,Product,Infasurf,,,,,,,,,,,,,,,,78000,8/13/2018,Cash or cash equivalent,Patient Care,,No,No,AERO-02,No,544386941,2018,6/28/2019,NCT03058666,https://clinicaltrials.gov/ct2/show/NCT03058666,Clinical Trial
Covered Recipient Teaching Hospital,,220116,6061,TUFTS MEDICAL CENTER,,,,,,750 Washington St,Box 018,Boston,MA,2111,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,No,,,,,,,,,,,,,,,,,,,,1375,11/20/2018,Cash or cash equivalent,,,Yes,No,,No,588022435,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,223302,6052,CHILDRENS HOSPITAL CORPORATION,,,,,,300 Longwood Ave,Patient Financial Services Atn Steven Nicoll,Boston,MA,2115,United States,,,,,,,,,,682432,BRAM,P,RAPHAEL,,300 LONGWOOD AVE,CHILDREN'S HOSPITAL BOSTON HUNN GROUND FLOOR,BOSTON,MA,02115-5724,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology,MA,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,Yes,Covered,Drug,INTERNAL MEDICINE,GATTEX,68875-0101-2,,,,,,,,,,,,,,,4743,11/6/2018,Cash or cash equivalent,,,No,No,"A PROSPECTIVE, OPEN LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF TEDUGLUTIDE IN PEDIATRIC PATIENTS WITH SHORT BOWEL SYNDROME WHO PARTICIPATED IN TED-C14-006",No,565228769,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 JOHN R,,DETROIT,MI,48201,United States,,,,,,,,,,1195774,AMY,M.,WEISE,,1560 E MAPLE ROAD,SUITE 400CREDENTIALING,TROY,MI,48083-1189,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,"Radius Health, Inc.",1.00E+11,"Radius Health, Inc.",MA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,95.04,5/22/2018,Cash or cash equivalent,,,No,No,"A Phase 1, First-in-Human, Multi-Part Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer",No,611495967,2018,6/28/2019,,,
Covered Recipient Physician,,,,,613414,PETAR,S,LENERT,,200 HAWKINS DR,,IOWA CITY,IA,52242-1009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,IA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Covered,Drug,IMMUNOLOGY,KEVZARA,0024-5908-01,,,,,,,,,,,,,,,50,10/12/2018,In-kind items and services,,,No,No,"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis",No,602004277,2018,6/28/2019,NCT03600805,,
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 CLIFTON ROAD,,ATLANTA,GA,30302,United States,,,,,,,,,,718297,HEBA,N,ISKANDAR,,EMORY UNIVERSITY 1365 CLIFTON RD NE,"BUILDING B, SUITE 1200",ATLANTA,GA,30322-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,GA,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,Yes,Covered,Biological,Immunology,Humira,0074-4339-02,,,,,,,,,,,,,,,1937,9/21/2018,Cash or cash equivalent,,,No,No,M14-115,No,566861967,2018,6/28/2019,NCT02065570,,
Covered Recipient Physician,,,,,189972,DAVID,M,GORSON,,140 HOSPITAL DR,STE 301,BENNINGTON,VT,5201,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",VT,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Tresiba,0169-2660-15,,,,,,,,,,,,,,,1638,8/2/2018,Cash or cash equivalent,,,No,No,NN1250-4252,No,606197093,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,363300,6385,CHILDRENS HOSPITAL MEDICAL CENTER,,,,,,3333 Burnet Ave,,Cincinnati,OH,45229,United States,,,,,,,,,,1052995,ERIC,,MULLINS,,3333 BURNET AVE,ML 7015,CINCINNATI,OH,45229-3026,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,OH,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,Yes,Covered,Biological,HEMATOLOGY,ADYNOVATE,0944-4252-02,,,,,,,,,,,,,,,76.23,6/22/2018,Cash or cash equivalent,,,No,No,"PHASE 3, PROSPECTIVE, MULTI-CENTER, OPEN LABEL STUDY TO INVESTIGATE SAFETY, IMMUNOGENICITY, AND HEMOSTATIC EFFICACY OF PEGYLATED FACTOR VIII BAX 855 IN PREVIOUSLY UNTREATED PATIENTS PUPS AND MINIMALLY TREATED PATIENTS MTPS  6 YEARS WITH SEVERE HEMOPHILIA A FVIII  1",No,565229315,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,460009,7144,U OF U HOSPITALS & CLINICS,,,,,,50 N Medical Dr,,Salt Lake City,UT,84132,United States,,,,,,,,,,461929,IGNACIO,,GARRIDO-LAGUNA,,1950 CIRCLE OF HOPE,CLINIC 1A,SALT LAKE CITY,UT,84112-5500,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,UT,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,70.44,2/26/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2, Open Label, Dose Escalation/Dose Expansion, Safety and Tolerability Study of INCB057643 in Subjects with Advanced Malignancies",No,576958243,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,230297,6200,KARMANOS CANCER HOSPITAL,,,,,,4100 JOHN R,,DETROIT,MI,48201,United States,,,,,,,,,,1195774,AMY,M.,WEISE,,1560 E MAPLE ROAD,SUITE 400CREDENTIALING,TROY,MI,48083-1189,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,"Radius Health, Inc.",1.00E+11,"Radius Health, Inc.",MA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,2028,7/5/2018,Cash or cash equivalent,,,No,No,"A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer",No,611496047,2018,6/28/2019,NCT02338349,,
Covered Recipient Teaching Hospital,,490052,6736,RIVERSIDE REGIONAL MEDICAL CENTER,,,,,,500 J Clyde Morris Blvd,,Newport News,VA,23601,United States,,,,,,,,,,310664,KERMIT,,LLOYD,,12200 WARWICK BLVD,SUITE 110,NEWPORT NEWS,VA,23601-2344,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,VA,,,,"Alkermes, Inc.",1.00E+11,"Alkermes, Inc.",MA,United States,Yes,Covered,Drug,CNS,DIMETHYL FUMARATE,,Non-Covered,,,,,,,,,,,,,,75,1/10/2018,Cash or cash equivalent,,,No,No,"A Two-Part, Phase 2/3, Randomized Study in Subjects with Relapsing Remitting Multiple Sclerosis (RRMS) to Evaluate the Tolerability of ALKS 8700 Compared with DIMETHYL FUMARATE and the Long-Term Safety and Tolerability of ALKS 8700",No,561773735,2018,6/28/2019,NCT02634307,,
Covered Recipient Teaching Hospital,,363300,6385,CHILDRENS HOSPITAL MEDICAL CENTER,,,,,,3333 Burnet Ave,,Cincinnati,OH,45229,United States,,,,,,,,,,1052995,ERIC,,MULLINS,,3333 BURNET AVE,ML 7015,CINCINNATI,OH,45229-3026,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,OH,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,Yes,Covered,Biological,HEMATOLOGY,ADYNOVATE,0944-4252-02,,,,,,,,,,,,,,,1518.3,12/6/2018,Cash or cash equivalent,,,No,No,"PHASE 3, PROSPECTIVE, MULTI-CENTER, OPEN LABEL STUDY TO INVESTIGATE SAFETY, IMMUNOGENICITY, AND HEMOSTATIC EFFICACY OF PEGYLATED FACTOR VIII BAX 855 IN PREVIOUSLY UNTREATED PATIENTS PUPS AND MINIMALLY TREATED PATIENTS MTPS  6 YEARS WITH SEVERE HEMOPHILIA A FVIII  1",No,565229865,2018,6/28/2019,,,
Covered Recipient Physician,,,,,431385,ELIZA,,CHAKRAVARTY,,820 NE 15TH ST,,OKLAHOMA CITY,OK,73104-4602,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,CA,OK,,,,,,,,,,,,,,,,,,,,,,,"UCB, Inc.",1.00E+11,"UCB, Inc.",GA,United States,Yes,Covered,Drug,Immunology,Cimzia,50474-710-79,,,,,,,,,,,,,,,420,5/1/2018,In-kind items and services,,,No,No,Fears and Misconceptions of Women with Chronic Rheumatic Diseases on Their Journey to Motherhood,No,594914533,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,60011,7127,DENVER HEALTH MEDICAL CENTER,,,,,,777 BANNOCK STREET,40411,DENVER,CO,80204,United States,,,,,,,,,,1018221,ROBERT,ERNEST,SWANEY,III,500 ELDORADO BLVD 6250,,BROOMFIELD,CO,80021-3408,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,CO,,,,Spectrum Pharmaceuticals Inc.,1.00E+11,Spectrum Pharmaceuticals Inc.,NV,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,9971.23,6/22/2018,Cash or cash equivalent,,,No,No,SPI-GCF-302,No,611792049,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230053,6543,HENRY FORD HOSPITAL,,,,,,2799 W Grand Blvd,,Detroit,MI,48202,United States,,,,,,,,,,520795,Reena,J,Salgia,,2799 W Grand Blvd,,Detroit,MI,48202,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hepatology,MI,,,,Bayer HealthCare Pharmaceuticals Inc.,1.00E+11,Bayer HealthCare Pharmaceuticals Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Stivarga,50419-171-03,,,,,,,,,,,,,,,457.5,12/14/2018,Cash or cash equivalent,,,No,No,Observational Study Agreement,No,537595857,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,63301,7107,CHILDRENS HOSPITAL COLORADO,,,,,,13123 E 16th Ave,B010,Aurora,CO,80045,United States,,,,,,,,,,995458,MEGAN,M,KELSEY,,13123 E 16TH AVE,13123 E 16TH AVE,AURORA,CO,80045-7106,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology,CO,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ENDOCRINOLOGY,JANUVIA,0006-0277-82,,,,,,,,,,,,,,,49.86,11/5/2018,In-kind items and services,,,No,No,"A Phase III, Multicenter, Double-Blind, Randomized, Placebo-Controlled Clinical Trialto Evaluate the Safety and Efficacy of Sitagliptin in Pediatric Patients with Type 2Diabetes Mellitus with Inadequate Glycemic Control",No,607129035,2018,6/28/2019,,,Equipment or non-drug supplies provided to a clinical study site.
Covered Recipient Teaching Hospital,,140209,6529,METHODIST MEDICAL CTR OF ILLINOIS,,,,,,221 NE Glen Oak Ave,,PEORIA,IL,61636,United States,,,,,,,,,,617954,DAVID,E,TRACHTENBARG,,900 MAIN ST,STE 100,PEORIA,IL,61602,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Family Medicine,IL,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Tresiba,0169-2660-15,,,,,,,,,,,,,,,2.8,9/17/2018,In-kind items and services,,,No,No,NN1250-4252,No,606199933,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,490009,6776,UNIVERSITY OF VIRGINIA MEDICAL CENTE,,,,,,1215 Lee St PFS,,Charlottesville,VA,22908,United States,,,,,,,,,,266016,ROBERT,,DREICER,,1240 LEE ST,,CHARLOTTESVILLE,VA,22908,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,OH,,,,Exelixis Inc.,1.00E+11,Exelixis Inc.,CA,United States,Yes,Covered,Drug,Oncology,Cabozantinib,42388-023-26,,,,,,,,,,,,,,,16891.2,10/31/2018,Cash or cash equivalent,,,No,No,Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors,No,562898815,2018,6/28/2019,,,
Covered Recipient Physician,,,,,176181,MARIO,,CASTRO,,4921 PARKVIEW PL FL 8,8TH FL,SAINT LOUIS,MO,63110-1032,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Anesthesiology|Critical Care Medicine,MO,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Drug,IMMUNOLOGY,DUPIXENT,0024-5914-01,,,,,,,,,,,,,,,787.43,6/30/2018,In-kind items and services,,,No,No,"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Severe Steroid Dependent Asthma",No,601960029,2018,6/28/2019,NCT02528214,,
Covered Recipient Teaching Hospital,,390049,6276,ST. LUKES HOSPITAL,,,,,,801 Ostrum St,,Bethlehem,PA,18015,United States,,,,,,,,,,1289635,SANJIV,S,AGARWALA,,801 OSTRUM STREET,801 OSTRUM STREET,BETHLEHEM,PA,18015-1000,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|General Practice,PA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,10005,8/17/2018,Cash or cash equivalent,,,No,No,"A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab MK-3475 as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy",No,606999187,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,490024,6758,CARILION MEDICAL CENTER,,,,,,1906 Belleview Ave SE,,Roanoke,VA,24014,United States,,,,,,,,,,4392,ANITA,SHERRY,KABLINGER,,2017 JEFFERSON ST SW,,ROANOKE,VA,24014-2419,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,VA,,,,Allergan Inc.,1.00E+11,Allergan Inc.,NJ,United States,Yes,Covered,Drug,NEUROSCIENCE,FETZIMA,0456-2240-30,,,,,,,,,,,,,,,1949.4,7/17/2018,Cash or cash equivalent,,,No,No,"A DOUBLE BLIND, PLACEBO- AND ACTIVE CONTROLLED EVALUATION OF THE SAFETY AND EFFICACY OF LEVOMILNACIPRAN ER IN ADOLESCENT PATIENTS WITH MAJOR DEPRESSIVE DISORDER",No,576657685,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 BROOKLINE AVE,,BOSTON,MA,2215,United States,,,,,,,,,,1080133,DAVID,P,RYAN,,24 BRIERBROOK STREET,,MILTON,MA,2186,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,MA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,11765,1/30/2018,Cash or cash equivalent,,,No,No,PHASE 1B2 STUDY OF PF04136309 IN COMBINATION WITH GEMCITABINE AND NABPACLITAXEL IN PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA,No,599786665,2018,6/28/2019,,,
Covered Recipient Physician,,,,,542734,WILLIAM,,JUSTIZ,,3200 BAILEY LN STE 200,,NAPLES,FL,34105-8523,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,FL,,,,,,,,,,,,,,,,,,,,,,,,ACADIA Pharmaceuticals Inc,1.00E+11,ACADIA Pharmaceuticals Inc,CA,United States,Yes,Covered,Drug,PARKINSONS DISEASE PSYCHOSIS,NUPLAZID,63090-170-60,,,,,,,,,,,,,,,2200,2/14/2018,Cash or cash equivalent,,,No,No,ACP-103-045,No,605762895,2018,6/28/2019,NCT03325556,,
Covered Recipient Teaching Hospital,,140010,6476,NORTHSHORE UNIVERSITY HEALTHSYSTEM,,,,,,2650 Ridge Ave,,EVANSTON,IL,60201,United States,,,,,,,,,,376100,LIANA,K,BILLINGS,,9977 WOODS DR,STE 300,SKOKIE,IL,60077,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",IL,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Tresiba,0169-2660-15,,,,,,,,,,,,,,,3.05,9/26/2018,In-kind items and services,,,No,No,NN1250-4419,No,606200235,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,340113,6798,CAROLINAS MEDICAL CENTER,,,,,,501 Billingsley Rd,,Charlotte,NC,28211,United States,,,,,,,,,,469303,MICHAEL,J,KENNELLY,,1023 EDGEHILL RD S,,CHARLOTTE,NC,28207-1829,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Urology,NC,,,,Allergan Inc.,1.00E+11,Allergan Inc.,NJ,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,63.24,8/29/2018,Cash or cash equivalent,,,No,No,A Safety and Efficacy Study of LiRIS in Females With Interstitial Cystitis With Hunners Lesions,No,576657819,2018,6/28/2019,NCT02395042,,
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 Clifton Rd NE,,Atlanta,GA,30322,United States,,,,,,,,,,295126,ROBERT,F,SIDONIO,JR.,2220 PIERCE AVE,395 PRESTON RESEARCH BUILDING,NASHVILLE,TN,37232-6310,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,GA,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,Yes,Covered,Biological,HEMATOLOGY,ADYNOVATE,0944-4252-02,,,,,,,,,,,,,,,2021.4,12/6/2018,Cash or cash equivalent,,,No,No,"PHASE 3, PROSPECTIVE, MULTI-CENTER, OPEN LABEL STUDY TO INVESTIGATE SAFETY, IMMUNOGENICITY, AND HEMOSTATIC EFFICACY OF PEGYLATED FACTOR VIII BAX 855 IN PREVIOUSLY UNTREATED PATIENTS PUPS AND MINIMALLY TREATED PATIENTS MTPS  6 YEARS WITH SEVERE HEMOPHILIA A FVIII  1",No,565230439,2018,6/28/2019,,,
Covered Recipient Physician,,,,,106784,ATUL,K,SINGHAL,,1600 REPUBLIC PKWY,SUITE 200,MESQUITE,TX,75150-6918,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,TX,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Covered,Drug,IMMUNOLOGY,KEVZARA,0024-5908-01,,,,,,,,,,,,,,,50,10/12/2018,In-kind items and services,,,No,No,"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Giant Cell Arteritis",No,602006779,2018,6/28/2019,NCT03600805,,
Covered Recipient Teaching Hospital,,450076,7039,UT MD ANDERSON CANCER CENTER,,,,,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,,,,,,,,58837,COURTNEY,D,DINARDO,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030-4009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,PA,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,Yes,Covered,Drug,Virology,Venclexta,0074-0576-22,,,,,,,,,,,,,,,5300,9/21/2018,Cash or cash equivalent,,,No,No,M14-358,No,566862737,2018,6/28/2019,NCT02203773,,
Covered Recipient Teaching Hospital,,10033,6942,UNIVERSITY OF ALABAMA HOSPITAL,,,,,,619 19TH AVE S,,BIRMINGHAM,AL,35249,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"ROCHE MOLECULAR SYSTEMS, INC.",1.00E+11,"ROCHE MOLECULAR SYSTEMS, INC.",CA,United States,Yes,Covered,Device,Molecular Diagnostics,COBAS INSTRUMENTS & REAGENTS,,,,,,,,,,,,,,,,75626.17,1/25/2018,Cash or cash equivalent,,,No,No,RD002879,No,609144844,2018,6/28/2019,,,
Covered Recipient Physician,,,,,328844,CRANFORD,L,SCOTT,,233 N PRAIRIE AVE,,INGLEWOOD,CA,90301-1412,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,CA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Drug,DIABETES,TOUJEO,0024-5869-03,,,,,,,,,,,,,,,2000,1/9/2018,Cash or cash equivalent,,,No,No,Toujeo Real World Insulin Nai,No,601876005,2018,6/28/2019,,,
Covered Recipient Physician,,,,,344204,MARVIN,L.,PEYTON,,2301 W I 44 SERVICE RD,SUITE 300,OKLAHOMA CITY,OK,73112-8729,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,OK,,,,,,,,,,,,,,,,,,,,,,,,West-Ward Pharmaceuticals,1.00E+11,West-Ward Pharmaceuticals,NJ,United States,Yes,Covered,Drug,Psychiatry/Psychology,Oxycodone hydrochloride ER tablet,59011-410-10,Covered,Drug,Psychiatry/Psychology,Morphine Sulfate ER tablets,59011-260-10,Covered,Drug,Psychiatry/Psychology,Oxymorphone hydrochloride ER tablet,63481-812-60,,,,,384.62,1/1/2018,Cash or cash equivalent,,,No,No,Opioid PMR Study,No,602084573,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230004,6572,MH - MERCY CAMPUS,,,,,,1500 E Sherman Blvd,,Muskegon,MI,49444,United States,,,,,,,,,,53866,LAWRENCE,I,MALLON,,1316 Mercy Dr,,Muskegon,MI,49444,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery,MI,,,,Bayer HealthCare Pharmaceuticals Inc.,1.00E+11,Bayer HealthCare Pharmaceuticals Inc.,NJ,United States,Yes,Covered,Drug,Cardio-pulmonary,Xarelto,50458-580-30,,,,,,,,,,,,,,,750,5/21/2018,Cash or cash equivalent,,,No,No,BAY59-7939 2.5mg reduction atherothrombotic events vs. ASA,No,537589489,2018,6/28/2019,,,
Covered Recipient Physician,,,,,998663,SALVADOR,,CRUZ-FLORES,,4800 ALBERTA AVE,,EL PASO,TX,79905,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurocritical Care,TX,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Ozempic,0169-4132-12,,,,,,,,,,,,,,,225,4/4/2018,Cash or cash equivalent,,,No,No,NN9535-4270,No,606197905,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,190036,6987,OCHSNER CLINIC FOUNDATION,,,,,,1516 Jefferson Hwy,,New Orleans,LA,70121,United States,,,,,,,,,,243253,HERSCHEL,DAVID,VARGAS,,1514 JEFFERSON HWY,,NEW ORLEANS,LA,70121-2429,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Colon & Rectal Surgery,KY,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,Yes,Covered,Drug,INTERNAL MEDICINE,GATTEX,68875-0101-2,,,,,,,,,,,,,,,761,10/25/2018,Cash or cash equivalent,,,No,No,"A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME",No,565232111,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,460009,7144,U OF U HOSPITALS & CLINICS,,,,,,50 N Medical Dr,,Salt Lake City,UT,84132,United States,,,,,,,,,,913884,WALLACE,,AKERLEY,,1950 CIRCLE OF HOPE,CLINIC 1A,SALT LAKE CITY,UT,84112-5500,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,UT,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,5542,10/30/2018,Cash or cash equivalent,,,No,No,An Open Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non Small Cell Lung Cancer,No,576958861,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,380009,7189,OHSU HOSPITAL AND CLINICS,,,,,,3181 SAM JACKSON PARK ROAD,,PORTLAND,OR,97239,United States,,,,,,,,,,1108917,NICOLE,M,FETT,,OREGON HEALTH AND SCIENCE UNIVERSITY,3303 SW BOND AVENUE,PORTLAND,OR,97239,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,OR,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,3192.48,10/26/2018,Cash or cash equivalent,,,No,No,A PHASE 2A DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF PF06823859 IN ADULT SUBJECTS WITH DERMATOMYOSITIS,No,599779435,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,393303,6270,THE CHILDRENS HOSPITAL OF PHILADELP,,,,,,34th & Civic Center Blvd,PARC Business Services,Philadelphia,PA,19104,United States,,,,,,,,,,285643,LESLIE,,RAFFINI,,3401 CIVIC CENTER BLVD,CHILDREN'S HOSPITAL OF PHILADELPHIA - HEMONC,PHILADELPHIA,PA,19104-4319,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,PA,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,Yes,Covered,Biological,HEMATOLOGY,VONVENDI,0944-7551-02,,,,,,,,,,,,,,,15500,2/22/2018,Cash or cash equivalent,,,No,No,"A PHASE 3, PROSPECTIVE, MULTICENTER, UNCONTROLLED, OPEN-LABEL CLINICAL STUDY TO DETERMINE THE EFFICACY, SAFETY, AND TOLERABILITY OF RVWF WITH OR WITHOUT ADVATE IN THE TREATMENT AND CONTROL OF BLEEDING EPISODES, THE EFFICACY AND SAFETY OF RVWF IN ELECTIVE AND EMERGENCY SURGERIES, AND THE PHARMACOKINETICS PK OF RVWF IN CHILDREN DIAGNOSED WITH SEVERE VON WILLEBRAND DISEASE",No,565233211,2018,6/28/2019,,,
Covered Recipient Physician,,,,,299492,AARON,,MILLER,,5 E 98TH ST,FIRST FLOOR,NEW YORK,NY,10029-6501,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,NY,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Drug,MULTIPLE SCLEROSIS,AUBAGIO,58468-0210-1,,,,,,,,,,,,,,,250.5,3/28/2018,In-kind items and services,,,No,No,Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients (TERI-PRO),No,601907005,2018,6/28/2019,NCT01895335,,
Covered Recipient Teaching Hospital,,450076,7039,UT MD ANDERSON CANCER CENTER,,,,,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,,,,,,,,227121,GUILLERMA,,GARCIA-MANERO,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030-4009,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,PA,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,Yes,Covered,Drug,Virology,Venclexta,0074-0576-22,,,,,,,,,,,,,,,18393.75,12/27/2018,Cash or cash equivalent,,,No,No,M15-522,No,566864019,2018,6/28/2019,NCT02966782,,
Covered Recipient Teaching Hospital,,63301,7107,CHILDRENS HOSPITAL COLORADO,,,,,,13123 E 16th Ave,B010,Aurora,CO,80045,United States,,,,,,,,,,551281,EDWARD,J,HOFFENBERG,,13123 E 16TH AVE,13123 E 16TH AVE,AURORA,CO,80045-7106,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology,CO,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,INFECTIOUS DISEASE,ZINPLAVA,0006-3025-01,,,,,,,,,,,,,,,111.6,5/14/2018,In-kind items and services,,,No,No,"Protocol Title  A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab MK-6072, Human Monoclonal Antibody to C. difficile Toxin B in Children Aged 1 to 18 Years Receiving Antibacterial Drug Treatment for C. difficile Infection MODIFY III",No,607083163,2018,6/28/2019,,,Equipment or non-drug supplies provided to a clinical study site.
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,108808,JOHN,CHRISTOPHER,KRAUSS,,1500 E MEDICAL CENTER DRIVE,B1 FLOOR CANCER CENTER RECP C,ANN ARBOR,MI,48109-5912,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,2795,5/10/2018,Cash or cash equivalent,,,No,No,"A PHASE 2A RANDOMIZED, OPEN-LABEL STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND EFFICACY OF BAX69 IN COMBINATION WITH 5-FULEUCOVORIN OR PANITUMUMAB VERSUS STANDARD OF CARE IN SUBJECTS WITH METASTATIC COLORECTAL CANCER",No,565234427,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,10033,6942,UNIVERSITY OF ALABAMA HOSPITAL,,,,,,619 19th St S,,Birmingham,AL,35249,United States,,,,,,,,,,999061,REED,,DIMMITT,,525 NHB,691 SOUTH 19TH STREET,BIRMINGHAM,AL,35249-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Neonatal-Perinatal Medicine,AL,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,Yes,Covered,Drug,INTERNAL MEDICINE,GATTEX,68875-0101-2,,,,,,,,,,,,,,,754,8/2/2018,Cash or cash equivalent,,,No,No,"A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME",No,565234999,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220110,6045,BRIGHAM AND WOMENS HOSPITAL,,,,,,75 Francis St,,Boston,MA,2115,United States,,,,,,,,,,1142201,REZA,,ABDI,,75 FRANCIS STREET,MRB 404 BRIGHAM AND WOMENS HOSPITAL RENAL DIVISION,BOSTON,MA,2115,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,MA,,,,Mallinckrodt LLC,1.00E+11,Mallinckrodt LLC,MO,United States,Yes,Covered,Biological,AUTOIMMUNE AND RARE DISEASE,ACTHAR,63004-8710-1,,,,,,,,,,,,,,,135000,10/16/2018,Cash or cash equivalent,,,No,No,EXPLORING THE IMMUNOREGULATORY FUNCTIONS OF MELANOCORTINS,No,617607497,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,150021,6450,PARKVIEW HOSPITAL,,,,,,11109 PARKVIEW PLAZA DRIVE,,FORT WAYNE,IN,46845,United States,,,,,,,,,,103487,DAVID,T.,SOWDEN,,1818 CAREW ST STE 160,,FORT WAYNE,IN,46805-4792,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery),IN,,,,"Endologix, Inc.",1.00E+11,"Endologix, Inc.",CA,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,AFX,,,,,,,,,,,,,,,,248,1/4/2018,Cash or cash equivalent,,,No,No,LEOPARD,No,568758087,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,450690,7072,UT HEALTH CENTER AT TYLER,,,,,,11937 US Highway 271,,Tyler,TX,75708,United States,,,,,,,,,,161258,JAMES,,STOCKS,,11937 US HIGHWAY 271,,TYLER,TX,75708-3154,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,TX,,,,Shire North American Group Inc,1.00E+11,Shire North American Group Inc,MA,United States,Yes,Covered,Biological,IMMUNOLOGY,GLASSIA,0944-2884-01,,,,,,,,,,,,,,,2000,1/15/2018,Cash or cash equivalent,,,No,No,"A PHASE 34 STUDY TO EVALUATE THE SAFETY, IMMUNOGENICITY, AND EFFECTS ON THE ALPHA1-PROTEINASE INHIBITOR A1PI LEVELS IN EPITHELIAL LINING FLUID FOLLOWING GLASSIA THERAPY IN A1PI-DEFICIENT SUBJECTS",No,565235589,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,73300,6076,CONNECTICUT CHILDRENS MEDICAL CENTER,,,,,,282 WASHINGTON STREET,,HARTFORD,CT,6106,United States,,,,,,,,,,14760,HEATHER,O,TORY,,282 WASHINGTON STREET,,HARTFORD,CT,6106,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Rheumatology,CT,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Covered,Drug,GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT,XELJANZ,0069-1001-01,,,,,,,,,,,,,,,1357.06,4/26/2018,Cash or cash equivalent,,,No,No,EFFICACY SAFETY AND TOLERABILITY OF TOFACITINIB FOR TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS JIA IN CHILDREN AND ADOLESCENT SUBJECTS,No,599782541,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,110010,6813,EMORY UNIVERSITY HOSPITAL,,,,,,1364 Clifton Rd NE,,Atlanta,GA,30322,United States,,,,,,,,,,682463,CHRISTINA,N,FOURNIER,,1365 CLIFTON RD NE,,ATLANTA,GA,30322-1013,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,GA,,,,Mallinckrodt LLC,1.00E+11,Mallinckrodt LLC,MO,United States,Yes,Covered,Biological,AUTOIMMUNE AND RARE DISEASE,ACTHAR,63004-8710-1,,,,,,,,,,,,,,,1755,12/27/2018,Cash or cash equivalent,,,No,No,"A DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF H.P. ACTHAR GEL IN THE MANAGEMENT OF AMYOTROPHIC LATERAL SCLEROSIS",No,617607895,2018,6/28/2019,NCT03068754,,
Covered Recipient Teaching Hospital,,110036,6387,MEMORIAL HEALTH UNIV MED CENTER,,,,,,4700 WATERS AVENUE,PO BOX 32,SAVANNAH,GA,31403,United States,,,,,,,,,,351903,CHRISTOPHER,EMIL,HABERMAN,,5400 SUTLIVE ST,,SAVANNAH,GA,31405-4721,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,GA,,,,Spectrum Pharmaceuticals Inc.,1.00E+11,Spectrum Pharmaceuticals Inc.,NV,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,225,3/22/2018,Cash or cash equivalent,,,No,No,SPI-GCF-301,No,611790225,2018,6/28/2019,,,
Covered Recipient Physician,,,,,229498,LARRY,D,STONESIFER,,34509 - 9TH AVE SO #200,,FEDERAL WAY,WA,98003-8708,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",WA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Drug,DIABETES,TOUJEO,0024-5869-03,,,,,,,,,,,,,,,1000,5/22/2018,Cash or cash equivalent,,,No,No,Toujeo Real World Insulin Nai,No,601926483,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,374000,7008,GRIFFIN MEMORIAL HOSPITAL,,,,,,900 E Main St,,NORMAN,OK,73070,United States,,,,,,,,,,239459,JONEA,,LIM,,1000 N LINCOLN BLVD,# 2900,OKLAHOMA CITY,OK,73104,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",OK,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,FIASP,0169-3201-11,,,,,,,,,,,,,,,292.2,4/2/2018,In-kind items and services,,,No,No,NN1218-4113,No,606199145,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50599,7263,UC DAVIS MEDICAL CENTER,,,,,,2315 Stockton Blvd,,Sacramento,CA,95817,United States,,,,,,,,,,65961,THOMAS,,SEMRAD,,10121 PINE AVE,,TRUCKEE,CA,96161-4835,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,CA,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,8.95,5/25/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of MK 3475 in Combination With INCB024360 in Subjects With Selected Cancers",No,576959527,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,133317,EMORY,H,ROBINETTE,,271 East Valley Street,ABINGDON LLC,Abingdon,VA,24210,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Sleep Medicine,VA,,,,,,,,,,,,,,,,,,,,,,,,"Teva Pharmaceuticals USA, Inc.",1.00E+11,"Teva Pharmaceuticals USA, Inc.",PA,United States,Yes,Covered,Biological,Respiratory,Cinqair,59310-610-31,,,,,,,,,,,,,,,805.88,9/18/2018,Cash or cash equivalent,,,No,No,"An Open-Label Extension Study of Reslizumab 110-mg Fixed, Subcutaneous Dosing in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma",No,590424707,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50348,7281,UCI MEDICAL CENTER,,,,,,101 The City Dr S,,Orange,CA,92868,United States,,,,,,,,,,1289373,ANGELA,,FLEISCHMAN,,839 MEDICAL SCIENCES CT,DIV OF HEMATOLOGY/ONCOLOGY,IRVINE,CA,92697-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,CA,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,57.3,3/28/2018,Cash or cash equivalent,,,No,No,A phase 3 randomized open label multi center study of ruxolitinib vs best available therapy in patients with corticosteroid refractory chronic graft vs host disease after allogenic stem cell transplantation,No,576959655,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,329152,SCOTT,R,BARTLEY,,11520 N CENTRAL EXPY STE 126,,DALLAS,TX,75243-6652,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,TX,,,,,,,,,,,,,,,,,,,,,,,,ACADIA Pharmaceuticals Inc,1.00E+11,ACADIA Pharmaceuticals Inc,CA,United States,Yes,Covered,Drug,PARKINSONS DISEASE PSYCHOSIS,NUPLAZID,63090-170-60,,,,,,,,,,,,,,,312.5,5/24/2018,Cash or cash equivalent,,,No,No,ACP-103-038,No,605761335,2018,6/28/2019,NCT02970305,,
Covered Recipient Physician,,,,,218594,Robert,,Fridman,,3616 Henry Hudson PKWY,,Bronx,NY,10463,United States,,,Doctor of Podiatric Medicine,Podiatric Medicine & Surgery Service Providers|Podiatrist|Foot & Ankle Surgery,NY,,,,,,,,,,,,,,,,,,,,,,,,Miromatrix Medical Inc.,1.00E+11,Miromatrix Medical Inc.,MN,United States,Yes,Covered,Device,Wound Care,Miroderm,,,,,,,,,,,,,,,,10150,7/19/2018,Cash or cash equivalent,,,No,No,H2H DFU,No,533558603,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,270051,6303,KALISPELL REGIONAL MEDICAL CENTER,,,,,,1333 Surgical Services Way,,KALISPELL,MT,59901,United States,,,,,,,,,,329566,JOSE,C,DESOUZA,,430 WINDWARD WAY,STE 100,KALISPELL,MT,59901,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",MT,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Tresiba,0169-2660-15,,,,,,,,,,,,,,,59.52,5/16/2018,In-kind items and services,,,No,No,NN1250-4252,No,606199481,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,50696,7265,KECK HOSPITAL OF USC,,,,,,1500 SAN PABLO STREET,,LOS ANGELES,CA,90033,United States,,,,,,,,,,267597,ANTHONY,,EL-KHOUEIRY,,1441 EASTLAKE AVE,NOR 8302E,LOS ANGELES,CA,90089,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,CA,,,,Exelixis Inc.,1.00E+11,Exelixis Inc.,CA,United States,Yes,Covered,Drug,Oncology,Cabozantinib,42388-023-26,,,,,,,,,,,,,,,445.5,3/15/2018,Cash or cash equivalent,,,No,No,"A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib",No,562896971,2018,6/28/2019,,,
Covered Recipient Physician,,,,,4111117,GERALD,ANTHONY,CEPHAS,,1 ELIZABETH PL STE G-3,,DAYTON,OH,45417-3445,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Preventive Medicine|Public Health & General Preventive Medicine,OH,,,,,,,,,,,,,,,,,,,,,,,,ACADIA Pharmaceuticals Inc,1.00E+11,ACADIA Pharmaceuticals Inc,CA,United States,Yes,Covered,Drug,PARKINSONS DISEASE PSYCHOSIS,NUPLAZID,63090-170-60,,,,,,,,,,,,,,,523.2,3/27/2018,In-kind items and services,,,No,No,ACP-103-034,No,605761641,2018,6/28/2019,NCT02970292,,
Covered Recipient Teaching Hospital,,220116,6061,TUFTS MEDICAL CENTER,,,,,,800 WASHINGTON ST,,BOSTON,MA,2111,United States,,,,,,,,,,997506,STEVEN,,VLAD,,725 ALBANY ST,"SHAPIRO 7, SUITE B",BOSTON,MA,02118-2526,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,MA,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,No,,,,,,,,,,,,,,,,,,,,338,11/19/2018,Cash or cash equivalent,,,No,No,M15-572,No,566865817,2018,6/28/2019,NCT03104400,,
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 BROOKLINE AVE,,BOSTON,MA,2215,United States,,,,,,,,,,714053,OTTO,,METZGER,,450 BROOKLINE AVE,DEPT OF,BOSTON,MA,2215,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Covered,Drug,ONCOLOGY,IBRANCE,0069-0187-21,,,,,,,,,,,,,,,219261,10/15/2018,In-kind items and services,,,No,No,PALBOCICLIB AND ENDOCRINE THERAPY FOR LOBULAR BREAST CANCER PREOPERATIVE STUDYA RANDOMIZED PHASE II STUDY OF PALBOCICLIB WITH LETROZOLE VERSUS LETROZOLE ALONE FOR INVASIVE LOBULAR CARCINOMA AND INVASIVE DUCTAL CARCINOMA,No,599784883,2018,6/28/2019,,,Study Drug
Covered Recipient Physician,,,,,300554,MICHAEL,JAMES,DOWNING,,5445 LA SIERRA DR,SUITE 101,DALLAS,TX,75231-4139,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,TX,,,,,,,,,,,,,,,,,,,,,,,,ACADIA Pharmaceuticals Inc,1.00E+11,ACADIA Pharmaceuticals Inc,CA,United States,Yes,Covered,Drug,PARKINSONS DISEASE PSYCHOSIS,NUPLAZID,63090-170-60,,,,,,,,,,,,,,,5091.4,3/9/2018,Cash or cash equivalent,,,No,No,ACP-103-042,No,605761969,2018,6/28/2019,NCT03018340,,
Covered Recipient Teaching Hospital,,230053,6543,HENRY FORD HOSPITAL,,,,,,2799 W Grand Blvd,,Detroit,MI,48202,United States,,,,,,,,,,224454,AARON,L,ELLENBOGEN,,28595 ORCHARD LAKE RD,SUITE 200,FARMINGTON HILLS,MI,48334-2977,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,MI,,,,"Acorda Therapeutics, Inc",1.00E+11,"Acorda Therapeutics, Inc",NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1291.67,4/6/2018,Cash or cash equivalent,,,No,No,Twelve Month Safety and Efficacy Study of CVT-301 In Parkinsons Disease Patients With OFF Episodes,No,580619377,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,500129,7168,TACOMA GENERAL ALLENMORE HOSPITAL,,,,,,315 SOUTH MLK JR WAY,5299,TACOMA,WA,98415,United States,,,,,,,,,,395422,DIANE,E,LEVITAN,,MULTICARE,315 MARTIN LUTHER KING JR WAY,TACOMA,WA,98405,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,WA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1180.35,1/17/2018,Cash or cash equivalent,,,No,No,A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER,No,599785527,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,160058,6639,UNIVERSITY OF IOWA HOSP & CLINICS,,,,,,200 Hawkins Dr,,Iowa City,IA,52242,United States,,,,,,,,,,686250,LAITH,,ABUSHAHIN,,200 Hawkins Drive,C21 GH,Iowa City,IA,52242,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,IA,,,,Exelixis Inc.,1.00E+11,Exelixis Inc.,CA,United States,Yes,Covered,Drug,Oncology,Cabozantinib,42388-023-26,,,,,,,,,,,,,,,810,2/13/2018,Cash or cash equivalent,,,No,No,Cabozantinib-s-malate or Sunitinib Malate in Treating Patients with Previously Untreated Locally Advanced or Metastatic Kidney Cancer CABOSUN),No,562898243,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,460009,7144,U OF U HOSPITALS & CLINICS,,,,,,50 N Medical Dr,,SALT LAKE CITY,UT,84132,United States,,,,,,,,,,958023,HASSAN,M,YAISH,,100 N MARIO CAPECCHI DR,APT 402,SALT LAKE CITY,UT,84113,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,UT,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Hemophilia,Novoeight,0169-7825-01,,,,,,,,,,,,,,,823,9/27/2018,Cash or cash equivalent,,,No,No,NN7008-3553,No,606201713,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,100128,6860,TAMPA GENERAL HOSPITAL,,,,,,1 Tampa General Circle,,Tampa,FL,33606,United States,,,,,,,,,,224762,DAVID,ABRAHAM,WEIN,,2 COLUMBIA DR,,TAMPA,FL,33606-3508,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Emergency Medicine,FL,,,,Allergan Inc.,1.00E+11,Allergan Inc.,NJ,United States,Yes,Covered,Drug,ANTI-INFECTIVE,DALVANCE,57970-100-01,,,,,,,,,,,,,,,420,1/23/2018,Cash or cash equivalent,,,No,No,A PRAGMATIC TRIAL DESIGNED TO EVALUATE A NEW CRITICAL PATHWAY LEVERAGING DALBAVANCIN DALVANCE FOR TREATMENT OF PATIENTS WITH ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS ADVANCE TRIAL,No,576658997,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,146023,BRUCE,,BANK,,800 BIESTERFIELD RD,SUITE 210,ELK GROVE VILLAGE,IL,60007-3311,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,IL,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,38.32,11/28/2018,Cash or cash equivalent,,,No,No,"PROSPECTIVE, LONGITUDINAL, NON INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW RISK MYELOFIBROSIS (MF) OR HIGH RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET DIRECTED THERAPY",No,576961279,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,440039,6471,VANDERBILT UNIVERSITY MEDICAL CENTER,,,,,,1211 MEDICAL CENTER DRIVE,,NASHVILLE,TN,37232,United States,,,,,,,,,,85141,INGRID,A,MAYER,,1211 MEDICAL CENTER DR,,NASHVILLE,TN,37232,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,TN,,,,Novartis Pharmaceuticals Corporation,1.00E+11,NOVARTIS PHARMACEUTICALS CORPORATION,NJ,United States,Yes,Covered,Drug,ONCOLOGY,TYKERB,0173-0752-00,,,,,,,,,,,,,,,1000,7/3/2018,Cash or cash equivalent,,,No,No,PHASE 2 LAPATINIB IN COMBINATION WITH TRASTUZUMAB AS FIRST OR SECOND-L,No,588832463,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,330285,6190,STRONG MEMORIAL HOSPITAL,,,,,,601 ELMWOOD AVE,BOX 684,ROCHESTER,NY,14642,United States,,,,,,,,,,1218023,IRENE,H,RICHARD,,919 WESTFALL RD,,ROCHESTER,NY,14618,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,NY,,,,"Genentech, Inc.",1.00E+11,"Roche TCRC, Inc.",NY,United States,Yes,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,,,,,,1025,12/14/2018,Cash or cash equivalent,,,No,No,PHASE II STUDY IN EARLY STAGE PARKINSON S DISEASE PATIENTS,No,590722619,2018,6/28/2019,,,
Covered Recipient Physician,,,,,1239425,JAMES,DANIEL,CAMPBELL,,22 S GREENE ST,,BALTIMORE,MD,21201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Infectious Diseases,MD,,,,,,,,,,,,,,,,,,,,,,,,"GlaxoSmithKline, LLC.",1.00E+11,"GlaxoSmithKline, LLC.",NC,United States,No,,,,,,,,,,,,,,,,,,,,623.7,4/30/2018,In-kind items and services,,,Yes,No,,No,593101621,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,330285,6190,STRONG MEMORIAL HOSPITAL,,,,,,601 Elmwood Ave,Box 684,Rochester,NY,14642,United States,,,,,,,,,,207002,MARCUS,S,NOEL,,601 ELMWOOD AVE,601 ELMWOOD AVE,ROCHESTER,NY,14642-0001,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,NY,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,3929.13,6/7/2018,Cash or cash equivalent,,,No,No,A Phase III Study of Pembrolizumab MK-3475 vs. Best Supportive Care as Second-LineTherapy in Subjects with Previously Systemically Treated Advanced HepatocellularCarcinoma KEYNOTE-240,No,607130911,2018,6/28/2019,,,
Covered Recipient Physician,,,,,691345,MARCY,JO,GOISSE,,100 RIDGEVIEW DR,,SMITHFIELD,PA,15478,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Family Medicine,PA,,,,,,,,,,,,,,,,,,,,,,,,"GlaxoSmithKline, LLC.",1.00E+11,"GlaxoSmithKline, LLC.",NC,United States,No,,,,,,,,,,,,,,,,,,,,41.95,2/21/2018,In-kind items and services,,,No,No,"A 28-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROU",No,593101761,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,440039,6471,VANDERBILT UNIVERSITY MEDICAL CENTER,,,,,,1211 MEDICAL CENTER DRIVE,,NASHVILLE,TN,37232,United States,,,,,,,,,,1313291,MATTHEW,ROBERT,DANTER,,1215 21st Ave S,Ste 5025,Nashville,TN,37232,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery),TN,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Ventricular Assist Devices,HeartWare HVAD,,,,,,,,,,,,,,,,850,3/30/2018,Cash or cash equivalent,,,No,No,HW004 Endurance DT,No,572144159,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,10033,6942,UNIVERSITY OF ALABAMA HOSPITAL,,,,,,619 19th St S,,Birmingham,AL,35249,United States,,,,,,,,,,770013,ANDRES,,FORERO-TORRES,,619 19TH ST S,,BIRMINGHAM,AL,35249-1900,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,AL,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,95,1/1/2018,Cash or cash equivalent,,,No,No,An Open Label Study Assessing the Effect of INCB057643 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects,No,576961491,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,390049,6276,ST. LUKES HOSPITAL,,,,,,801 Ostrum St,,Bethlehem,PA,18015,United States,,,,,,,,,,254584,YACOUB,,FAROUN,,1600 RIVERSIDE CIR,1600 RIVERSIDE CIR,EASTON,PA,18045-5671,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,NJ,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,1710,8/28/2018,Cash or cash equivalent,,,No,No,A phase III study of Lenalidomide and low-dose Dexamethasone with or without Pembrolizumab MK3475 in newly diagnosed and treatment naive Multiple Myeloma KEYNOTE 185.,No,607131129,2018,6/28/2019,,,
Covered Recipient Physician,,,,,941407,ABEL,D,JARELL,,51 WEBB PL STE 240,,DOVER,NH,3820,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,NH,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,1.00E+11,Eli Lilly and Company,IN,United States,Yes,Covered,Drug,Immunology,TALTZ,0002-1445-11,,,,,,,,,,,,,,,5845.2,12/11/2018,Cash or cash equivalent,,,No,No,A 12 WEEK MULTICENTER RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED STUDY COMPARING THE EFFICACY AND SAFETY OF LY2439821 TO ETANERCEPT AND PLACEBO IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS WITH A LONG TERM EXTENSION PERIOD,No,585600583,2018,6/28/2019,NCT01646177,https://clinicaltrials.gov/ct2/show/NCT01646177,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details, please visit clinicaltrials.gov."
Covered Recipient Physician,,,,,21983,PETER,A,LIO,,363 W ERIE ST  350,,CHICAGO,IL,60654-6903,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,IL,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",1.00E+11,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,INFLAMMATION AND  IMMUNOLOGY,DUPIXENT DUPILUMAB INJECTION,0024-5914-01,,,,,,,,,,,,,,,306.84,12/10/2018,Cash or cash equivalent,,,No,No,DUPIXENT CLINICAL DEVELOPMENT PROGRAM,No,577363051,2018,6/28/2019,,,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."
Covered Recipient Teaching Hospital,,10033,6942,UNIVERSITY OF ALABAMA HOSPITAL,,,,,,619 19th St S,,Birmingham,AL,35249,United States,,,,,,,,,,66594,MANSOOR,,SALEH,,1100 JOHNSON FERRY RD NE,SUITE 600,SANDY SPRINGS,GA,30342-1709,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,AL,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,2141,1/2/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2, Open Label, Dose Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies",No,576961599,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,36040,MOSHE,,TALPAZ,,1500 EAST MEDICAL CENTER DR,B1 FLOOR CANCER CTR RECP B,ANN ARBOR,MI,48109-5914,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,19.86,3/28/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2, Open Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and INCB039110 in Subjects With Previously Treated B Cell Malignancies",No,576960327,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,50760,7198,KFH - ANTIOCH,,,,,,4501 SAND CREEK ROAD,,ANTIOCH,CA,94531,United States,,,,,,,,,,1081946,NICOLA,P,KLEIN,,KAISER PERMANENTE VACCINE STUDY CENTER,1 KAISER PLAZA 16TH FLOOR,OAKLAND,CA,94612,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics,CA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,15437.55,8/15/2018,Cash or cash equivalent,,,No,No,A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER,No,599787169,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,190036,6987,OCHSNER CLINIC FOUNDATION,,,,,,1516 Jefferson Hwy,,NEW ORLEANS,LA,70121,United States,,,,,,,,,,728667,LAWRENCE,,BLONDE,,1514 JEFFERSON HWY,FL 9,NEW ORLEANS,LA,70121,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",LA,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Victoza,0169-4060-12,,,,,,,,,,,,,,,883.67,11/6/2018,Cash or cash equivalent,,,No,No,NN2211-4315,No,606200389,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,363300,6385,CHILDRENS HOSPITAL MEDICAL CENTER,,,,,,3333 Burnet Ave,,Cincinnati,OH,45229,United States,,,,,,,,,,264034,WILLIAM,ROBERT,DEFOOR,JR.,3333 BURNET AVE,ML 5037,CINCINNATI,OH,45229-3039,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Urology|Pediatric Urology,KY,,,,Allergan Inc.,1.00E+11,Allergan Inc.,NJ,United States,Yes,Non-Covered,Biological,,BOTOX,0023-3919-50,,,,,,,,,,,,,,,100,8/21/2018,Cash or cash equivalent,,,No,No,A Long-Term Extension Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity,No,576657951,2018,6/28/2019,NCT01852058,,
Covered Recipient Physician,,,,,45407,ANIL,K,NAIR,,54 MILLER ST,4TH FLOOR,QUINCY,MA,02169-4725,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,MA,,,,,,,,,,,,,,,,,,,,,,,,ACADIA Pharmaceuticals Inc,1.00E+11,ACADIA Pharmaceuticals Inc,CA,United States,Yes,Covered,Drug,PARKINSONS DISEASE PSYCHOSIS,NUPLAZID,63090-170-60,,,,,,,,,,,,,,,8626.5,3/7/2018,Cash or cash equivalent,,,No,No,ACP-103-045,No,605763529,2018,6/28/2019,NCT03325556,,
Covered Recipient Teaching Hospital,,450018,7038,The University of Texas Medical Br.,,,,,,303 University Blvd,,Galveston,TX,77555,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HOLOGIC INC,1.00E+11,"Gen-Probe, Inc.",MA,United States,Yes,Covered,Device,Diagnostics,Aptima Candida,,,,,,,,,,,,,,,,12314,11/1/2018,Cash or cash equivalent,,,No,No,Performance Evaluation of the Candida vaginitis and Trichomonas vaginalis tests on the Panther system,No,530296303,2018,6/28/2019,,,Evaluate the performance of the Hologic tests Candida vaginitis and Trichomonas vaginalis tests on the Panther system
Covered Recipient Teaching Hospital,,420009,7096,OCONEE MEMORIAL HOSPITAL,,,,,,298 Memorial Dr,,SENECA,SC,29672,United States,,,,,,,,,,127574,SANDRA,LEE,WEBER,,877 W FARIS RD,STE D,GREENVILLE,SC,29605,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",SC,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,FIASP,0169-3201-11,,,,,,,,,,,,,,,23.06,6/5/2018,In-kind items and services,,,No,No,NN1218-4113,No,606200539,2018,6/28/2019,,,
Covered Recipient Physician,,,,,252897,VEENA,,CHARU,,1801 W ROMNEYA DR,STE 203,ANAHEIM,CA,92801-1830,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,CA,,,,,185358,JAYARAM,S.,BHARADWAJ,,1801 W ROMNEYA DR STE 203,,ANAHEIM,CA,92801-1824,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,CA,,,,Spectrum Pharmaceuticals Inc.,1.00E+11,Spectrum Pharmaceuticals Inc.,NV,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,6683.04,3/15/2018,Cash or cash equivalent,,,No,No,SPI-GCF-301,No,611794133,2018,6/28/2019,,,
Covered Recipient Physician,,,,,298219,EDWARD,M,KERWIN,,3860 CRATER LAKE AVE,,MEDFORD,OR,97504-9741,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Allergy & Immunology|Allergy,OR,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,SAR440340,,,,,,,,,,,,,,,,27.82,4/12/2018,In-kind items and services,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, 12-week Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety, and Tolerability of SAR440340 and the Coadministration of SAR440340",No,601930211,2018,6/28/2019,NCT03387852,,
Covered Recipient Physician,,,,,715381,DAVID,C,PURSELLE,,235 E PONCE DE LEON AVE STE 120,,DECATUR,GA,30030-3412,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,GA,,,,,,,,,,,,,,,,,,,,,,,,ACADIA Pharmaceuticals Inc,1.00E+11,ACADIA Pharmaceuticals Inc,CA,United States,Yes,Covered,Drug,PARKINSONS DISEASE PSYCHOSIS,NUPLAZID,63090-170-60,,,,,,,,,,,,,,,264,3/20/2018,In-kind items and services,,,No,No,ACP-103-038,No,605763828,2018,6/28/2019,NCT02970305,,
Covered Recipient Teaching Hospital,,70025,6073,HARTFORD HOSPITAL,,,,,,80 Seymour St,,Hartford,CT,6102,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Allergan Inc.,1.00E+11,Allergan Inc.,NJ,United States,Yes,Covered,Drug,ANTI-INFECTIVE,DALVANCE,57970-100-01,,,,,,,,,,,,,,,7001.8,6/19/2018,Cash or cash equivalent,,,No,No,A PRAGMATIC TRIAL DESIGNED TO EVALUATE A NEW CRITICAL PATHWAY LEVERAGING DALBAVANCIN DALVANCE FOR TREATMENT OF PATIENTS WITH ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS ADVANCE TRIAL,No,576658211,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,98566,DAVID,,SMITH,,1500 EAST MEDICAL CENTER DR,B1 FLOOR CANCER RECP D,ANN ARBOR,MI,48109-5913,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,8.95,5/25/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2, Open Label, Dose Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies",No,576960647,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,332140,STEVEN,M,MELTZER,,3816 WOODRUFF AVE,SUITE 209,LONG BEACH,CA,90808-2147,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Allergy & Immunology,CA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI US SERVICES INC.,NJ,United States,Yes,Non-Covered,Drug,,SAR440340,,,,,,,,,,,,,,,,27.82,4/12/2018,In-kind items and services,,,No,No,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, 12-week Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety, and Tolerability of SAR440340 and the Coadministration of SAR440340",No,601930539,2018,6/28/2019,NCT03387852,,
Covered Recipient Teaching Hospital,,193300,6986,CHILDRENS HOSPITAL,,,,,,200 HENRY CLAY AVENUE,,NEW ORLEANS,LA,70118,United States,,,,,,,,,,840270,ANN,C,HENDERSON TILTON,,CHILDREN'S HOSPITAL - NEUROLOGY,200 HENRY CLAY AVENUE,NEW ORLEANS,LA,70118,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,LA,,,,Ipsen Innovation,1.00E+11,Ipsen Innovation,,France,Yes,Covered,Drug,Neurology,Dysport,15054-0500-1,,,,,,,,,,,,,,,22371,1/26/2018,Cash or cash equivalent,,,No,No,"A Phase III, Multicentre, Double Blind, Prospective, Randomised, Controlled, Multiple Treatment Study Assessing Efficacy And Safety Of DYSPORT Used In The Treatment Of Upper Limb Spasticity In Children",No,545143957,2018,6/28/2019,NCT02106351,,
Covered Recipient Physician,,,,,1011346,JULIO,C,CHAVEZ,,12902 USF MAGNOLIA DR,,TAMPA,FL,33612-9416,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,FL,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",1.00E+11,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,813.37,12/1/2018,Cash or cash equivalent,,,No,No,REGN1979-Clinical Development Program,No,577361192,2018,6/28/2019,,,"The transfer of value captured herein was not a distribution of cash or goods.  Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication.  The value of this assistance was divided among the authors of the publication."
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,309500,BRYAN,,SCHNEIDER,,1500 E MEDICAL CENTER DR,B1 FLOOR CANCER RECP C,ANN ARBOR,MI,48109-5000,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,188.58,6/27/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies",No,576960755,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,460001,7251,UTAH VALLEY REGIONAL MED. CTR.,,,,,,1034 N 500 W,,PROVO,UT,84603,United States,,,,,,,,,,755053,BRIAN,KEITH,WHISENANT,,5169 S COTTONWOOD ST,STE 520,MURRAY,UT,84107,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,UT,WY,,,Abbott Laboratories,1.00E+11,Abbott Laboratories,IL,United States,Yes,Covered,Device,Vascular,Absorb,,,,,,,,,,,,,,,,875,4/11/2018,Cash or cash equivalent,,,No,No,A Clinical Evaluation of Absorb BVS the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions,No,617029123,2018,6/28/2019,,,
Covered Recipient Physician,,,,,349563,JOEL,M,GELFAND,,3400 SPRUCE STREET,2 RHODES PAVILION,PHILADELPHIA,PA,19104,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,PA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Drug,IMMUNOLOGY,DUPIXENT,0024-5914-01,,,,,,,,,,,,,,,100.8,9/17/2018,In-kind items and services,,,No,No,"Burden of illness in adults with atopic dermatitis: analysis of National Health and Wellness Survey data from France, Germany, Italy, Spain and the U.K.",No,601967983,2018,6/28/2019,,,
Covered Recipient Physician,,,,,19962,MARY,L,STEDMAN,,14506 UNIVERSITY POINT PL,,TAMPA,FL,33613,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Forensic Psychiatry,FL,,,,,,,,,,,,,,,,,,,,,,,,ACADIA Pharmaceuticals Inc,1.00E+11,ACADIA Pharmaceuticals Inc,CA,United States,Yes,Covered,Drug,PARKINSONS DISEASE PSYCHOSIS,NUPLAZID,63090-170-60,,,,,,,,,,,,,,,3297,6/1/2018,Cash or cash equivalent,,,No,No,ACP-103-034,No,605764407,2018,6/28/2019,NCT02970292,,
Covered Recipient Teaching Hospital,,193300,6986,CHILDRENS HOSPITAL,,,,,,200 HENRY CLAY AVENUE,,NEW ORLEANS,LA,70118,United States,,,,,,,,,,205382,EDWARD,R,DABROWSKI,,28595 ORCHARD LAKE RD,SUITE 200,FARMINGTON HILLS,MI,48334-2977,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics,MI,,,,Ipsen Innovation,1.00E+11,Ipsen Innovation,,France,Yes,Covered,Drug,Neurology,Dysport,15054-0500-1,,,,,,,,,,,,,,,1726,8/24/2018,Cash or cash equivalent,,,No,No,"A Phase III, Multicentre, Double Blind, Prospective, Randomised, Controlled, Multiple Treatment Study Assessing Efficacy And Safety Of DYSPORT Used In The Treatment Of Upper Limb Spasticity In Children",No,545144497,2018,6/28/2019,NCT02106351,,
Covered Recipient Physician,,,,,328399,DAVID,PAUL,FIVENSON,,3001 MILLER RD,,ANN ARBOR,MI,48103,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology|Clinical & Laboratory Dermatological Immunology,MI,,,,,,,,,,,,,,,,,,,,,,,,Amgen Inc.,1.00E+11,Amgen Inc.,CA,United States,Yes,Covered,Biological,Inflammation,Enbrel,58406-445-04,,,,,,,,,,,,,,,90,4/9/2018,In-kind items and services,,,No,No,P4 - Enbrel in Otezla IR (open label),No,572226483,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,309500,BRYAN,,SCHNEIDER,,1500 E MEDICAL CENTER DR,B1 FLOOR CANCER RECP C,ANN ARBOR,MI,48109-5000,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,1541.81,10/23/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies",No,576960857,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,200009,6029,MAINE MEDICAL CENTER,,,,,,335 Brighton Ave,Suite 200,PORTLAND,ME,4102,United States,,,,,,,,,,685928,THOMAS,J,RYAN,,96 CAMPUS DR,STE 1,SCARBOROUGH,ME,4074,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,ME,,,,Abbott Laboratories,1.00E+11,Abbott Laboratories,IL,United States,Yes,Covered,Device,Vascular,Absorb,,,,,,,,,,,,,,,,3842,6/14/2018,Cash or cash equivalent,,,No,No,A Clinical Evaluation of Absorb BVS the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions,No,617029397,2018,6/28/2019,,,
Covered Recipient Physician,,,,,115688,DANIEL,LEE,HAMILOS,,MGH ALLERGY ASSOCIATES CLINIC,55 FRUIT ST - COX 201,BOSTON,MA,02114-3117,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Allergy & Immunology,MA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Drug,IMMUNOLOGY,DUPIXENT,0024-5914-01,,,,,,,,,,,,,,,238.43,9/30/2018,In-kind items and services,,,No,No,"A Randomized, Double-Blind, Phase 2, Placebo Controlled, 2 Arm Study To Evaluate Dupilumab In Patients With Bilateral Nasal Polyposis And Chronic Symptoms Of Sinusitis",No,601969235,2018,6/28/2019,NCT01920893,,
Covered Recipient Physician,,,,,26640,KASHINATH,G,YADALAM,,1 LAKESHORE DR,SUITE 1695,LAKE CHARLES,LA,70629-0100,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,LA,,,,,,,,,,,,,,,,,,,,,,,,ACADIA Pharmaceuticals Inc,1.00E+11,ACADIA Pharmaceuticals Inc,CA,United States,Yes,Covered,Drug,PARKINSONS DISEASE PSYCHOSIS,NUPLAZID,63090-170-60,,,,,,,,,,,,,,,158.73,5/23/2018,Cash or cash equivalent,,,No,No,ACP-103-034,No,605764845,2018,6/28/2019,NCT02970292,,
Covered Recipient Physician,,,,,152719,MARK,,BERRY,,300 PASTEUR DR,,PALO ALTO,CA,94304,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery),CA,,,,,,,,,,,,,,,,,,,,,,,,"Becton, Dickinson and Company",1.00E+11,"Becton, Dickinson and Company",NJ,United States,Yes,Non-Covered,,Medical Systems,,,,,,,,,,,,,,,,,9699.22,4/19/2018,Cash or cash equivalent,,,No,No,A Clinical Evaluation of a novel catheter compared to a currently marketed catheter for managing Pleural Effusions.,No,605259797,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,360180,6422,CLEVELAND CLINIC HOSPITAL,,,,,,9500 EUCLID AVENUE,,CLEVELAND,OH,44195,United States,,,,,,,,,,359070,LEVESTER,,KIRKSEY,Jr,9500 Euclid Ave,Ste H32,Cleveland,OH,44195,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery,OH,,,,"Medtronic Vascular, Inc.",1.00E+11,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Drug-Coated Balloons,IN.PACT Admiral,,,,,,,,,,,,,,,,1795,2/7/2018,In-kind items and services,,,No,No,IN.PACT AV Access,No,572142971,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,190036,6987,OCHSNER CLINIC FOUNDATION,,,,,,1516 Jefferson Hwy,,New Orleans,LA,70121,United States,,,,,,,,,,345054,MARC,R,MATRANA,,1514 JEFFERSON HIGHWAY,1514 JEFFERSON HIGHWAY,NEW ORLEANS,LA,70121,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,LA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-01,,,,,,,,,,,,,,,1211.04,3/6/2018,In-kind items and services,,,No,No,"A Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab MK-3475 in Combination with Axitinib versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma mRCC KEYNOTE-426",No,607084399,2018,6/28/2019,,,Study drug provided to a clinical study site.
Covered Recipient Teaching Hospital,,390111,6278,HOSPITAL OF THE UNIV OF PENNA,,,,,,3701 Market St,,Phila,PA,19104,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACADIA Pharmaceuticals Inc,1.00E+11,ACADIA Pharmaceuticals Inc,CA,United States,Yes,Covered,Drug,PARKINSONS DISEASE PSYCHOSIS,NUPLAZID,63090-170-60,,,,,,,,,,,,,,,11773.35,3/9/2018,Cash or cash equivalent,,,No,No,ACP-103-042,No,605765121,2018,6/28/2019,NCT03018340,,
Covered Recipient Teaching Hospital,,50077,7274,SCRIPPS MERCY HOSPITAL,,,,,,4077 5th Ave,,SAN DIEGO,CA,92103,United States,,,,,,,,,,959048,ATHENA,,PHILIS-TSIMIKAS,,9888 GENESEE AVE,,LA JOLLA,CA,92037,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",CA,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Tresiba,0169-2660-15,,,,,,,,,,,,,,,216,10/16/2018,In-kind items and services,,,No,No,NN1250-4252,No,606201419,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,290001,7146,RENOWN REGIONAL MEDICAL CENTER,,,,,,1155 Mill Street,,Reno,NV,89502,United States,,,,,,,,,,226150,JORGE,I,LOPEZ,,1600 MEDICAL CENTER DR STE B500,,HUNTINGTON,WV,25701-3655,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology,AL,,,,Allergan Inc.,1.00E+11,Allergan Inc.,NJ,United States,Yes,Non-Covered,Biological,,BOTOX,0023-3919-50,,,,,,,,,,,,,,,2235,5/1/2018,Cash or cash equivalent,,,No,No,Efficacy and Safety Study of BOTOX Compared to Topiramate for the Prevention of Chronic Migraine in Adults,No,576658733,2018,6/28/2019,NCT02191579,,
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,98566,DAVID,,SMITH,,1500 EAST MEDICAL CENTER DR,B1 FLOOR CANCER RECP D,ANN ARBOR,MI,48109-5913,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,8.95,11/28/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2, Open Label, Dose Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies",No,576961067,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Physician,,,,,356580,GEORGE,E,DAILEY,,10666 N TORREY PINES RD,,LA JOLLA,CA,92037-1027,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",CA,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Drug,DIABETES,SOLIQUA,0024-5761-05,,,,,,,,,,,,,,,1607.72,6/30/2018,In-kind items and services,,,No,No,Lixi GetGoal insulin subs; Lixi GetGoal-O (elderly) insulin subset,No,601982845,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,503300,7157,SEATTLE CHILDRENS HOSPITAL,,,,,,1101 Madison St,Suite 550,Seattle,WA,98104,United States,,,,,,,,,,465654,DANIELLE,M,ZERR,,4800 SAND POINT WAY NE,4800 SAND POINT WAY NE,SEATTLE,WA,98105-3901,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Infectious Diseases,WA,,,,Merck Sharp & Dohme Corporation,1.00E+11,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,INFECTIOUS DISEASE,ZERBAXA,67919-030-01,,,,,,,,,,,,,,,91.21,4/25/2018,In-kind items and services,,,No,No,"A Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozone,Tazobactam MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Subjects with Complicated Intra-Abdominal Infections",No,607084545,2018,6/28/2019,,,Equipment or non-drug supplies provided to a clinical study site.
Covered Recipient Physician,,,,,426158,KRISHNANSU,,TEWARI,,101 THE CITY DR S,,ORANGE,CA,92868-3201,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,CA,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",1.00E+11,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,ONCOLOGY,LIBTAYO CEMIPLIMAB-RWLC INJECTION,61755-008-01,,,,,,,,,,,,,,,34.89,9/1/2018,Cash or cash equivalent,,,No,No,Libtayo Clinical Publication Program,No,577362113,2018,6/28/2019,,,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."
Covered Recipient Teaching Hospital,,230046,6587,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,98566,DAVID,,SMITH,,1500 EAST MEDICAL CENTER DR,B1 FLOOR CANCER RECP D,ANN ARBOR,MI,48109-5913,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MI,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,17.9,11/28/2018,Cash or cash equivalent,,,No,No,"A Phase 1/2, Open Label, Dose Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies",No,576961173,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,310073,6254,JERSEY SHORE UNIVERSITY MED CTR,,,,,,1945 ROUTE 33,,NEPTUNE,NJ,7753,United States,,,,,,,,,,20411,MARK,,MARTENS,,19 DAVIS AVE FL 7,,NEPTUNE,NJ,07753-4488,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology,NJ,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,Yes,Covered,Drug,Endocrinology,Orilissa,0074-0038-28,,,,,,,,,,,,,,,1604.2,10/15/2018,Cash or cash equivalent,,,No,No,M12-816,No,566869145,2018,6/28/2019,NCT02925494,,
Covered Recipient Teaching Hospital,,70006,6081,THE STAMFORD HOSPITAL,,,,,,30 Shelburne Rd,,Stamford,CT,6904,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HOLOGIC INC,1.00E+11,HOLOGIC INC,MA,United States,Yes,Covered,Device,Breast and Skeletal Health,Viera,,,,,,,,,,,,,,,,12393,7/2/2018,Cash or cash equivalent,,,No,No,18-02- Viera,No,530296287,2018,6/28/2019,,,A prospective image collection and reader study for clinical evaluation of commercially available handheld ultrasound unit
Covered Recipient Physician,,,,,1380598,ANDREW,RICHARD,WILLIAMS,,HUNTINGTON MEMORIAL HOSPITAL GRADUATE MEDICAL ED,100 W CALIFORNIA BLVD,PASADENA,CA,91105,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,CA,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,1.00E+11,Eli Lilly and Company,IN,United States,No,,,,,,,,,,,,,,,,,,,,2250,5/10/2018,Cash or cash equivalent,,,No,No,"A SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF LY3375880 IN HEALTHY SUBJECTS",No,585600861,2018,6/28/2019,NCT03343587,https://clinicaltrials.gov/ct2/show/NCT03343587,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"
Covered Recipient Physician,,,,,106350,PATRICK,M,MORIARTY,,3901 RAINBOW BLVD,MAIL STOP 3008,KANSAS CITY,KS,66160,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Clinical Pharmacology,KS,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",1.00E+11,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,CARDIOVASCULAR AND METABOLISM,PRALUENT ALIROCUMAB INJECTION,0024-5901-00,,,,,,,,,,,,,,,415.57,11/30/2018,Cash or cash equivalent,,,No,No,PRALUENT CLINICAL DEVELOPMENT PROGRAM,No,577363255,2018,6/28/2019,,,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."
Covered Recipient Teaching Hospital,,10033,6942,UNIVERSITY OF ALABAMA HOSPITAL,,,,,,619 19th St S,,Birmingham,AL,35249,United States,,,,,,,,,,770013,ANDRES,,FORERO-TORRES,,619 19TH ST S,,BIRMINGHAM,AL,35249-1900,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,AL,,,,Incyte Corporation,1.00E+11,Incyte Corporation,DE,United States,No,,,,,,,,,,,,,,,,,,,,10835,1/17/2018,Cash or cash equivalent,,,No,No,"A Phase 1, Open label, Dose Escalation, Safety and Tolerability Study of INCB040093 in Subjects With Previously Treated B Cell Malignancies",No,576961717,2018,6/28/2019,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
Covered Recipient Teaching Hospital,,220162,6044,DANA-FARBER CANCER INSTITUTE,,,,,,450 Brookline Ave,,Boston,MA,2215,United States,,,,,,,,,,348779,ANDREW,XIUXUAN,ZHU,,55 FRUIT ST,YAWKEY 7E,BOSTON,MA,02114-2696,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,MA,,,,"Agios Pharmaceuticals, Inc.",1.00E+11,"Agios Pharmaceuticals, Inc.",MA,United States,Yes,Covered,Drug,ONCOLOGY,TIBSOVO,71334-100-01,,,,,,,,,,,,,,,3268.2,11/8/2018,Cash or cash equivalent,,,No,No,Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations ClarIDHy,No,616779179,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,220110,6045,BRIGHAM AND WOMENS HOSPITAL,,,,,,75 FRANCIS STREET,3714,BOSTON,MA,2115,United States,,,,,,,,,,116914,VANITA,R,ARODA,,3033 BUNKER HILL ST,,SAN DIEGO,CA,92109-5705,United States,,,Medical Doctor,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",CA,,,,Sanofi and Genzyme US Companies,1.00E+11,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Drug,DIABETES,ADLYXIN,0024-5745-02,,,,,,,,,,,,,,,11240,9/25/2018,Cash or cash equivalent,,,No,No,"A 26-week Randomized, Open-label, Active-controlled, 2-treatment Arm, Parallel Group Multi-center Study, Comparing the Efficacy and Safety of Soliqua 100/33 Versus Lantus in Ethnically/Racially Divers",No,602020137,2018,6/28/2019,NCT03434119,,
Covered Recipient Physician,,,,,243395,HENRY,A,RODRIGUEZ GINORIO,,735 PONCE DE LEON AVE,TORRE DE AUXILIO MUTUO,SAN JUAN,PR,00917-5022,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecology,PR,,,,,,,,,,,,,,,,,,,,,,,,"AbbVie, Inc.",1.00E+11,"AbbVie, Inc.",IL,United States,Yes,Covered,Drug,Endocrinology,Orilissa,0074-0038-28,,,,,,,,,,,,,,,1203,11/8/2018,Cash or cash equivalent,,,No,No,M16-283,No,566870427,2018,6/28/2019,NCT03271489,,
Covered Recipient Physician,,,,,362051,ERIC,L,SIMPSON,,3181 SW SAM JACKSON PARK RD,,PORTLAND,OR,97239-3011,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Dermatology,OR,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",1.00E+11,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,INFLAMMATION AND  IMMUNOLOGY,DUPIXENT DUPILUMAB INJECTION,0024-5914-01,,,,,,,,,,,,,,,277.1,4/18/2018,Cash or cash equivalent,,,No,No,DUPIXENT CLINICAL DEVELOPMENT PROGRAM,No,577365077,2018,6/28/2019,,,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."
Covered Recipient Teaching Hospital,,54009,7300,RESNICK NEUROPSYCHIATRIC HOSPITAL AT,,,,,,150 UCLA MEDICAL PLAZA,,LOS ANGELES,CA,90095,United States,,,,,,,,,,1215053,ZACHARY,A,RUBIN,,924 WESTWOOD BLVD,,LOS ANGELES,CA,90095,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,CA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,1566.88,5/9/2018,Cash or cash equivalent,,,No,No,A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER,No,599798879,2018,6/28/2019,,,
Covered Recipient Physician,,,,,282103,JOSHUA,P,JUNE,,3394 E JOLLY RD STE C,,LANSING,MI,48910,United States,,,Doctor of Osteopathy,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,MI,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,1.00E+11,Eli Lilly and Company,IN,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,64.17,4/27/2018,In-kind items and services,,,No,No,A PHASE 3 MULTICENTER STUDY TO EVALUATE THE LONG TERM SAFETY AND EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS,No,585603239,2018,6/28/2019,NCT01885078,https://clinicaltrials.gov/ct2/show/NCT01885078,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details, please visit clinicaltrials.gov."
Covered Recipient Teaching Hospital,,340069,6804,WAKEMED RALEIGH CAMPUS,,,,,,3000 New Bern Ave,,RALEIGH,NC,27620,United States,,,,,,,,,,187302,MICHAEL,F,SOBOEIRO,,400 US 70 HWY E,,GARNER,NC,27529,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine,NC,,,,Novo Nordisk Inc,1.00E+11,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Victoza,0169-4060-12,,,,,,,,,,,,,,,412.5,6/28/2018,In-kind items and services,,,No,No,NN2211-4232,No,606203617,2018,6/28/2019,,,
Covered Recipient Physician,,,,,41068,KRISTI,JO,MCINTYRE,,8196 WALNUT HILL LN STE 100,,DALLAS,TX,75231,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,TX,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,1.00E+11,Eli Lilly and Company,IN,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,19899,2/13/2018,Cash or cash equivalent,,,No,No,"A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER",No,585603505,2018,6/28/2019,NCT03155997,https://clinicaltrials.gov/ct2/show/NCT03155997,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"
Covered Recipient Teaching Hospital,,54009,7300,RESNICK NEUROPSYCHIATRIC HOSPITAL AT,,,,,,150 UCLA MEDICAL PLAZA,,LOS ANGELES,CA,90095,United States,,,,,,,,,,1215053,ZACHARY,A,RUBIN,,924 WESTWOOD BLVD,,LOS ANGELES,CA,90095,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,CA,,,,Pfizer Inc.,1.00E+11,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,5600.77,4/25/2018,Cash or cash equivalent,,,No,No,A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER,No,599800063,2018,6/28/2019,,,
Covered Recipient Teaching Hospital,,330285,6190,STRONG MEMORIAL HOSPITAL,,,,,,601 Elmwood Ave,Box 684,ROCHESTER,NY,14623,United States,,,,,,,,,,83696,LEWAY,,CHEN,,601 ELMWOOD AVE,STE 679T,ROCHESTER,NY,14642,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,NY,,,,Abbott Laboratories,1.00E+11,Abbott Laboratories,IL,United States,Yes,Covered,Device,Cardiac Arrhythmias and Heart Failure,CRM-Research Only,,,,,,,,,,,,,,,,1000,3/19/2018,Cash or cash equivalent,,,No,No,CardioMEMS HF System Post Approval Study,No,617034353,2018,6/28/2019,,,
Covered Recipient Physician,,,,,158060,ARNOLD,L,SILVA,,3525 E LOUISE DR,,MERIDIAN,ID,83642,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,AZ,,,,,,,,,,,,,,,,,,,,,,,,"GlaxoSmithKline, LLC.",1.00E+11,"GlaxoSmithKline, LLC.",NC,United States,No,,,,,,,,,,,,,,,,,,,,31.45,4/11/2018,In-kind items and services,,,No,No,"A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P",No,593103261,2018,6/28/2019,,,
Covered Recipient Physician,,,,,863368,MARC,AARON,SHAY,,421 MERRIMACK ST STE 203,,METHUEN,MA,1844,United States,,,Medical Doctor,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry,MA,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,1.00E+11,Eli Lilly and Company,IN,United States,No,,,,,,,,,,,,,,,,,,,,19375,2/26/2018,Cash or cash equivalent,,,No,No,EFFECT OF LY3154207 ON COGNITION IN MILD TO MODERATE PARKINSONS DISEASE DEMENTIA PDD - THE PRESENCE STUDY,No,585603765,2018,6/28/2019,,,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"
